{
    "studies": [
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT01524276",
                    "orgStudyIdInfo": {
                        "id": "PSR"
                    },
                    "organization": {
                        "fullName": "Medtronic",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "Product Surveillance Registry",
                    "officialTitle": "Medtronic Product Surveillance Registry",
                    "acronym": "PSR"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2012-01"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2030-01",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2030-01",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2012-01-30",
                    "studyFirstSubmitQcDate": "2012-01-30",
                    "studyFirstPostDateStruct": {
                        "date": "2012-02-01",
                        "type": "ESTIMATED"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Medtronic",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false,
                    "isUsExport": false
                },
                "descriptionModule": {
                    "briefSummary": "The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach."
                },
                "conditionsModule": {
                    "conditions": [
                        "Cardiac Rhythm Disorders",
                        "Urological Disorders",
                        "Neurological Disorders",
                        "Cardiovascular Disorders",
                        "Digestive Disorders",
                        "Intracranial Aneurysm",
                        "Mechanical Circulatory Support",
                        "Respiratory Therapy",
                        "Aortic, Peripheral Vascular and Venous Disorders",
                        "Minimally Invasive Surgical Procedures",
                        "Diagnostic Techniques and Procedures",
                        "Surgical Procedures, Operative",
                        "Renal Insufficiency",
                        "Neurovascular",
                        "Coronary Artery Disease",
                        "Ear, Nose and Throat Disorder"
                    ]
                },
                "designModule": {
                    "studyType": "OBSERVATIONAL",
                    "designInfo": {
                        "observationalModel": "COHORT",
                        "timePerspective": "PROSPECTIVE"
                    },
                    "enrollmentInfo": {
                        "count": 100000,
                        "type": "ESTIMATED"
                    }
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Safety and Effectiveness of Market Released products",
                            "timeFrame": "Every 6-12 months (Therapy-dependent)"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements\n* Patient has or is intended to receive or be treated with an eligible Medtronic product\n* Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment\n\nExclusion Criteria:\n\n* Patient who is, or will be, inaccessible for follow-up\n* Patient with exclusion criteria required by local law\n* Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "stdAges": [
                        "CHILD",
                        "ADULT",
                        "OLDER_ADULT"
                    ],
                    "studyPopulation": "Subjects implanted with Medtronic qualifying therapy product.",
                    "samplingMethod": "NON_PROBABILITY_SAMPLE"
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Medtronic Product Surveillance Registry",
                            "role": "CONTACT",
                            "email": "rs.productsurveillanceregistry@medtronic.com"
                        }
                    ],
                    "locations": [
                        {
                            "status": "RECRUITING",
                            "city": "Birmingham",
                            "state": "Alabama",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.52066,
                                "lon": -86.80249
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Huntsville",
                            "state": "Alabama",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.7304,
                                "lon": -86.58594
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Anchorage",
                            "state": "Alaska",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 61.21806,
                                "lon": -149.90028
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Chandler",
                            "state": "Arizona",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.30616,
                                "lon": -111.84125
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Phoenix",
                            "state": "Arizona",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.44838,
                                "lon": -112.07404
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Jonesboro",
                            "state": "Arkansas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.8423,
                                "lon": -90.70428
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Little Rock",
                            "state": "Arkansas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.74648,
                                "lon": -92.28959
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Aliso Viejo",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.56504,
                                "lon": -117.72712
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Carlsbad",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.15809,
                                "lon": -117.35059
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Chula Vista",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.64005,
                                "lon": -117.0842
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Colton",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.0739,
                                "lon": -117.31365
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Los Angeles",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Napa",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.29714,
                                "lon": -122.28553
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Rancho Mirage",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.73974,
                                "lon": -116.41279
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Redwood City",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.48522,
                                "lon": -122.23635
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "San Diego",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.71533,
                                "lon": -117.15726
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Stanford",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.42411,
                                "lon": -122.16608
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Torrance",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.83585,
                                "lon": -118.34063
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Van Nuys",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.18667,
                                "lon": -118.44897
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Ventura",
                            "state": "California",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.27834,
                                "lon": -119.29317
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Aurora",
                            "state": "Colorado",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.72943,
                                "lon": -104.83192
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Colorado Springs",
                            "state": "Colorado",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.83388,
                                "lon": -104.82136
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Lakewood",
                            "state": "Colorado",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.70471,
                                "lon": -105.08137
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Darien",
                            "state": "Connecticut",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.07871,
                                "lon": -73.46929
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hartford",
                            "state": "Connecticut",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.76371,
                                "lon": -72.68509
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "New Haven",
                            "state": "Connecticut",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.30815,
                                "lon": -72.92816
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Washington",
                            "state": "District of Columbia",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.89511,
                                "lon": -77.03637
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bradenton",
                            "state": "Florida",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 27.49893,
                                "lon": -82.57482
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Clearwater",
                            "state": "Florida",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 27.96585,
                                "lon": -82.8001
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Davie",
                            "state": "Florida",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 26.06287,
                                "lon": -80.2331
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Jacksonville",
                            "state": "Florida",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.33218,
                                "lon": -81.65565
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Naples",
                            "state": "Florida",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 26.14234,
                                "lon": -81.79596
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Panama City",
                            "state": "Florida",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.15946,
                                "lon": -85.65983
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Safety Harbor",
                            "state": "Florida",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 27.99085,
                                "lon": -82.69316
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Sarasota",
                            "state": "Florida",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 27.33643,
                                "lon": -82.53065
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Weston",
                            "state": "Florida",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 26.10037,
                                "lon": -80.39977
                            }
                        },
                        {
                            "status": "ACTIVE_NOT_RECRUITING",
                            "city": "Gainesville",
                            "state": "Georgia",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.29788,
                                "lon": -83.82407
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Chicago",
                            "state": "Illinois",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.85003,
                                "lon": -87.65005
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Evansville",
                            "state": "Indiana",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.97476,
                                "lon": -87.55585
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Indianapolis",
                            "state": "Indiana",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.76838,
                                "lon": -86.15804
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Iowa City",
                            "state": "Iowa",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.66113,
                                "lon": -91.53017
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "West Des Moines",
                            "state": "Iowa",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.57721,
                                "lon": -93.71133
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kansas City",
                            "state": "Kansas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.11417,
                                "lon": -94.62746
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Edgewood",
                            "state": "Kentucky",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.01867,
                                "lon": -84.58189
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Louisville",
                            "state": "Kentucky",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.25424,
                                "lon": -85.75941
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "New Orleans",
                            "state": "Louisiana",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.95465,
                                "lon": -90.07507
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hyattsville",
                            "state": "Maryland",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.95594,
                                "lon": -76.94553
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Salisbury",
                            "state": "Maryland",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.36067,
                                "lon": -75.59937
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Silver Spring",
                            "state": "Maryland",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.99067,
                                "lon": -77.02609
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Boston",
                            "state": "Massachusetts",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.35843,
                                "lon": -71.05977
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Holyoke",
                            "state": "Massachusetts",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.20426,
                                "lon": -72.6162
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Ann Arbor",
                            "state": "Michigan",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.27756,
                                "lon": -83.74088
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bay City",
                            "state": "Michigan",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.59447,
                                "lon": -83.88886
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Lansing",
                            "state": "Michigan",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.73253,
                                "lon": -84.55553
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Rochester Hills",
                            "state": "Michigan",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.65837,
                                "lon": -83.14993
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Ypsilanti",
                            "state": "Michigan",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.24115,
                                "lon": -83.61299
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Coon Rapids",
                            "state": "Minnesota",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 45.11997,
                                "lon": -93.28773
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Minneapolis",
                            "state": "Minnesota",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.97997,
                                "lon": -93.26384
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Robbinsdale",
                            "state": "Minnesota",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 45.03219,
                                "lon": -93.33856
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Rochester",
                            "state": "Minnesota",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.02163,
                                "lon": -92.4699
                            }
                        },
                        {
                            "status": "ACTIVE_NOT_RECRUITING",
                            "city": "Saint Cloud",
                            "state": "Minnesota",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 45.5608,
                                "lon": -94.16249
                            }
                        },
                        {
                            "status": "ACTIVE_NOT_RECRUITING",
                            "city": "Jackson",
                            "state": "Mississippi",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.29876,
                                "lon": -90.18481
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Columbia",
                            "state": "Missouri",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.95171,
                                "lon": -92.33407
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kansas City",
                            "state": "Missouri",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.09973,
                                "lon": -94.57857
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "St. Louis",
                            "state": "Missouri",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.62727,
                                "lon": -90.19789
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Omaha",
                            "state": "Nebraska",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.25626,
                                "lon": -95.94043
                            }
                        },
                        {
                            "status": "ACTIVE_NOT_RECRUITING",
                            "city": "Lebanon",
                            "state": "New Hampshire",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.64229,
                                "lon": -72.25176
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Camden",
                            "state": "New Jersey",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.92595,
                                "lon": -75.11962
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Marlton",
                            "state": "New Jersey",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.89122,
                                "lon": -74.92183
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Morristown",
                            "state": "New Jersey",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.79677,
                                "lon": -74.48154
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Ocean Township",
                            "state": "New Jersey",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.248,
                                "lon": -74.0298
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Teaneck",
                            "state": "New Jersey",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.8976,
                                "lon": -74.01597
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Albuquerque",
                            "state": "New Mexico",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.08449,
                                "lon": -106.65114
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Albany",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.65258,
                                "lon": -73.75623
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bay Shore",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.7251,
                                "lon": -73.24539
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Huntington",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.86815,
                                "lon": -73.42568
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Manhasset",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.79788,
                                "lon": -73.69957
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Mount Kisco",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.20426,
                                "lon": -73.72708
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "New Hyde Park",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.7351,
                                "lon": -73.68791
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "New York",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.71427,
                                "lon": -74.00597
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Poughkeepsie",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.70037,
                                "lon": -73.92097
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Riverhead",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.91704,
                                "lon": -72.66204
                            }
                        },
                        {
                            "status": "ACTIVE_NOT_RECRUITING",
                            "city": "Roslyn",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.79982,
                                "lon": -73.65096
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Staten Island",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.56233,
                                "lon": -74.13986
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Stony Brook",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.92565,
                                "lon": -73.14094
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Utica",
                            "state": "New York",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.1009,
                                "lon": -75.23266
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Chapel Hill",
                            "state": "North Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.9132,
                                "lon": -79.05584
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Durham",
                            "state": "North Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.99403,
                                "lon": -78.89862
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Pinehurst",
                            "state": "North Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.19543,
                                "lon": -79.46948
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Raleigh",
                            "state": "North Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.7721,
                                "lon": -78.63861
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Winston Salem",
                            "state": "North Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.09986,
                                "lon": -80.24422
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Akron",
                            "state": "Ohio",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.08144,
                                "lon": -81.51901
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Cincinnati",
                            "state": "Ohio",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.12713,
                                "lon": -84.51435
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Cleveland",
                            "state": "Ohio",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.4995,
                                "lon": -81.69541
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Columbus",
                            "state": "Ohio",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.96118,
                                "lon": -82.99879
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Dayton",
                            "state": "Ohio",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.75895,
                                "lon": -84.19161
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Mount Orab",
                            "state": "Ohio",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.02757,
                                "lon": -83.91965
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Portland",
                            "state": "Oregon",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 45.52345,
                                "lon": -122.67621
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Allentown",
                            "state": "Pennsylvania",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.60843,
                                "lon": -75.49018
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bethlehem",
                            "state": "Pennsylvania",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.62593,
                                "lon": -75.37046
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Danville",
                            "state": "Pennsylvania",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.96342,
                                "lon": -76.61273
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Erie",
                            "state": "Pennsylvania",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.12922,
                                "lon": -80.08506
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Lancaster",
                            "state": "Pennsylvania",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.03788,
                                "lon": -76.30551
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Mechanicsburg",
                            "state": "Pennsylvania",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.21426,
                                "lon": -77.00859
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Pittsburgh",
                            "state": "Pennsylvania",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.44062,
                                "lon": -79.99589
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Wilkes-Barre",
                            "state": "Pennsylvania",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.24591,
                                "lon": -75.88131
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Charleston",
                            "state": "South Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.77657,
                                "lon": -79.93092
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Columbia",
                            "state": "South Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.00071,
                                "lon": -81.03481
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Orangeburg",
                            "state": "South Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.49182,
                                "lon": -80.85565
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Spartanburg",
                            "state": "South Carolina",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.94957,
                                "lon": -81.93205
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Sioux Falls",
                            "state": "South Dakota",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.54997,
                                "lon": -96.70033
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Germantown",
                            "state": "Tennessee",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.08676,
                                "lon": -89.81009
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Memphis",
                            "state": "Tennessee",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.14953,
                                "lon": -90.04898
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Nashville",
                            "state": "Tennessee",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.16589,
                                "lon": -86.78444
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Austin",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 30.26715,
                                "lon": -97.74306
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Dallas",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.78306,
                                "lon": -96.80667
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Ft. Worth",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.72541,
                                "lon": -97.32085
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Houston",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.76328,
                                "lon": -95.36327
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kyle",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.98911,
                                "lon": -97.87723
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Plano",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.01984,
                                "lon": -96.69889
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "San Antonio",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.42412,
                                "lon": -98.49363
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Tyler",
                            "state": "Texas",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.35126,
                                "lon": -95.30106
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Salt Lake City",
                            "state": "Utah",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.76078,
                                "lon": -111.89105
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Burlington",
                            "state": "Vermont",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.47588,
                                "lon": -73.21207
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Charlottesville",
                            "state": "Virginia",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.02931,
                                "lon": -78.47668
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Fairfax",
                            "state": "Virginia",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.84622,
                                "lon": -77.30637
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Fredericksburg",
                            "state": "Virginia",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.30318,
                                "lon": -77.46054
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bremerton",
                            "state": "Washington",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.56732,
                                "lon": -122.63264
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Seattle",
                            "state": "Washington",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.60621,
                                "lon": -122.33207
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Spokane",
                            "state": "Washington",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.65966,
                                "lon": -117.42908
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Morgantown",
                            "state": "West Virginia",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.62953,
                                "lon": -79.9559
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Madison",
                            "state": "Wisconsin",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.07305,
                                "lon": -89.40123
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Milwaukee",
                            "state": "Wisconsin",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.0389,
                                "lon": -87.90647
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Buenos Aires",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -34.61315,
                                "lon": -58.37723
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Westmead",
                            "state": "New South Wales",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -33.80383,
                                "lon": 150.98768
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Chermside",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -27.38472,
                                "lon": 153.03062
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Murdoch",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -32.06987,
                                "lon": 115.83757
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Southport",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -27.96724,
                                "lon": 153.39796
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Innsbruck",
                            "country": "Austria",
                            "geoPoint": {
                                "lat": 47.26266,
                                "lon": 11.39454
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Linz",
                            "country": "Austria",
                            "geoPoint": {
                                "lat": 48.30639,
                                "lon": 14.28611
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Aalst",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 50.93604,
                                "lon": 4.0355
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Brugge",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 51.20892,
                                "lon": 3.22424
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Brussel",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 50.85045,
                                "lon": 4.34878
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Edegem",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 51.15662,
                                "lon": 4.44504
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Gent",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 51.05,
                                "lon": 3.71667
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Leuven",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 50.87959,
                                "lon": 4.70093
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Liege",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 50.63373,
                                "lon": 5.56749
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Roeselare",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 50.94653,
                                "lon": 3.12269
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "S\u00e3o Paulo",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -23.5475,
                                "lon": -46.63611
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Calgary",
                            "state": "Alberta",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 51.05011,
                                "lon": -114.08529
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kingston",
                            "state": "Ontario",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 44.22976,
                                "lon": -76.48101
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Montreal",
                            "state": "Quebec",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Quebec City",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 46.81228,
                                "lon": -71.21454
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Quebec",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 46.81228,
                                "lon": -71.21454
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Toronto",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.70011,
                                "lon": -79.4163
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Chengdu",
                            "state": "Sichuan",
                            "country": "China",
                            "geoPoint": {
                                "lat": 30.66667,
                                "lon": 104.06667
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Beijing",
                            "country": "China",
                            "geoPoint": {
                                "lat": 39.9075,
                                "lon": 116.39723
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Dalian",
                            "country": "China",
                            "geoPoint": {
                                "lat": 38.91222,
                                "lon": 121.60222
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Guangzhou",
                            "country": "China",
                            "geoPoint": {
                                "lat": 23.11667,
                                "lon": 113.25
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hangzhou",
                            "country": "China",
                            "geoPoint": {
                                "lat": 30.29365,
                                "lon": 120.16142
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Harbin",
                            "country": "China",
                            "geoPoint": {
                                "lat": 45.75,
                                "lon": 126.65
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kunming",
                            "country": "China",
                            "geoPoint": {
                                "lat": 25.03889,
                                "lon": 102.71833
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Nanchang",
                            "country": "China",
                            "geoPoint": {
                                "lat": 28.68396,
                                "lon": 115.85306
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Shanghai",
                            "country": "China",
                            "geoPoint": {
                                "lat": 31.22222,
                                "lon": 121.45806
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Suzhou",
                            "country": "China",
                            "geoPoint": {
                                "lat": 31.30408,
                                "lon": 120.59538
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Taiyuan",
                            "country": "China",
                            "geoPoint": {
                                "lat": 37.86944,
                                "lon": 112.56028
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Tianjin",
                            "country": "China",
                            "geoPoint": {
                                "lat": 39.14222,
                                "lon": 117.17667
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Cartagena",
                            "country": "Colombia",
                            "geoPoint": {
                                "lat": 10.39972,
                                "lon": -75.51444
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Medellin",
                            "country": "Colombia",
                            "geoPoint": {
                                "lat": 6.25184,
                                "lon": -75.56359
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Pereira",
                            "country": "Colombia",
                            "geoPoint": {
                                "lat": 4.81333,
                                "lon": -75.69611
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Rionegro",
                            "country": "Colombia",
                            "geoPoint": {
                                "lat": 6.15515,
                                "lon": -75.37371
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Praha",
                            "country": "Czechia",
                            "geoPoint": {
                                "lat": 50.08804,
                                "lon": 14.42076
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hellerup",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.73204,
                                "lon": 12.57093
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hiller\u00f8d",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.92791,
                                "lon": 12.30081
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kobenhavn",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.67594,
                                "lon": 12.56553
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Odense",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.39594,
                                "lon": 10.38831
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Helsinki",
                            "country": "Finland",
                            "geoPoint": {
                                "lat": 60.16952,
                                "lon": 24.93545
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Tampere",
                            "country": "Finland",
                            "geoPoint": {
                                "lat": 61.49911,
                                "lon": 23.78712
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Avignon",
                            "country": "France",
                            "geoPoint": {
                                "lat": 43.94834,
                                "lon": 4.80892
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bordeaux",
                            "country": "France",
                            "geoPoint": {
                                "lat": 44.84044,
                                "lon": -0.5805
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Boulogne-Billancourt",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.83333,
                                "lon": 2.25
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Brest Cedex",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.3903,
                                "lon": -4.48628
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Caen",
                            "country": "France",
                            "geoPoint": {
                                "lat": 49.18585,
                                "lon": -0.35912
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Chambray",
                            "country": "France",
                            "geoPoint": {
                                "lat": 49.07588,
                                "lon": 1.3088
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Clermont Ferrand",
                            "country": "France",
                            "geoPoint": {
                                "lat": 45.77966,
                                "lon": 3.08628
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Cr\u00e9teil",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.78333,
                                "lon": 2.46667
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Dijon",
                            "country": "France",
                            "geoPoint": {
                                "lat": 47.31667,
                                "lon": 5.01667
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "La Rochelle",
                            "country": "France",
                            "geoPoint": {
                                "lat": 46.16667,
                                "lon": -1.15
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "La Tronche",
                            "country": "France",
                            "geoPoint": {
                                "lat": 45.20429,
                                "lon": 5.73645
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Lille Cedex",
                            "country": "France",
                            "geoPoint": {
                                "lat": 50.63297,
                                "lon": 3.05858
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Marseille Cedex 5",
                            "country": "France",
                            "geoPoint": {
                                "lat": 43.29551,
                                "lon": 5.38958
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Montpellier Cedex 5",
                            "country": "France",
                            "geoPoint": {
                                "lat": 43.61092,
                                "lon": 3.87723
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Nantes",
                            "country": "France",
                            "geoPoint": {
                                "lat": 47.21725,
                                "lon": -1.55336
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Neuilly-sur-Seine",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.8846,
                                "lon": 2.26965
                            }
                        },
                        {
                            "status": "ACTIVE_NOT_RECRUITING",
                            "city": "Ollioules",
                            "country": "France",
                            "geoPoint": {
                                "lat": 43.13517,
                                "lon": 5.848
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Paris",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.85341,
                                "lon": 2.3488
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Pringy",
                            "country": "France",
                            "geoPoint": {
                                "lat": 45.94622,
                                "lon": 6.12608
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Rennes",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.11198,
                                "lon": -1.67429
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Saint-Priest-en-Jarez",
                            "country": "France",
                            "geoPoint": {
                                "lat": 45.47501,
                                "lon": 4.37614
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Strasbourg",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.58392,
                                "lon": 7.74553
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Villeurbanne",
                            "country": "France",
                            "geoPoint": {
                                "lat": 45.76667,
                                "lon": 4.88333
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Aachen",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.77664,
                                "lon": 6.08342
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bad Oeynhausen",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.20699,
                                "lon": 8.80365
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bremen",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.07516,
                                "lon": 8.80777
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "D\u00fcsseldorf",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.22172,
                                "lon": 6.77616
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Essen",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.45657,
                                "lon": 7.01228
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Frankfurt am main",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.11552,
                                "lon": 8.68417
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Freiburg",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 47.9959,
                                "lon": 7.85222
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hagen",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.36081,
                                "lon": 7.47168
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hamburg",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.57532,
                                "lon": 10.01534
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hannover",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.37052,
                                "lon": 9.73322
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Jena",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.92878,
                                "lon": 11.5899
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Karlsruhe",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.00937,
                                "lon": 8.40444
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "K\u00f6ln",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.93333,
                                "lon": 6.95
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Leipzig",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.33962,
                                "lon": 12.37129
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "L\u00fcbeck",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.86893,
                                "lon": 10.68729
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Munster",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.96236,
                                "lon": 7.62571
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "M\u00fcnchen",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 48.13743,
                                "lon": 11.57549
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Ulm",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 48.39841,
                                "lon": 9.99155
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Wiesbaden",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.08258,
                                "lon": 8.24932
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Athens",
                            "country": "Greece",
                            "geoPoint": {
                                "lat": 37.97945,
                                "lon": 23.71622
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Maro\u00fasi",
                            "country": "Greece",
                            "geoPoint": {
                                "lat": 38.05,
                                "lon": 23.8
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Thessalon\u00edki",
                            "country": "Greece",
                            "geoPoint": {
                                "lat": 40.64361,
                                "lon": 22.93086
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hong Kong",
                            "country": "Hong Kong",
                            "geoPoint": {
                                "lat": 22.27832,
                                "lon": 114.17469
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Budapest",
                            "country": "Hungary",
                            "geoPoint": {
                                "lat": 47.49801,
                                "lon": 19.03991
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hyderabad",
                            "state": "Telangana",
                            "country": "India",
                            "geoPoint": {
                                "lat": 17.38405,
                                "lon": 78.45636
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Chennai",
                            "country": "India",
                            "geoPoint": {
                                "lat": 13.08784,
                                "lon": 80.27847
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "New Delhi",
                            "country": "India",
                            "geoPoint": {
                                "lat": 28.63576,
                                "lon": 77.22445
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Galway",
                            "country": "Ireland",
                            "geoPoint": {
                                "lat": 53.27194,
                                "lon": -9.04889
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Be'er Sheva",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 31.25181,
                                "lon": 34.7913
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Jerusalem",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 31.76904,
                                "lon": 35.21633
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Ramat Gan",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 32.08227,
                                "lon": 34.81065
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Acquaviva Delle Fonti",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 40.89704,
                                "lon": 16.8433
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Ancona",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 43.5942,
                                "lon": 13.50337
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bari",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.11148,
                                "lon": 16.8554
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bassano Del Grappa",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.76656,
                                "lon": 11.72739
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bologna",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 44.49381,
                                "lon": 11.33875
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Brescia",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.53558,
                                "lon": 10.21472
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Caserta",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.07262,
                                "lon": 14.33231
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Castrovillari",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 39.81632,
                                "lon": 16.20183
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Chieri",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.01054,
                                "lon": 7.82133
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Lecce",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 40.35481,
                                "lon": 18.17244
                            }
                        },
                        {
                            "status": "NOT_YET_RECRUITING",
                            "city": "Milano",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.46427,
                                "lon": 9.18951
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Monza",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.58005,
                                "lon": 9.27246
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Palermo",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 38.13205,
                                "lon": 13.33561
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Pavia",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.19205,
                                "lon": 9.15917
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Roma",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.89193,
                                "lon": 12.51133
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Rome",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.89193,
                                "lon": 12.51133
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Taranto",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 40.46435,
                                "lon": 17.24707
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Udine",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 46.0693,
                                "lon": 13.23715
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Vimercate",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 45.61545,
                                "lon": 9.36801
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Sakai",
                            "state": "Osaka",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.58333,
                                "lon": 135.46667
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Ageo",
                            "state": "Saitama",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.97145,
                                "lon": 139.61382
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hidaka",
                            "state": "Saitama",
                            "country": "Japan"
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Koshigaya",
                            "state": "Saitama",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.89035,
                                "lon": 139.78916
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Tokyo",
                            "state": "Tachikawa",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.6895,
                                "lon": 139.69171
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bunky\u014d-Ku",
                            "state": "Tokyo",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.37517,
                                "lon": 139.92991
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Minato-Ku",
                            "state": "Tokyo",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.2152,
                                "lon": 135.1501
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Yonago",
                            "state": "Tottori",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.43333,
                                "lon": 133.33333
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Chiba",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.6,
                                "lon": 140.11667
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Fukuoka",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 33.6,
                                "lon": 130.41667
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Gifu",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.42291,
                                "lon": 136.76039
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hirosaki",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 40.59306,
                                "lon": 140.4725
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hiroshima City",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.4,
                                "lon": 132.45
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hiroshima",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.4,
                                "lon": 132.45
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kagoshima",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 31.56667,
                                "lon": 130.55
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kamakura",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.30889,
                                "lon": 139.55028
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kawasaki",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.52056,
                                "lon": 139.71722
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kitakyushu",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 33.85181,
                                "lon": 130.85034
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kofu",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.66669,
                                "lon": 138.56668
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kumamoto",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 32.80589,
                                "lon": 130.69182
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kyoto",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.02107,
                                "lon": 135.75385
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Mitaka",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.68351,
                                "lon": 139.55963
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Nagoya",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.18147,
                                "lon": 136.90641
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Niigata",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 37.88637,
                                "lon": 139.00589
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Okayama",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.65,
                                "lon": 133.93333
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Sapporo",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 43.06667,
                                "lon": 141.35
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Shinagawa-Ku",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 33.63627,
                                "lon": 133.00572
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Shizuoka",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.98333,
                                "lon": 138.38333
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Suita",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.76143,
                                "lon": 135.51567
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Toyoake",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.038,
                                "lon": 136.99931
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Urasoe",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 26.25902,
                                "lon": 127.73012
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Yokohama",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.43333,
                                "lon": 139.65
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "\u014csaka-sayama",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.69374,
                                "lon": 135.50218
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Yangsan",
                            "state": "Gyeongsangnam-do",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 35.34199,
                                "lon": 129.03358
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Busan",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 35.10278,
                                "lon": 129.04028
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Changwon",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 35.22806,
                                "lon": 128.68111
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Cheongju-si",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 36.63722,
                                "lon": 127.48972
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Daegu",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 35.87028,
                                "lon": 128.59111
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Daejeon",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 36.32139,
                                "lon": 127.41972
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Gangneung",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.75556,
                                "lon": 128.89611
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Gwangju",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 35.15472,
                                "lon": 126.91556
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Gyeonggi-do",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.58944,
                                "lon": 126.76917
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Incheon",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.45646,
                                "lon": 126.70515
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Jeonju",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 35.82194,
                                "lon": 127.14889
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Seongnam-si",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.43861,
                                "lon": 127.13778
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Seoul",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Suwon-si",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.29111,
                                "lon": 127.00889
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kuwait",
                            "country": "Kuwait",
                            "geoPoint": {
                                "lat": 29.36972,
                                "lon": 47.97833
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Kuala Lumpur",
                            "country": "Malaysia",
                            "geoPoint": {
                                "lat": 3.1412,
                                "lon": 101.68653
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Ciudad de mexico",
                            "country": "Mexico",
                            "geoPoint": {
                                "lat": 19.42847,
                                "lon": -99.12766
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Eindhoven",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 51.44083,
                                "lon": 5.47778
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Enschede",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 52.21833,
                                "lon": 6.89583
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Groningen",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 53.21917,
                                "lon": 6.56667
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Heerlen",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 50.88365,
                                "lon": 5.98154
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Hengelo",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 52.26583,
                                "lon": 6.79306
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Leiden",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 52.15833,
                                "lon": 4.49306
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Maastricht",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 50.84833,
                                "lon": 5.68889
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Nieuwegein",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 52.02917,
                                "lon": 5.08056
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Rotterdam",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 51.9225,
                                "lon": 4.47917
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Christchurch",
                            "country": "New Zealand",
                            "geoPoint": {
                                "lat": -43.53333,
                                "lon": 172.63333
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bergen",
                            "country": "Norway",
                            "geoPoint": {
                                "lat": 60.39299,
                                "lon": 5.32415
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Oslo",
                            "country": "Norway",
                            "geoPoint": {
                                "lat": 59.91273,
                                "lon": 10.74609
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Trondheim",
                            "country": "Norway",
                            "geoPoint": {
                                "lat": 63.43049,
                                "lon": 10.39506
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Pozna\u0144",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 52.40692,
                                "lon": 16.92993
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Warszawa",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 52.22977,
                                "lon": 21.01178
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Zabrze",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 50.32492,
                                "lon": 18.78576
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Creixomil",
                            "country": "Portugal",
                            "geoPoint": {
                                "lat": 41.53949,
                                "lon": -8.68562
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Lisboa",
                            "country": "Portugal",
                            "geoPoint": {
                                "lat": 38.71667,
                                "lon": -9.13333
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Porto",
                            "country": "Portugal",
                            "geoPoint": {
                                "lat": 41.14961,
                                "lon": -8.61099
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Santar\u00e9m",
                            "country": "Portugal",
                            "geoPoint": {
                                "lat": 39.23333,
                                "lon": -8.68333
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Aibonito",
                            "country": "Puerto Rico",
                            "geoPoint": {
                                "lat": 18.13996,
                                "lon": -66.266
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Rio Piedras",
                            "country": "Puerto Rico",
                            "geoPoint": {
                                "lat": 18.39745,
                                "lon": -66.04989
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Jeddah",
                            "country": "Saudi Arabia",
                            "geoPoint": {
                                "lat": 21.54238,
                                "lon": 39.19797
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Belgrade",
                            "country": "Serbia",
                            "geoPoint": {
                                "lat": 44.80401,
                                "lon": 20.46513
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bratislava",
                            "country": "Slovakia",
                            "geoPoint": {
                                "lat": 48.14816,
                                "lon": 17.10674
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "A Coru\u00f1a",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 43.37135,
                                "lon": -8.396
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Barcelona",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.38879,
                                "lon": 2.15899
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "C\u00f3rdoba",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 37.89155,
                                "lon": -4.77275
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Girona",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.98311,
                                "lon": 2.82493
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Granada",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 37.18817,
                                "lon": -3.60667
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "L'Hospitalet De Llobregat",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.35967,
                                "lon": 2.10028
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Madrid",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 40.4165,
                                "lon": -3.70256
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "M\u00e1laga",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 36.72016,
                                "lon": -4.42034
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Palma De Mallorca",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 39.56939,
                                "lon": 2.65024
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Salamanca",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 40.96882,
                                "lon": -5.66388
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Santa Cruz De Tenerife",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 28.46824,
                                "lon": -16.25462
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Santiago De Compostela",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 42.88052,
                                "lon": -8.54569
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Toledo",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 39.8581,
                                "lon": -4.02263
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Valencia",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 39.46975,
                                "lon": -0.37739
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Valladolid",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.65518,
                                "lon": -4.72372
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "G\u00f6teborg",
                            "country": "Sweden",
                            "geoPoint": {
                                "lat": 57.70716,
                                "lon": 11.96679
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Lund",
                            "country": "Sweden",
                            "geoPoint": {
                                "lat": 55.70584,
                                "lon": 13.19321
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Sk\u00f6vde",
                            "country": "Sweden",
                            "geoPoint": {
                                "lat": 58.39118,
                                "lon": 13.84506
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Basel",
                            "country": "Switzerland",
                            "geoPoint": {
                                "lat": 47.55839,
                                "lon": 7.57327
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bern",
                            "country": "Switzerland",
                            "geoPoint": {
                                "lat": 46.94809,
                                "lon": 7.44744
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Fribourg",
                            "country": "Switzerland",
                            "geoPoint": {
                                "lat": 46.80237,
                                "lon": 7.15128
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Geneve",
                            "country": "Switzerland",
                            "geoPoint": {
                                "lat": 46.20222,
                                "lon": 6.14569
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Lausanne",
                            "country": "Switzerland",
                            "geoPoint": {
                                "lat": 46.516,
                                "lon": 6.63282
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Lugano",
                            "country": "Switzerland",
                            "geoPoint": {
                                "lat": 46.01008,
                                "lon": 8.96004
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Morges",
                            "country": "Switzerland",
                            "geoPoint": {
                                "lat": 46.51127,
                                "lon": 6.49854
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Z\u00fcrich",
                            "country": "Switzerland",
                            "geoPoint": {
                                "lat": 47.36667,
                                "lon": 8.54999
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Barnstaple",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.08022,
                                "lon": -4.05808
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Birmingham",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 52.48142,
                                "lon": -1.89983
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Blackpool",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 53.81667,
                                "lon": -3.05
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Bristol",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.45523,
                                "lon": -2.59665
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Leeds",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 53.79648,
                                "lon": -1.54785
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Leicester",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 52.6386,
                                "lon": -1.13169
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Liverpool",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 53.41058,
                                "lon": -2.97794
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "London",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.50853,
                                "lon": -0.12574
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Manchester",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 53.48095,
                                "lon": -2.23743
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Middlesbrough",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 54.57623,
                                "lon": -1.23483
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Newcastle Upon Tyne",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 54.97328,
                                "lon": -1.61396
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Northampton",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 52.25,
                                "lon": -0.88333
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Nottingham",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 52.9536,
                                "lon": -1.15047
                            }
                        },
                        {
                            "status": "RECRUITING",
                            "city": "Sheffield",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 53.38297,
                                "lon": -1.4659
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "35925831",
                            "type": "DERIVED",
                            "citation": "Qin D, Filippaios A, Murphy J, Berg M, Lampert R, Schloss EJ, Noone M, Mela T. Short- and Long-Term Risk of Lead Dislodgement Events: Real-World Experience From Product Surveillance Registry. Circ Arrhythm Electrophysiol. 2022 Aug;15(8):e011029. doi: 10.1161/CIRCEP.122.011029. Epub 2022 Aug 4."
                        },
                        {
                            "pmid": "32763431",
                            "type": "DERIVED",
                            "citation": "Garg A, Koneru JN, Fagan DH, Stromberg K, Padala SK, El-Chami MF, Roberts PR, Piccini JP, Cheng A, Ellenbogen KA. Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker. Heart Rhythm. 2020 Dec;17(12):2056-2063. doi: 10.1016/j.hrthm.2020.07.035. Epub 2020 Aug 4."
                        },
                        {
                            "pmid": "32009263",
                            "type": "DERIVED",
                            "citation": "Singh JP, Cha YM, Lunati M, Chung ES, Li S, Smeets P, O'Donnell D. Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: Effect on mortality and atrial fibrillation incidence. J Cardiovasc Electrophysiol. 2020 Apr;31(4):825-833. doi: 10.1111/jce.14376. Epub 2020 Feb 28."
                        },
                        {
                            "pmid": "31567325",
                            "type": "DERIVED",
                            "citation": "Stearns LM, Abd-Elsayed A, Perruchoud C, Spencer R, Hammond K, Stromberg K, Weaver T. Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry. Anesth Analg. 2020 Feb;130(2):289-297. doi: 10.1213/ANE.0000000000004425."
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18",
                    "removedCountries": [
                        "Chile",
                        "Iceland",
                        "Jordan",
                        "Kazakhstan",
                        "Russian Federation",
                        "Slovenia",
                        "South Africa",
                        "Turkey",
                        "United Arab Emirates"
                    ]
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D004066",
                            "term": "Digestive System Diseases"
                        },
                        {
                            "id": "D002532",
                            "term": "Intracranial Aneurysm"
                        },
                        {
                            "id": "D009422",
                            "term": "Nervous System Diseases"
                        },
                        {
                            "id": "D051437",
                            "term": "Renal Insufficiency"
                        },
                        {
                            "id": "D014570",
                            "term": "Urologic Diseases"
                        },
                        {
                            "id": "D003324",
                            "term": "Coronary Artery Disease"
                        },
                        {
                            "id": "D002318",
                            "term": "Cardiovascular Diseases"
                        },
                        {
                            "id": "D001145",
                            "term": "Arrhythmias, Cardiac"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D003327",
                            "term": "Coronary Disease"
                        },
                        {
                            "id": "D017202",
                            "term": "Myocardial Ischemia"
                        },
                        {
                            "id": "D006331",
                            "term": "Heart Diseases"
                        },
                        {
                            "id": "D001161",
                            "term": "Arteriosclerosis"
                        },
                        {
                            "id": "D001157",
                            "term": "Arterial Occlusive Diseases"
                        },
                        {
                            "id": "D014652",
                            "term": "Vascular Diseases"
                        },
                        {
                            "id": "D000783",
                            "term": "Aneurysm"
                        },
                        {
                            "id": "D007674",
                            "term": "Kidney Diseases"
                        },
                        {
                            "id": "D052776",
                            "term": "Female Urogenital Diseases"
                        },
                        {
                            "id": "D005261",
                            "term": "Female Urogenital Diseases and Pregnancy Complications"
                        },
                        {
                            "id": "D000091642",
                            "term": "Urogenital Diseases"
                        },
                        {
                            "id": "D052801",
                            "term": "Male Urogenital Diseases"
                        },
                        {
                            "id": "D020765",
                            "term": "Intracranial Arterial Diseases"
                        },
                        {
                            "id": "D002561",
                            "term": "Cerebrovascular Disorders"
                        },
                        {
                            "id": "D001927",
                            "term": "Brain Diseases"
                        },
                        {
                            "id": "D002493",
                            "term": "Central Nervous System Diseases"
                        },
                        {
                            "id": "D010335",
                            "term": "Pathologic Processes"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M26718",
                            "name": "Renal Insufficiency",
                            "asFound": "Renal Insufficiency",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M6546",
                            "name": "Coronary Artery Disease",
                            "asFound": "Coronary Artery Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M19506",
                            "name": "Myocardial Ischemia",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5781",
                            "name": "Intracranial Aneurysm",
                            "asFound": "Intracranial Aneurysm",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4113",
                            "name": "Aneurysm",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7255",
                            "name": "Digestive System Diseases",
                            "asFound": "Digestive Disorders",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M6549",
                            "name": "Coronary Disease",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17319",
                            "name": "Urologic Diseases",
                            "asFound": "Urological Disorders",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4453",
                            "name": "Arrhythmias, Cardiac",
                            "asFound": "Cardiac Rhythm Disorder",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M8883",
                            "name": "Gastrointestinal Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10543",
                            "name": "Ischemia",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9419",
                            "name": "Heart Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4469",
                            "name": "Arteriosclerosis",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4465",
                            "name": "Arterial Occlusive Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17400",
                            "name": "Vascular Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10698",
                            "name": "Kidney Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M2875",
                            "name": "Urogenital Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M27093",
                            "name": "Female Urogenital Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14127",
                            "name": "Pregnancy Complications",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8399",
                            "name": "Female Urogenital Diseases and Pregnancy Complications",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M27095",
                            "name": "Male Urogenital Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22521",
                            "name": "Intracranial Arterial Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5810",
                            "name": "Cerebrovascular Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5204",
                            "name": "Brain Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5742",
                            "name": "Central Nervous System Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BXS",
                            "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC14",
                            "name": "Heart and Blood Diseases"
                        },
                        {
                            "abbrev": "BC10",
                            "name": "Nervous System Diseases"
                        },
                        {
                            "abbrev": "BC06",
                            "name": "Digestive System Diseases"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT04964960",
                    "orgStudyIdInfo": {
                        "id": "MCC-21-NEURO-11"
                    },
                    "organization": {
                        "fullName": "University of Kentucky",
                        "class": "OTHER"
                    },
                    "briefTitle": "Pembro+Chemo in Brain Mets",
                    "officialTitle": "Phase II Investigation of Use of CNS Active Pembrolizumab and Chemotherapy for Asymptomatic Brain Metastasis From Non-small Cell Lung Cancer (NSCLC)"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "TERMINATED",
                    "whyStopped": "Slow Accrual",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2022-05-19",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2023-06-19",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2023-12-19",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2021-07-06",
                    "studyFirstSubmitQcDate": "2021-07-06",
                    "studyFirstPostDateStruct": {
                        "date": "2021-07-16",
                        "type": "ACTUAL"
                    },
                    "resultsFirstSubmitDate": "2024-06-19",
                    "resultsFirstSubmitQcDate": "2024-10-17",
                    "resultsFirstPostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR_INVESTIGATOR",
                        "investigatorFullName": "John L. Villano, MD, PhD",
                        "investigatorTitle": "Principal Investigator",
                        "investigatorAffiliation": "University of Kentucky"
                    },
                    "leadSponsor": {
                        "name": "John L. Villano, MD, PhD",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false,
                    "isUsExport": false
                },
                "descriptionModule": {
                    "briefSummary": "The goal of this study is to evaluate whether providing Pembrolizumab prolongs survival and preserves quality of life while minimizing side effects for patients with NSCLC with untreated asymptomatic brain metastasis."
                },
                "conditionsModule": {
                    "conditions": [
                        "Lung Cancer",
                        "Lung Cancer Metastatic",
                        "Brain Cancer",
                        "Cancer"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE2"
                    ],
                    "designInfo": {
                        "allocation": "NA",
                        "interventionModel": "SINGLE_GROUP",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 3,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Pembrolizumab with standard of care chemotherapy treatment",
                            "type": "EXPERIMENTAL",
                            "description": "Patients will receive 200mg or 400mg of Pembrolizumab (standard of care dosing at the discretion of treating physician) over thirty minutes on day 1 every three or six weeks with standard of care chemotherapy treatment (carboplatin, pemetrexed, paclitaxel, nab-paclitaxel).",
                            "interventionNames": [
                                "Drug: Pembrolizumab",
                                "Drug: Nab paclitaxel",
                                "Drug: Paclitaxel",
                                "Drug: Pemetrexed",
                                "Drug: Carboplatin"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Pembrolizumab",
                            "description": "Pembrolizumab is an immunotherapy that can help fight certain cancers.",
                            "armGroupLabels": [
                                "Pembrolizumab with standard of care chemotherapy treatment"
                            ],
                            "otherNames": [
                                "Keytruda"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Nab paclitaxel",
                            "description": "Nab-paclitaxel is a taxane derivative that is an albumin-bound paclitaxel nanoparticle formulation that promotes microtubule assembly.",
                            "armGroupLabels": [
                                "Pembrolizumab with standard of care chemotherapy treatment"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Paclitaxel",
                            "description": "Paclitaxel is a taxane derivative that promotes microtubule assembly by enhancing the action of tubulin dimers, stabilizing existing microtubules, and inhibiting their disassembly, interfering with the late G2 mitotic phase, and inhibiting cell replication.",
                            "armGroupLabels": [
                                "Pembrolizumab with standard of care chemotherapy treatment"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Pemetrexed",
                            "description": "Pemetrexed is an antifolate agent that disrupts folate-dependent metabolic processes essential for cell replication.",
                            "armGroupLabels": [
                                "Pembrolizumab with standard of care chemotherapy treatment"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Carboplatin",
                            "description": "Carboplatin is a platinum compound alkylating agent which covalently binds to DNA and interferes with the function of DNA by producing interstrand DNA cross-links.",
                            "armGroupLabels": [
                                "Pembrolizumab with standard of care chemotherapy treatment"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Disease Control Rate",
                            "description": "Intracranial benefit defined as stable disease, partial response, and complete response",
                            "timeFrame": "6 months (baseline to 6 months)"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Number of Participants With Overall Survival at 12-month Post-enrollment",
                            "description": "Overall survival at 12-month post-enrollment",
                            "timeFrame": "12 months"
                        },
                        {
                            "measure": "Change in Extracranial Disease Control",
                            "description": "Kaplan-Meier estimates will be calculated for progression-free survival along with estimates of median survival time and proportion of surviving at specific time points (6 and 12 months).",
                            "timeFrame": "12 months (6 months post-enrollment, 12 months post-enrollment)"
                        },
                        {
                            "measure": "Change in Patient-reported Cognitive Functioning - Functional Assessment of Cancer Therapy-Cognitive (FACT-Cog)",
                            "description": "The FACT-Cog questionnaire was developed to assess perceived cognitive function and impact on quality of life (QOL) in cancer patients. The level of perceived cognitive impairments is measured on a four-point Likert scale (4 = several times a day to 0 = never) FACT-Cog has been widely administered across clinical settings and validated across different cultures and languages. Subjects can complete it in 5 minutes. A higher score indicates a better quality of life/cognitive function.",
                            "timeFrame": "12 months (Baseline, 3 months post-enrollment, 6 months post-enrollment, 9 months post-enrollment, 12 months post enrollment)"
                        },
                        {
                            "measure": "Change in Quality of Life - Functional Assessment of Cancer Therapy-Brain (FACT-Br)",
                            "description": "The FACT-Br is a commonly used instrument measuring general quality of life (QOL) that reflects symptoms or problems associated with brain malignancies across 5 subscales. The level of well-being is measured on a four-point Likert scale (4 = very much to 0 = not at all). The measure yields information about total quality of life, as well as information about the dimensions of physical well-being, social/family well-being, emotional well-being, functional well-being, and disease-specific concerns. The score range is 0-200 where a higher score indicated a better quality of life. The FACT-Br is written at the 4th grade reading level, and subjects can complete it in 5-10 minutes.",
                            "timeFrame": "12 months (Baseline, 3 months post-enrollment, 6 months post-enrollment, 9 months post-enrollment, 12 months post enrollment)"
                        },
                        {
                            "measure": "Change in Quality of Life - FACIT Fatigue Scale (FACIT-F)",
                            "description": "FACIT-F is a short, 13-item, easy to administer tool that measures an individual's level of fatigue during their usual daily activities over the past week. The level of fatigue is measured on a four-point Likert scale (4 = not at all fatigued to 0 = very much fatigued) with a score range of 0-52. Subjects can complete the questionnaire in 2-3 minutes and the higher the score, the better the quality of life.",
                            "timeFrame": "12 months (Baseline, 3 months post-enrollment, 6 months post-enrollment, 9 months post-enrollment, 12 months post enrollment)"
                        },
                        {
                            "measure": "Change in Mild Cognitive Impairment (MoCA)",
                            "description": "Neurocognitive functioning will be evaluated utilizing the Montreal Cognitive Assessment (MoCA). MoCA assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. Participants will complete the MoCA (estimated time 10 minutes). The MoCA is scored to obtain an item total, scores can range from 0 to 30 and score of 26 or above is considered normal.",
                            "timeFrame": "12 months (Baseline, 3 months post-enrollment, 6 months post-enrollment, 9 months post-enrollment, 12 months post enrollment)"
                        },
                        {
                            "measure": "Change in Performance Status",
                            "description": "Participant performance status will be evaluated utilizing the Eastern Cooperative Oncology Group (ECGO) performance status instrument. Performance status is graded from 0-5 where lower scores indicate better performance/patient daily living abilities.",
                            "timeFrame": "12 months (Baseline, 3 months post-enrollment, 6 months post-enrollment, 9 months post-enrollment, 12 months post enrollment)"
                        }
                    ],
                    "otherOutcomes": [
                        {
                            "measure": "Immune Based Biomarker Activity",
                            "description": "PD-1 and several immune-based markers, such as cytotoxic T cells, will be measured and summarized descriptively. Correlations with PD-1 and between markers will be estimated using Pearson or Spearman's correlation coefficient. Exploratory association of these biological markers with DCR will be performed using two-group comparison tests. Adjustment for multiple testing due to several immune-based markers will be considered using Holm's p-value adjustment method.",
                            "timeFrame": "12 weeks (Baseline, 6 weeks after baseline, 6 weeks after prior collection)"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Non-small cell lunch cancer (NSLC) with untreated asymptomatic brain metastases\n* NSLC lacks oncogenic driver mutations\n* Absence of new onset neurological symptoms\n* Presence of fewer than ten intracranial lesions\n* Each lesion measures three centimeters or less\n* Life expectancy of greater than three months\n* Adequate organ and marrow function\n* Ability to understand and willingness to sign a written informed consent document\n\nExclusion Criteria:\n\n* Presence of oncogenic driver mutations\n* Measurable lesion located within 10mm of the optic chiasm or optic nerve, or within the brainstem\n* Known leptomeningeal involvement.\n* Midline shift\n* Serious non-healing wound, ulcer or bone fracture\n* Baseline inability to participate or complete neurocognitive testing\n* Major surgical procedure (including craniotomy and open brain biopsy) or significant traumatic injury within 14 days prior to registration\n* Receipt of a non-CNS minor surgical procedure (e.g. core biopsy or fine needle aspiration) within three days prior to registration\n* History of allergic reactions attributed to monoclonal antibodies (mAb), compounds of similar chemical or biologic composition to Pembrolizumab\n* Clinically significant cardiovascular disease\n* Patients with uncontrolled intercurrent illness\n* Patients with psychiatric illness/social situations that would limit compliance with study requirements",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "maximumAge": "85 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "John Villano, MD, PhD",
                            "affiliation": "University of Kentucky",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "University of Kentucky, Markey Cancer Center",
                            "city": "Lexington",
                            "state": "Kentucky",
                            "zip": "40536",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.98869,
                                "lon": -84.47772
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Pembrolizumab With Standard of Care Chemotherapy Treatment",
                            "description": "Patients will receive 200mg or 400mg of Pembrolizumab (standard of care dosing at the discretion of treating physician) over thirty minutes on day 1 every three or six weeks with standard of care chemotherapy treatment (carboplatin, pemetrexed, paclitaxel, nab-paclitaxel).\n\nPembrolizumab: Pembrolizumab is an immunotherapy that can help fight certain cancers.\n\nNab paclitaxel: Nab-paclitaxel is a taxane derivative that is an albumin-bound paclitaxel nanoparticle formulation that promotes microtubule assembly.\n\nPaclitaxel: Paclitaxel is a taxane derivative that promotes microtubule assembly by enhancing the action of tubulin dimers, stabilizing existing microtubules, and inhibiting their disassembly, interfering with the late G2 mitotic phase, and inhibiting cell replication.\n\nPemetrexed: Pemetrexed is an antifolate agent that disrupts folate-dependent metabolic processes essential for cell replication.\n\nCarboplatin: Carboplatin is a platinum compound alkylating agent which covalently binds to DNA and interferes with the function of DNA by producing interstrand DNA cross-links."
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "3"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "2"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "Withdrawal by Subject",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Pembrolizumab With Standard of Care Chemotherapy Treatment",
                            "description": "Patients will receive 200mg or 400mg of Pembrolizumab (standard of care dosing at the discretion of treating physician) over thirty minutes on day 1 every three or six weeks with standard of care chemotherapy treatment (carboplatin, pemetrexed, paclitaxel, nab-paclitaxel).\n\nPembrolizumab: Pembrolizumab is an immunotherapy that can help fight certain cancers.\n\nNab paclitaxel: Nab-paclitaxel is a taxane derivative that is an albumin-bound paclitaxel nanoparticle formulation that promotes microtubule assembly.\n\nPaclitaxel: Paclitaxel is a taxane derivative that promotes microtubule assembly by enhancing the action of tubulin dimers, stabilizing existing microtubules, and inhibiting their disassembly, interfering with the late G2 mitotic phase, and inhibiting cell replication.\n\nPemetrexed: Pemetrexed is an antifolate agent that disrupts folate-dependent metabolic processes essential for cell replication.\n\nCarboplatin: Carboplatin is a platinum compound alkylating agent which covalently binds to DNA and interferes with the function of DNA by producing interstrand DNA cross-links."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "3"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Categorical",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "<=18 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Between 18 and 65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": ">=65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "2"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "2"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "American Indian or Alaska Native",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Asian",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Native Hawaiian or Other Pacific Islander",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Black or African American",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "White",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "2"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "More than one race",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Region of Enrollment",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "participants",
                            "classes": [
                                {
                                    "title": "United States",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Disease Control Rate",
                            "description": "Intracranial benefit defined as stable disease, partial response, and complete response",
                            "populationDescription": "Number of participants enrolled at 6 month timepoint",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "6 months (baseline to 6 months)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Pembrolizumab With Standard of Care Chemotherapy Treatment",
                                    "description": "Patients will receive 200mg or 400mg of Pembrolizumab (standard of care dosing at the discretion of treating physician) over thirty minutes on day 1 every three or six weeks with standard of care chemotherapy treatment (carboplatin, pemetrexed, paclitaxel, nab-paclitaxel).\n\nPembrolizumab: Pembrolizumab is an immunotherapy that can help fight certain cancers.\n\nNab paclitaxel: Nab-paclitaxel is a taxane derivative that is an albumin-bound paclitaxel nanoparticle formulation that promotes microtubule assembly.\n\nPaclitaxel: Paclitaxel is a taxane derivative that promotes microtubule assembly by enhancing the action of tubulin dimers, stabilizing existing microtubules, and inhibiting their disassembly, interfering with the late G2 mitotic phase, and inhibiting cell replication.\n\nPemetrexed: Pemetrexed is an antifolate agent that disrupts folate-dependent metabolic processes essential for cell replication.\n\nCarboplatin: Carboplatin is a platinum compound alkylating agent which covalently binds to DNA and interferes with the function of DNA by producing interstrand DNA cross-links."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Stable Disease",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Partial Response",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Complete Response",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Number of Participants With Overall Survival at 12-month Post-enrollment",
                            "description": "Overall survival at 12-month post-enrollment",
                            "populationDescription": "participants enrolled at 12 month timepoint",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "12 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Pembrolizumab With Standard of Care Chemotherapy Treatment",
                                    "description": "Patients will receive 200mg or 400mg of Pembrolizumab (standard of care dosing at the discretion of treating physician) over thirty minutes on day 1 every three or six weeks with standard of care chemotherapy treatment (carboplatin, pemetrexed, paclitaxel, nab-paclitaxel).\n\nPembrolizumab: Pembrolizumab is an immunotherapy that can help fight certain cancers.\n\nNab paclitaxel: Nab-paclitaxel is a taxane derivative that is an albumin-bound paclitaxel nanoparticle formulation that promotes microtubule assembly.\n\nPaclitaxel: Paclitaxel is a taxane derivative that promotes microtubule assembly by enhancing the action of tubulin dimers, stabilizing existing microtubules, and inhibiting their disassembly, interfering with the late G2 mitotic phase, and inhibiting cell replication.\n\nPemetrexed: Pemetrexed is an antifolate agent that disrupts folate-dependent metabolic processes essential for cell replication.\n\nCarboplatin: Carboplatin is a platinum compound alkylating agent which covalently binds to DNA and interferes with the function of DNA by producing interstrand DNA cross-links."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in Extracranial Disease Control",
                            "description": "Kaplan-Meier estimates will be calculated for progression-free survival along with estimates of median survival time and proportion of surviving at specific time points (6 and 12 months).",
                            "reportingStatus": "NOT_POSTED",
                            "timeFrame": "12 months (6 months post-enrollment, 12 months post-enrollment)",
                            "denomUnitsSelected": "Participants"
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in Patient-reported Cognitive Functioning - Functional Assessment of Cancer Therapy-Cognitive (FACT-Cog)",
                            "description": "The FACT-Cog questionnaire was developed to assess perceived cognitive function and impact on quality of life (QOL) in cancer patients. The level of perceived cognitive impairments is measured on a four-point Likert scale (4 = several times a day to 0 = never) FACT-Cog has been widely administered across clinical settings and validated across different cultures and languages. Subjects can complete it in 5 minutes. A higher score indicates a better quality of life/cognitive function.",
                            "reportingStatus": "NOT_POSTED",
                            "timeFrame": "12 months (Baseline, 3 months post-enrollment, 6 months post-enrollment, 9 months post-enrollment, 12 months post enrollment)",
                            "denomUnitsSelected": "Participants"
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in Quality of Life - Functional Assessment of Cancer Therapy-Brain (FACT-Br)",
                            "description": "The FACT-Br is a commonly used instrument measuring general quality of life (QOL) that reflects symptoms or problems associated with brain malignancies across 5 subscales. The level of well-being is measured on a four-point Likert scale (4 = very much to 0 = not at all). The measure yields information about total quality of life, as well as information about the dimensions of physical well-being, social/family well-being, emotional well-being, functional well-being, and disease-specific concerns. The score range is 0-200 where a higher score indicated a better quality of life. The FACT-Br is written at the 4th grade reading level, and subjects can complete it in 5-10 minutes.",
                            "reportingStatus": "NOT_POSTED",
                            "timeFrame": "12 months (Baseline, 3 months post-enrollment, 6 months post-enrollment, 9 months post-enrollment, 12 months post enrollment)",
                            "denomUnitsSelected": "Participants"
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in Quality of Life - FACIT Fatigue Scale (FACIT-F)",
                            "description": "FACIT-F is a short, 13-item, easy to administer tool that measures an individual's level of fatigue during their usual daily activities over the past week. The level of fatigue is measured on a four-point Likert scale (4 = not at all fatigued to 0 = very much fatigued) with a score range of 0-52. Subjects can complete the questionnaire in 2-3 minutes and the higher the score, the better the quality of life.",
                            "reportingStatus": "NOT_POSTED",
                            "timeFrame": "12 months (Baseline, 3 months post-enrollment, 6 months post-enrollment, 9 months post-enrollment, 12 months post enrollment)",
                            "denomUnitsSelected": "Participants"
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in Mild Cognitive Impairment (MoCA)",
                            "description": "Neurocognitive functioning will be evaluated utilizing the Montreal Cognitive Assessment (MoCA). MoCA assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. Participants will complete the MoCA (estimated time 10 minutes). The MoCA is scored to obtain an item total, scores can range from 0 to 30 and score of 26 or above is considered normal.",
                            "reportingStatus": "NOT_POSTED",
                            "timeFrame": "12 months (Baseline, 3 months post-enrollment, 6 months post-enrollment, 9 months post-enrollment, 12 months post enrollment)",
                            "denomUnitsSelected": "Participants"
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in Performance Status",
                            "description": "Participant performance status will be evaluated utilizing the Eastern Cooperative Oncology Group (ECGO) performance status instrument. Performance status is graded from 0-5 where lower scores indicate better performance/patient daily living abilities.",
                            "reportingStatus": "NOT_POSTED",
                            "timeFrame": "12 months (Baseline, 3 months post-enrollment, 6 months post-enrollment, 9 months post-enrollment, 12 months post enrollment)",
                            "denomUnitsSelected": "Participants"
                        },
                        {
                            "type": "OTHER_PRE_SPECIFIED",
                            "title": "Immune Based Biomarker Activity",
                            "description": "PD-1 and several immune-based markers, such as cytotoxic T cells, will be measured and summarized descriptively. Correlations with PD-1 and between markers will be estimated using Pearson or Spearman's correlation coefficient. Exploratory association of these biological markers with DCR will be performed using two-group comparison tests. Adjustment for multiple testing due to several immune-based markers will be considered using Holm's p-value adjustment method.",
                            "reportingStatus": "NOT_POSTED",
                            "timeFrame": "12 weeks (Baseline, 6 weeks after baseline, 6 weeks after prior collection)",
                            "denomUnitsSelected": "Participants"
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "0",
                    "timeFrame": "12 months",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Pembrolizumab With Standard of Care Chemotherapy Treatment",
                            "description": "Patients will receive 200mg or 400mg of Pembrolizumab (standard of care dosing at the discretion of treating physician) over thirty minutes on day 1 every three or six weeks with standard of care chemotherapy treatment (carboplatin, pemetrexed, paclitaxel, nab-paclitaxel).\n\nPembrolizumab: Pembrolizumab is an immunotherapy that can help fight certain cancers.\n\nNab paclitaxel: Nab-paclitaxel is a taxane derivative that is an albumin-bound paclitaxel nanoparticle formulation that promotes microtubule assembly.\n\nPaclitaxel: Paclitaxel is a taxane derivative that promotes microtubule assembly by enhancing the action of tubulin dimers, stabilizing existing microtubules, and inhibiting their disassembly, interfering with the late G2 mitotic phase, and inhibiting cell replication.\n\nPemetrexed: Pemetrexed is an antifolate agent that disrupts folate-dependent metabolic processes essential for cell replication.\n\nCarboplatin: Carboplatin is a platinum compound alkylating agent which covalently binds to DNA and interferes with the function of DNA by producing interstrand DNA cross-links.",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 2,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 2,
                            "otherNumAffected": 2,
                            "otherNumAtRisk": 2
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "Atrial Fibrillation",
                            "organSystem": "Cardiac disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Cardiac disorders - Other",
                            "organSystem": "Cardiac disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Palpitations",
                            "organSystem": "Cardiac disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Nausea",
                            "organSystem": "Gastrointestinal disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Constipation",
                            "organSystem": "Gastrointestinal disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Fatigue",
                            "organSystem": "General disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Flu like symptoms",
                            "organSystem": "General disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Other",
                            "organSystem": "General disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Sinusitis",
                            "organSystem": "Infections and infestations",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Tooth infection",
                            "organSystem": "Infections and infestations",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Alanine aminotransferase increased",
                            "organSystem": "Investigations",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Alkaline phosphatase increased",
                            "organSystem": "Investigations",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Aspartate aminotransferase increased",
                            "organSystem": "Investigations",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Creatinine increased",
                            "organSystem": "Investigations",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Lymphocyte count decreased",
                            "organSystem": "Investigations",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Weight gain",
                            "organSystem": "Investigations",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Hypokalemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Pain in extremity",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Peripheral sensory neuropathy",
                            "organSystem": "Nervous system disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        },
                        {
                            "term": "Spasticity",
                            "organSystem": "Nervous system disorders",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 2
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": true
                    },
                    "pointOfContact": {
                        "title": "Dr. John Villano",
                        "organization": "University of Kentucky",
                        "email": "jlvillano@uky.edu",
                        "phone": "859-323-0405"
                    }
                }
            },
            "documentSection": {
                "largeDocumentModule": {
                    "largeDocs": [
                        {
                            "typeAbbrev": "Prot_SAP",
                            "hasProtocol": true,
                            "hasSap": true,
                            "hasIcf": false,
                            "label": "Study Protocol and Statistical Analysis Plan",
                            "date": "2022-02-08",
                            "uploadDate": "2024-06-18T16:34",
                            "filename": "Prot_SAP_000.pdf",
                            "size": 1372806
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18",
                    "submissionTracking": {
                        "firstMcpInfo": {
                            "postDateStruct": {
                                "date": "2024-07-18",
                                "type": "ACTUAL"
                            }
                        }
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D008175",
                            "term": "Lung Neoplasms"
                        },
                        {
                            "id": "D001932",
                            "term": "Brain Neoplasms"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D012142",
                            "term": "Respiratory Tract Neoplasms"
                        },
                        {
                            "id": "D013899",
                            "term": "Thoracic Neoplasms"
                        },
                        {
                            "id": "D009371",
                            "term": "Neoplasms by Site"
                        },
                        {
                            "id": "D009369",
                            "term": "Neoplasms"
                        },
                        {
                            "id": "D008171",
                            "term": "Lung Diseases"
                        },
                        {
                            "id": "D012140",
                            "term": "Respiratory Tract Diseases"
                        },
                        {
                            "id": "D016543",
                            "term": "Central Nervous System Neoplasms"
                        },
                        {
                            "id": "D009423",
                            "term": "Nervous System Neoplasms"
                        },
                        {
                            "id": "D001927",
                            "term": "Brain Diseases"
                        },
                        {
                            "id": "D002493",
                            "term": "Central Nervous System Diseases"
                        },
                        {
                            "id": "D009422",
                            "term": "Nervous System Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M12307",
                            "name": "Neoplasm Metastasis",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11172",
                            "name": "Lung Neoplasms",
                            "asFound": "Lung Cancer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M5546",
                            "name": "Carcinoma, Non-Small-Cell Lung",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5209",
                            "name": "Brain Neoplasms",
                            "asFound": "Brain Cancer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M14979",
                            "name": "Respiratory Tract Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M16658",
                            "name": "Thoracic Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11168",
                            "name": "Lung Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14977",
                            "name": "Respiratory Tract Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12367",
                            "name": "Nervous System Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M18937",
                            "name": "Central Nervous System Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5204",
                            "name": "Brain Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M5742",
                            "name": "Central Nervous System Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC04",
                            "name": "Neoplasms"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC08",
                            "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "abbrev": "BC10",
                            "name": "Nervous System Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D017239",
                            "term": "Paclitaxel"
                        },
                        {
                            "id": "D000068196",
                            "term": "Albumin-Bound Paclitaxel"
                        },
                        {
                            "id": "D016190",
                            "term": "Carboplatin"
                        },
                        {
                            "id": "C582435",
                            "term": "Pembrolizumab"
                        },
                        {
                            "id": "D000068437",
                            "term": "Pemetrexed"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000972",
                            "term": "Antineoplastic Agents, Phytogenic"
                        },
                        {
                            "id": "D000970",
                            "term": "Antineoplastic Agents"
                        },
                        {
                            "id": "D050257",
                            "term": "Tubulin Modulators"
                        },
                        {
                            "id": "D050256",
                            "term": "Antimitotic Agents"
                        },
                        {
                            "id": "D050258",
                            "term": "Mitosis Modulators"
                        },
                        {
                            "id": "D045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D000074322",
                            "term": "Antineoplastic Agents, Immunological"
                        },
                        {
                            "id": "D000082082",
                            "term": "Immune Checkpoint Inhibitors"
                        },
                        {
                            "id": "D004791",
                            "term": "Enzyme Inhibitors"
                        },
                        {
                            "id": "D005493",
                            "term": "Folic Acid Antagonists"
                        },
                        {
                            "id": "D019384",
                            "term": "Nucleic Acid Synthesis Inhibitors"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M349416",
                            "name": "Pembrolizumab",
                            "asFound": "Once daily",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M19537",
                            "name": "Paclitaxel",
                            "asFound": "Time",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M231",
                            "name": "Albumin-Bound Paclitaxel",
                            "asFound": "Time",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M18650",
                            "name": "Carboplatin",
                            "asFound": "Followed",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M264",
                            "name": "Pemetrexed",
                            "asFound": "Approximately",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M2853",
                            "name": "Immunomodulating Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8618",
                            "name": "Folic Acid",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17546",
                            "name": "Vitamin B Complex",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M147959",
                            "name": "Taxane",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3820",
                            "name": "Alkylating Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8619",
                            "name": "Folic Acid Antagonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M26197",
                            "name": "Tubulin Modulators",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M26196",
                            "name": "Antimitotic Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M1346",
                            "name": "Antineoplastic Agents, Immunological",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M2342",
                            "name": "Immune Checkpoint Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7951",
                            "name": "Enzyme Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T447",
                            "name": "Folinic Acid",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T446",
                            "name": "Folic Acid",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T448",
                            "name": "Folate",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T475",
                            "name": "Vitamin B9",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "ANeo",
                            "name": "Antineoplastic Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Micro",
                            "name": "Micronutrients"
                        },
                        {
                            "abbrev": "Hemat",
                            "name": "Hematinics"
                        },
                        {
                            "abbrev": "Vi",
                            "name": "Vitamins"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT06649682",
                    "orgStudyIdInfo": {
                        "id": "K6754"
                    },
                    "organization": {
                        "fullName": "Peking Union Medical College Hospital",
                        "class": "OTHER"
                    },
                    "briefTitle": "68Ga-NYM096/177Lu-NYM096 in Metastatic CcRCC",
                    "officialTitle": "Safety, Tolerability, Imaging Characteristics, and Efficacy of 68Ga-NYM096/177Lu-NYM096 in the Treatment of Patients with Metastatic Clear Cell Renal Cell Carcinoma",
                    "acronym": "NYCRRLT"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2024-11",
                        "type": "ESTIMATED"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2026-10",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2027-10",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2024-10-15",
                    "studyFirstSubmitQcDate": "2024-10-18",
                    "studyFirstPostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Peking Union Medical College Hospital",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false,
                    "isUsExport": false
                },
                "descriptionModule": {
                    "briefSummary": "This is a single-center, phase I study. Patients with metastatic clear cell renal cell carcinoma will be recruited in this study to (Phase A) evaluate using 68Ga-NYM096 PET/CT and to (Phase B) treat with 177Lu-NYM096.\n\nThe study will be conducted in two phases. The purpose is Phase A: to evaluate the safety, tolerability, and imaging characteristics of 68Ga-NYM096 Phase B: to evaluate the safety, tolerability, and recommended phase 2 dose of 177Lu-NYM096"
                },
                "conditionsModule": {
                    "conditions": [
                        "Clear Cell Renal Cell Carcinoma"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE1"
                    ],
                    "designInfo": {
                        "allocation": "NA",
                        "interventionModel": "SINGLE_GROUP",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 20,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Imaging and therapy",
                            "type": "EXPERIMENTAL",
                            "description": "68Ga-NYM096 PET/CT and 177Lu-NYM096",
                            "interventionNames": [
                                "Drug: 68Ga-NYM096 PET/CT and 177Lu-NYM096"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "68Ga-NYM096 PET/CT and 177Lu-NYM096",
                            "description": "Patients recruited in this study will undergo 68Ga-NYM096 PET/CT to evaluate the expression of carbonic anhydrase 9. Those with high CA9 expression will undergo 177Lu-NYM096 treatment, starting from 50mCi and increasing to 100mCi, 150mCi, 200mCi at most using a 3+3 design.",
                            "armGroupLabels": [
                                "Imaging and therapy"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "(Phase A) The number to patients with treatment-emergent adverse event (TEAE) and serious adverse event (SAE)",
                            "timeFrame": "From the start of 68Ga-NYM096 PET/CT to 1 week after the 68Ga-NYM096 PET/CT"
                        },
                        {
                            "measure": "(Phase B) The number of patients with dose-limiting toxicity (DLT) after the first treatment of 177Lu-NYM096",
                            "description": "177Lu-NYM096 will be delivered to participants up to 4 cycles with the same dosing amount. Each cycle will start 8 +/- 1 weeks after the previous cycle. The dose administrated to the participants will start at 50mCi and increase to 100, 150, and 200mCi at most in differnt dosing groups. While the AEs will be monitered for 8 months (2 months after the 4th dose), the decision whether the dose can increase to the next higher group will be decided only upon the DLT between the 1st and 2nd cycle.",
                            "timeFrame": "From the start of 1st cycle of 177Lu-NYM096 treatment (each cycle is 8 weeks) to 8 weeks later."
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "(Phase A) Dosimetry of 68Ga-NYM096",
                            "timeFrame": "1 month after the 68Ga-NYM096 PET/CT"
                        },
                        {
                            "measure": "(Phase A) Number of lesions detected by 68Ga-NYM096 PET/CT",
                            "timeFrame": "1 week after the 68Ga-NYM096 PET/CT"
                        },
                        {
                            "measure": "(Phase A) Tumor uptake of 68Ga-NYM096",
                            "timeFrame": "1 week after the 68Ga-NYM096 PET/CT"
                        },
                        {
                            "measure": "(Phase A) Optimal imaging window of 68Ga-NYM096 PET/CT",
                            "timeFrame": "1 week after the 68Ga-NYM096 PET/CT"
                        },
                        {
                            "measure": "(Phase B) The number of patients with treatment-emergent adverse event (TEAE) and serious adverse event (SAE) after 177Lu-NYM096",
                            "description": "177Lu-NYM096 will be delivered to participants up to 4 cycles with the same dosing amount. Each cycle will start 8 +/- 1 weeks after the previous cycle. The administration of 177Lu-NYM096 costs about half an hour.",
                            "timeFrame": "From the start of 1st cycle of 177Lu-NYM096 administration (each cycle is 8 weeks) to 8 months later (8 weeks after the 4th cycle of treatment)."
                        },
                        {
                            "measure": "(Phase B) Dosimetry of 177Lu-NYM096",
                            "timeFrame": "1 month after 177Lu-NYM096 treatment"
                        },
                        {
                            "measure": "(Phase B) Radioactive concentration of 177Lu-NYM096 in the blood at different time point after 177Lu-NYM096 administration",
                            "description": "177Lu-NYM096 will be delivered to participants up to 4 cycles with the same dosing amount. Each cycle will start 8 +/- 1 weeks after the previous cycle. The administration of 177Lu-NYM096 costs about half an hour.",
                            "timeFrame": "From the start of 1st cycle of 177Lu-NYM096 administration (each cycle is 8 weeks) to 168 hours later."
                        },
                        {
                            "measure": "(Phase B) Tumor uptake of 177Lu-NYM096 on post-therapy scan",
                            "timeFrame": "1 week after 177Lu-NYM096 administration"
                        },
                        {
                            "measure": "(Phase B) ORR (overall response rate) of 177Lu-NYM096 treatment",
                            "description": "177Lu-NYM096 will be delivered to participants up to 4 cycles with the same dosing amount. Each cycle will start 8 +/- 1 weeks after the previous cycle. The tumor reponse will be evaluated before each cycle during the treatment (roughly every 2 months) and every 3 months after the end of the 4th cycle until 2 years after treatment start or tumor progression.",
                            "timeFrame": "From the start of 1st cycle of 177Lu-NYM096 treatment (each cycle is 8 weeks) to 2 years later."
                        },
                        {
                            "measure": "(Phase B) DCR (disease control rate) of 177Lu-NYM096 treatment",
                            "description": "177Lu-NYM096 will be delivered to participants up to 4 cycles with the same dosing amount. Each cycle will start 8 +/- 1 weeks after the previous cycle. The tumor reponse will be evaluated before each cycle during the treatment (roughly every 2 months) and every 3 months after the end of the 4th cycle until 2 years after treatment start or tumor progression.",
                            "timeFrame": "From the start of 1st cycle of 177Lu-NYM096 treatment (each cycle is 8 weeks) to 2 years later."
                        },
                        {
                            "measure": "(Phase B) PFS (progression free survival) of 177Lu-NYM096 treatment",
                            "description": "177Lu-NYM096 will be delivered to participants up to 4 cycles with the same dosing amount. Each cycle will start 8 +/- 1 weeks after the previous cycle. The tumor reponse will be evaluated before each cycle during the treatment (roughly every 2 months) and every 3 months after the end of the 4th cycle until 2 years after treatment start or tumor progression.",
                            "timeFrame": "From the start of 1st cycle of 177Lu-NYM096 treatment (each cycle is 8 weeks) to 2 years later."
                        },
                        {
                            "measure": "(Phase B) DOR (duration of response) of 177Lu-NYM096 treatment",
                            "description": "177Lu-NYM096 will be delivered to participants up to 4 cycles with the same dosing amount. Each cycle will start 8 +/- 1 weeks after the previous cycle. The tumor reponse will be evaluated before each cycle during the treatment (roughly every 2 months) and every 3 months after the end of the 4th cycle until 2 years after treatment start or tumor progression.",
                            "timeFrame": "From the start of 1st cycle of 177Lu-NYM096 treatment (each cycle is 8 weeks) to 2 years later."
                        },
                        {
                            "measure": "(Phase B) OS (overall survival) of 177Lu-NYM096 treatment",
                            "description": "177Lu-NYM096 will be delivered to participants up to 4 cycles with the same dosing amount. Each cycle will start 8 +/- 1 weeks after the previous cycle. The tumor reponse will be evaluated before each cycle during the treatment (roughly every 2 months) and every 3 months after the end of the 4th cycle until 2 years after treatment start or tumor progression. The survival info will be followed every 6 months until all-caused death of participant, assessed up to 60 months.",
                            "timeFrame": "From the start of 1st cycle of 177Lu-NYM096 treatment (each cycle is 8 weeks) to the date of first documented date of death from any cause, assessed up to 60 months."
                        },
                        {
                            "measure": "(Phase B) PFS rate at 6 months of 177Lu-NYM096 treatment",
                            "description": "177Lu-NYM096 will be delivered to participants up to 4 cycles with the same dosing amount. Each cycle will start 8 +/- 1 weeks after the previous cycle. The tumor reponse will be evaluated before each cycle during the treatment (roughly every 2 months).",
                            "timeFrame": "6 month after the start of 1st cycle of 177Lu-NYM096 treatment (each cycle is 8 weeks) ."
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age\u226518y\n2. Histologically or cytologically confirmed metastatic clear cell renal cell carcinoma\n3. Progression after or cannot undergo standard therapy with tyrosine kinase inhibitor (TKI) treatment or TKI combined with immune checkpoint inhibitor treatment.\n4. Presence of at least 1 non-irradiated tumor lesion detected at conventional imaging (computed tomography / magnetic resonance imaging (CT/MRI)) documented within 4 weeks prior to the 68Ga-NYM096 administration which should be measurable per response evaluation criteria in solid tumors (RECIST) v1.1.\n5. ECOG= 0 or 1\n6. Written informed consent.\n7. For Phase B: 68Ga-NYM096 should meet the imaging inclusion criteria\n\nExclusion Criteria:\n\n1. Any major surgery within 12 weeks before enrollment\n2. Inability to stay in the scanner bed and keep still for the duration of the scan\n3. Participants who have not had resolution of clinically significant toxic effects of prior systemic cancer therapy, surgery, or radiotherapy to Grade \u22641\n4. EGFR no higher than 30ml/min\\*1.73m2\n5. Inflammatory bowel disease\n6. Phase A: TKI treatment within one week before 68Ga-NYM096 administration\n7. Phase B: Participants who received any systemic antineoplastic therapy for the underlying disease and/or other investigational agents within a period which is \u22645 half-lives or \u22644 weeks (whichever is shorter).\n8. Any previous CA IX-targeting treatment\n9. Prior external beam radiation therapy (EBRT) to more than 25% of the bone marrow\n10. Pregnant or breastfeeding",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Li Huo, MD",
                            "role": "CONTACT",
                            "phone": "+86 186 1267 2038",
                            "email": "huoli@pumch.cn"
                        },
                        {
                            "name": "Wenjia Zhu, MD",
                            "role": "CONTACT",
                            "phone": "+86 186 1408 0164",
                            "email": "zhuwenjia_pumc@163.com"
                        }
                    ],
                    "overallOfficials": [
                        {
                            "name": "Li Huo, MD",
                            "affiliation": "Peking Uion Medical College Hospital",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Peking Union Medical College Hospital",
                            "status": "RECRUITING",
                            "city": "Beijing",
                            "state": "Beijing",
                            "zip": "100730",
                            "country": "China",
                            "contacts": [
                                {
                                    "name": "Li Huo, MD",
                                    "role": "CONTACT",
                                    "phone": "+86 186 1267 2038",
                                    "email": "huoli@pumch.cn"
                                },
                                {
                                    "name": "Wenjia Zhu, MD",
                                    "role": "CONTACT",
                                    "phone": "+86 186 1408 0164",
                                    "email": "zhuwenjia_pumc@163.com"
                                },
                                {
                                    "name": "Li Huo, MD",
                                    "role": "CONTACT"
                                },
                                {
                                    "name": "Wenjia Zhu, MDD",
                                    "role": "CONTACT"
                                }
                            ],
                            "geoPoint": {
                                "lat": 39.9075,
                                "lon": 116.39723
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "YES",
                    "description": "Available upon request",
                    "infoTypes": [
                        "STUDY_PROTOCOL",
                        "ICF"
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D002277",
                            "term": "Carcinoma"
                        },
                        {
                            "id": "D002292",
                            "term": "Carcinoma, Renal Cell"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D009375",
                            "term": "Neoplasms, Glandular and Epithelial"
                        },
                        {
                            "id": "D009370",
                            "term": "Neoplasms by Histologic Type"
                        },
                        {
                            "id": "D009369",
                            "term": "Neoplasms"
                        },
                        {
                            "id": "D000230",
                            "term": "Adenocarcinoma"
                        },
                        {
                            "id": "D007680",
                            "term": "Kidney Neoplasms"
                        },
                        {
                            "id": "D014571",
                            "term": "Urologic Neoplasms"
                        },
                        {
                            "id": "D014565",
                            "term": "Urogenital Neoplasms"
                        },
                        {
                            "id": "D009371",
                            "term": "Neoplasms by Site"
                        },
                        {
                            "id": "D052776",
                            "term": "Female Urogenital Diseases"
                        },
                        {
                            "id": "D005261",
                            "term": "Female Urogenital Diseases and Pregnancy Complications"
                        },
                        {
                            "id": "D000091642",
                            "term": "Urogenital Diseases"
                        },
                        {
                            "id": "D007674",
                            "term": "Kidney Diseases"
                        },
                        {
                            "id": "D014570",
                            "term": "Urologic Diseases"
                        },
                        {
                            "id": "D052801",
                            "term": "Male Urogenital Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M5534",
                            "name": "Carcinoma",
                            "asFound": "Carcinoma",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M5548",
                            "name": "Carcinoma, Renal Cell",
                            "asFound": "Clear Cell Renal Cell Carcinoma",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M12320",
                            "name": "Neoplasms, Glandular and Epithelial",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12315",
                            "name": "Neoplasms by Histologic Type",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3585",
                            "name": "Adenocarcinoma",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10703",
                            "name": "Kidney Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17320",
                            "name": "Urologic Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17315",
                            "name": "Urogenital Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M2875",
                            "name": "Urogenital Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M27093",
                            "name": "Female Urogenital Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14127",
                            "name": "Pregnancy Complications",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8399",
                            "name": "Female Urogenital Diseases and Pregnancy Complications",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10698",
                            "name": "Kidney Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17319",
                            "name": "Urologic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M27095",
                            "name": "Male Urogenital Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T4906",
                            "name": "Renal Cell Carcinoma",
                            "asFound": "Renal Cell Carcinoma",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "T1341",
                            "name": "Clear Cell Renal Cell Carcinoma",
                            "asFound": "Clear Cell Renal Cell Carcinoma",
                            "relevance": "HIGH"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC04",
                            "name": "Neoplasms"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BXS",
                            "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        },
                        {
                            "abbrev": "Rare",
                            "name": "Rare Diseases"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT04876482",
                    "orgStudyIdInfo": {
                        "id": "NCKUH-10902002"
                    },
                    "organization": {
                        "fullName": "National Cheng-Kung University Hospital",
                        "class": "OTHER"
                    },
                    "briefTitle": "Myofunctional Training for Obstructive Sleep Apnea Patients After Transoral Robotic Surgery",
                    "officialTitle": "Efficacy of Oropharyngeal Myofunctional Therapeutic Training for Obstructive Sleep Apnea Patients After Transoral Robotic Surgery"
                },
                "statusModule": {
                    "statusVerifiedDate": "2021-09",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2020-01-01",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2022-12-31",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2022-12-31",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2021-02-03",
                    "studyFirstSubmitQcDate": "2021-05-02",
                    "studyFirstPostDateStruct": {
                        "date": "2021-05-06",
                        "type": "ACTUAL"
                    },
                    "resultsFirstSubmitDate": "2023-03-22",
                    "resultsFirstSubmitQcDate": "2024-07-29",
                    "resultsFirstPostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-07-29",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "National Cheng-Kung University Hospital",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "Background: Obstructive Sleep Apnea Syndrome (OSA) is a kind of sleep disorder. The symptoms are intermittent, partial or complete upper airway collapse, seriously impacting oxygen saturation and oxidative stress. Some patients choose to do upper airway surgeries, but the success rate is only 60-70%. The symptoms might relapse because of aging and gaining weights. The purpose of our study is to compare the effect of transoral robotic surgery (TORS) and oropharyngeal rehabilitation (OPR) on patients after TORS. Methods: Participants above 20 years old who are newly diagnosed with mild to severe OSA (Apnea-hypopnea Index \\>5/h), and the physician will explain the treatment programs to every subject in clinic. Expected results: The hypothesis of this study is the success rate of surgery will be enhance by increasing tongue and jaw-opening muscle strength after OPR. The biomarkers of cardiovascular disease may decrease and both the collapse of upper airway and sleep quality may be improved after TORS and OPR.",
                    "detailedDescription": "The participants above 20 years old who are newly diagnosed with mild to severe OSA (Apnea-hypopnea Index \\>5/h), and the physician will explain the treatment programs to every subject. By their willingness to choose the therapeutic method, the participants who select the surgery interventions will be assign to TORS or TORS+OPR group. The matched controls as well as age-, sex-, and body mass index-matched OSA participants will be selected from the patients who are waiting for oral appliance, losing weight and using continuous positive airway pressure. Before surgery, 6 week and 18 week after surgery, the investiagters will compare the polysomnography data, questionnaires of sleep quality, drug-induced sleep endoscopy and computed tomography as primary outcomes. The investigators will also compare the tongue and jaw-opening muscle strength and biomarkers of oxidative stress, anti-oxidative stress, inflammatory cytokines and matrix metalloproteinases 9 as secondary outcomes. The OPR would begin at 6 week after surgery, and participants will undergo three months of the home-based oropharyngeal myofunctional therapeutic training. During the training intervention period, participants will be interviewed one time per week for adjusting the treatment intensity."
                },
                "conditionsModule": {
                    "conditions": [
                        "Sleep Apnea, Obstructive"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "NON_RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 81,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Control",
                            "type": "SHAM_COMPARATOR",
                            "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.",
                            "interventionNames": [
                                "Device: oral appliance",
                                "Device: using continuous positive airway pressure",
                                "Behavioral: losing weights"
                            ]
                        },
                        {
                            "label": "Transoral robotic surgery (TORS)",
                            "type": "EXPERIMENTAL",
                            "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.",
                            "interventionNames": [
                                "Procedure: transoral robotic surgery"
                            ]
                        },
                        {
                            "label": "TORS+OPR",
                            "type": "EXPERIMENTAL",
                            "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.",
                            "interventionNames": [
                                "Procedure: transoral robotic surgery",
                                "Combination Product: oropharyngeal rehabilitation"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "PROCEDURE",
                            "name": "transoral robotic surgery",
                            "description": "transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study",
                            "armGroupLabels": [
                                "TORS+OPR",
                                "Transoral robotic surgery (TORS)"
                            ]
                        },
                        {
                            "type": "DEVICE",
                            "name": "oral appliance",
                            "description": "It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.",
                            "armGroupLabels": [
                                "Control"
                            ]
                        },
                        {
                            "type": "DEVICE",
                            "name": "using continuous positive airway pressure",
                            "description": "The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.",
                            "armGroupLabels": [
                                "Control"
                            ],
                            "otherNames": [
                                "CPAP"
                            ]
                        },
                        {
                            "type": "BEHAVIORAL",
                            "name": "losing weights",
                            "description": "The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries.",
                            "armGroupLabels": [
                                "Control"
                            ]
                        },
                        {
                            "type": "COMBINATION_PRODUCT",
                            "name": "oropharyngeal rehabilitation",
                            "description": "OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist.",
                            "armGroupLabels": [
                                "TORS+OPR"
                            ],
                            "otherNames": [
                                "OPR"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Apnea Hypopnea Index (AHI)",
                            "description": "Polysomnography included electroencephalographic, electro-oculographic, thoracic and abdominal respiratory inductance plethysmography and body position sensor to confirm the sleeping stage in one-night observation. Above measurements will be aggregated to arrive AHI.\n\nUnabbreviated scale title:Apnea and Hypopnea index The minimum value:0 The maximum values: none Higher scores mean a worse outcome.",
                            "timeFrame": "through study completion, an average of 6 months"
                        },
                        {
                            "measure": "Computer Tomography (CT)_Volume",
                            "description": "All patients underwent CT in a supine position. Each patient was instructed to maintain his/her tongue in the resting position, without swallowing, during CT. Volume from hard palate to the base of epiglottis was measured.",
                            "timeFrame": "through study completion, an average of 6 months"
                        },
                        {
                            "measure": "Computer Tomography (CT)_minimal Area",
                            "description": "All patients underwent CT in a supine position. Each patient was instructed to maintain his/her tongue in the resting position, without swallowing, during CT. Cross section area on the tip of epiglottis was measured.",
                            "timeFrame": "through study completion, an average of 6 months"
                        },
                        {
                            "measure": "Computer Tomography (CT)_AP Distance",
                            "description": "All patients underwent CT in a supine position. Each patient was instructed to maintain his/her tongue in the resting position, without swallowing, during CT. Anterior to posterior distance on the tip of epiglottis was measured.",
                            "timeFrame": "through study completion, an average of 6 months"
                        },
                        {
                            "measure": "Computer Tomography (CT)_Lateral Distance",
                            "description": "All patients underwent CT in a supine position. Each patient was instructed to maintain his/her tongue in the resting position, without swallowing, during CT. Lateral distance on the tip of epiglottis was measured.",
                            "timeFrame": "through study completion, an average of 6 months"
                        },
                        {
                            "measure": "Drug-induced Sleep Endoscopy (DISE)",
                            "description": "All patients underwent DISE in a supine position. The possible outcomes were unilevel collapse at the velum, oropharynx, tongue base, or epiglottis and multilevel collapse at any of these locations. The velum is the part of the upper airway at the level of the soft palate and uvula; the oropharynx is the pharyngeal portion at the level of the tonsils, above the tongue base. The tongue base was considered the retroglossal area; epiglottis was considered the pharyngeal region below the tongue base. The degree of obstruciton was diagnosed by an ear nose throat surgeon. The degree of obstruction ranged from 0 to 2. 0: no obstruction (\\<50%); 1: partial obstruction (50-75%); 2: complete obstruction (\\>75%).",
                            "timeFrame": "through study completion, an average of 6 months"
                        },
                        {
                            "measure": "Jaw Opening Muscle Strength",
                            "description": "Muscle strength of jaw was measured with a 'handheld' dynamometer (MicroFET\u25cbR2, Hoggan Scientific, USA) mounted on an adapted ophthalmic examination frame, to avoid alterations in chin and head position and to ensure consistent compression.",
                            "timeFrame": "through study completion, an average of 6 months"
                        },
                        {
                            "measure": "Tongue Protrusion Muscle Strength",
                            "description": "The muscle strength of the tongue was evaluated by the IOPI system, model 2.2 (Northwest, Co., LLC, Carnation, WA, USA).",
                            "timeFrame": "through study completion, an average of 6 months"
                        },
                        {
                            "measure": "Tongue Elevation Muscle Strength",
                            "description": "The muscle strength of the tongue was evaluated by the IOPI system, model 2.2 (Northwest, Co., LLC, Carnation, WA, USA).",
                            "timeFrame": "through study completion, an average of 6 months"
                        },
                        {
                            "measure": "Tongue Depression Muscle Strength",
                            "description": "The muscle strength of the tongue was evaluated by the IOPI system, model 2.2 (Northwest, Co., LLC, Carnation, WA, USA).",
                            "timeFrame": "through study completion, an average of 6 months"
                        },
                        {
                            "measure": "Tongue Lateralization Muscle Strength",
                            "description": "The muscle strength of the tongue was evaluated by the IOPI system, model 2.2 (Northwest, Co., LLC, Carnation, WA, USA).",
                            "timeFrame": "through study completion, an average of 6 months"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Clinical diagnosis of mild to severe OSA in the past year\n* Age between 20-65 years old.\n\nExclusion Criteria:\n\n* A history of malignancy or infection of the head and neck region and laryngeal trauma\n* Craniofacial malformation\n* Stroke\n* Neuromuscular disease\n* Heart failure\n* Coronary artery disease.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "20 Years",
                    "maximumAge": "65 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "locations": [
                        {
                            "facility": "National Cheng Kung University Hospital",
                            "city": "Tainan",
                            "state": "Please Select",
                            "zip": "412",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 22.99083,
                                "lon": 120.21333
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "recruitmentDetails": "Recruited time:2020/01/01-2022/05/11",
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Control",
                            "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                        },
                        {
                            "id": "FG001",
                            "title": "Transoral Robotic Surgery (TORS)",
                            "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                        },
                        {
                            "id": "FG002",
                            "title": "TORS+OPR",
                            "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "20"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "42"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "19"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "17"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "38"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "19"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "4"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Control",
                            "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                        },
                        {
                            "id": "BG001",
                            "title": "Transoral Robotic Surgery (TORS)",
                            "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                        },
                        {
                            "id": "BG002",
                            "title": "TORS+OPR",
                            "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                        },
                        {
                            "id": "BG003",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "20"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "42"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "19"
                                },
                                {
                                    "groupId": "BG003",
                                    "value": "81"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Categorical",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "<=18 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Between 18 and 65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "20"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "42"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "19"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "81"
                                                }
                                            ]
                                        },
                                        {
                                            "title": ">=65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "44.25",
                                                    "spread": "9.55"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "43.12",
                                                    "spread": "10.87"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "45.10",
                                                    "spread": "8.63"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "43.91",
                                                    "spread": "9.93"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "11"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "15"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "37"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "18"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "70"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race/Ethnicity, Customized",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "Asian",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "20"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "42"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "19"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "81"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Region of Enrollment",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "title": "Taiwan",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "20"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "42"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "19"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "81"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Polysomonography",
                            "description": "Apnea hypopnea index (AHI) is the main measurement, so the mean and SD below was for AHI.\n\nApnea was defined as a reduction in airflow \\>90% lasting \\>10 seconds.The definition of hypopnea was a reduction in airflow \\>30% lasting \\>10 seconds and a decrease in oxygen saturation \\>3% or presence of microarousal. AHI quantifies the severity of sleep apnea by counting the number of apneas and hypopneas during sleep. Mild sleep apnea means 5\\< =AHI\\<15; Moderate sleep apnea means 15\\< =AHI\\<30; Severe sleep apnea means AHI \\>=30",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "events per hour",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "38.39",
                                                    "spread": "22.15"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "43.98",
                                                    "spread": "19.86"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "45.43",
                                                    "spread": "21.71"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "42.92",
                                                    "spread": "20.86"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Body mass index",
                            "description": "using weight and height and the formula is kg/m\\^2",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "kg/m^2",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "27.11",
                                                    "spread": "3.48"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "28.09",
                                                    "spread": "3.72"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "27.31",
                                                    "spread": "4.18"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "27.62",
                                                    "spread": "3.76"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Neck circumference",
                            "description": "Using the unit as centimeter",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "cm",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "37.81",
                                                    "spread": "2.53"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "39.38",
                                                    "spread": "3.48"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "39.53",
                                                    "spread": "2.08"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "39.00",
                                                    "spread": "2.98"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Tongue protrusion muscle strength",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "kPa",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "52.50",
                                                    "spread": "12.82"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "61.16",
                                                    "spread": "16.94"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "51.00",
                                                    "spread": "15.87"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "56.10",
                                                    "spread": "16.17"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Tongue elevation muscle strength",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "kPa",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "52.50",
                                                    "spread": "14.13"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "58.25",
                                                    "spread": "15.25"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "50.47",
                                                    "spread": "10.52"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "54.61",
                                                    "spread": "14.05"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Tongue depression muscle strength",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "kPa",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "43.56",
                                                    "spread": "10.19"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "47.16",
                                                    "spread": "11.04"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "40.95",
                                                    "spread": "10.86"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "44.51",
                                                    "spread": "10.95"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Tongue lateralization muscle strength",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "kPa",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "35.72",
                                                    "spread": "9.98"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "42.20",
                                                    "spread": "11.81"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "41.79",
                                                    "spread": "11.45"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "40.40",
                                                    "spread": "11.44"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Computed Tomography_ Volume",
                            "description": "Volume from hard palate to epiglottis tip",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "cm^3",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "19.04",
                                                    "spread": "11.40"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "19.33",
                                                    "spread": "8.67"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "16.80",
                                                    "spread": "6.07"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "18.56",
                                                    "spread": "8.82"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Computed Tomography_ minimal area",
                            "description": "Minimal area on the epiglottis tip",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "cm^2",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3.71",
                                                    "spread": "1.94"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "3.88",
                                                    "spread": "1.44"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3.54",
                                                    "spread": "1.38"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "3.74",
                                                    "spread": "1.55"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Computed Tomography_ AP distance",
                            "description": "Anterior to posterior distance on epiglottis tip",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "cm",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1.72",
                                                    "spread": "0.77"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1.70",
                                                    "spread": "0.49"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1.66",
                                                    "spread": "0.40"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "1.69",
                                                    "spread": "0.55"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Computed Tomography_ lateral distance distance",
                            "description": "Left to right distance on epiglottis tip. Unit was measured in centimeter.",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "cm",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3.02",
                                                    "spread": "0.84"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "3.30",
                                                    "spread": "0.74"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3.22",
                                                    "spread": "0.51"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "3.20",
                                                    "spread": "0.71"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Drug-induced sleep endoscopy",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "20"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "42"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "19"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "81"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Jaw opening muscle strength",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "kg",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "8.97",
                                                    "spread": "3.70"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "9.70",
                                                    "spread": "3.87"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "9.84",
                                                    "spread": "2.52"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "9.55",
                                                    "spread": "3.47"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Apnea Hypopnea Index (AHI)",
                            "description": "Polysomnography included electroencephalographic, electro-oculographic, thoracic and abdominal respiratory inductance plethysmography and body position sensor to confirm the sleeping stage in one-night observation. Above measurements will be aggregated to arrive AHI.\n\nUnabbreviated scale title:Apnea and Hypopnea index The minimum value:0 The maximum values: none Higher scores mean a worse outcome.",
                            "populationDescription": "Seven participants didn't complete the whole protocol, so we didn't analyze their data.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "events per hour",
                            "timeFrame": "through study completion, an average of 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Control",
                                    "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Transoral Robotic Surgery (TORS)",
                                    "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                                },
                                {
                                    "id": "OG002",
                                    "title": "TORS+OPR",
                                    "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "44.89",
                                                    "spread": "21.09"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "44.65",
                                                    "spread": "19.91"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "36.87",
                                                    "spread": "21.87"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001",
                                        "OG002"
                                    ],
                                    "groupDescription": "We hypothesized that the improvements in the AHI would be higher in patients who underwent TORS combined with OPR than in those who underwent only TORS and those who received conservative treatment (controls).\n\n.",
                                    "nonInferiorityType": "OTHER",
                                    "nonInferiorityComment": "The Overall Number of Participants Analyzed do not appear to be equal, so we used linear regrssion to compare the mean difference among three groups.",
                                    "pValue": "<0.05",
                                    "statisticalMethod": "Regression, Linear",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "-10.76",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Computer Tomography (CT)_Volume",
                            "description": "All patients underwent CT in a supine position. Each patient was instructed to maintain his/her tongue in the resting position, without swallowing, during CT. Volume from hard palate to the base of epiglottis was measured.",
                            "populationDescription": "Seven participants didn't complete the whole protocol, so we didn't analyze their data.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "cm^3",
                            "timeFrame": "through study completion, an average of 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Control",
                                    "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Transoral Robotic Surgery (TORS)",
                                    "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                                },
                                {
                                    "id": "OG002",
                                    "title": "TORS+OPR",
                                    "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "18.39",
                                                    "spread": "11.47"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "18.72",
                                                    "spread": "6.43"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "16.80",
                                                    "spread": "6.07"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001",
                                        "OG002"
                                    ],
                                    "groupDescription": "We hypothesized that the improvements in the upper airway volume would be higher in patients who underwent TORS combined with OPR than in those who underwent only TORS and those who received conservative treatment (controls).",
                                    "nonInferiorityType": "OTHER",
                                    "nonInferiorityComment": "The Overall Number of Participants Analyzed do not appear to be equal, so we used linear regrssion to compare the mean difference among three groups.",
                                    "pValue": "<0.05",
                                    "statisticalMethod": "Regression, Linear",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "2.05",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Computer Tomography (CT)_minimal Area",
                            "description": "All patients underwent CT in a supine position. Each patient was instructed to maintain his/her tongue in the resting position, without swallowing, during CT. Cross section area on the tip of epiglottis was measured.",
                            "populationDescription": "Seven participants didn't complete the whole protocol, so we didn't analyze their data.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "cm^2",
                            "timeFrame": "through study completion, an average of 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Control",
                                    "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Transoral Robotic Surgery (TORS)",
                                    "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                                },
                                {
                                    "id": "OG002",
                                    "title": "TORS+OPR",
                                    "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "42"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.60",
                                                    "spread": "1.94"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "3.80",
                                                    "spread": "1.13"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "3.54",
                                                    "spread": "1.38"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001",
                                        "OG002"
                                    ],
                                    "groupDescription": "We hypothesized that the improvements in the minimal area on the tip of epiglottis would be more in patients who underwent TORS combined with OPR than in those who underwent only TORS and those who received conservative treatment (controls)",
                                    "nonInferiorityType": "OTHER",
                                    "nonInferiorityComment": "The Overall Number of Participants Analyzed do not appear to be equal, so we used linear regrssion to compare the mean difference among three groups.",
                                    "pValue": "<0.05",
                                    "statisticalMethod": "Regression, Linear",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "0.275",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Computer Tomography (CT)_AP Distance",
                            "description": "All patients underwent CT in a supine position. Each patient was instructed to maintain his/her tongue in the resting position, without swallowing, during CT. Anterior to posterior distance on the tip of epiglottis was measured.",
                            "populationDescription": "Seven participants didn't complete the whole protocol, so we didn't analyze their data.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "cm",
                            "timeFrame": "through study completion, an average of 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Control",
                                    "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Transoral Robotic Surgery (TORS)",
                                    "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                                },
                                {
                                    "id": "OG002",
                                    "title": "TORS+OPR",
                                    "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1.71",
                                                    "spread": "0.79"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "1.64",
                                                    "spread": "0.39"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "1.66",
                                                    "spread": "0.40"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001",
                                        "OG002"
                                    ],
                                    "groupDescription": "We hypothesized that the improvements in the anteror to posterior distance on the tip of epiglottis would be more in patients who underwent TORS combined with OPR than in those who underwent only TORS and those who received conservative treatment (controls).",
                                    "nonInferiorityType": "OTHER",
                                    "nonInferiorityComment": "The Overall Number of Participants Analyzed do not appear to be equal, so we used linear regrssion to compare the mean difference among three groups.",
                                    "pValue": "<0.05",
                                    "statisticalMethod": "Regression, Linear",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "-0.14",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Computer Tomography (CT)_Lateral Distance",
                            "description": "All patients underwent CT in a supine position. Each patient was instructed to maintain his/her tongue in the resting position, without swallowing, during CT. Lateral distance on the tip of epiglottis was measured.",
                            "populationDescription": "Seven participants didn't complete the whole protocol, so we didn't analyze their data.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "cm",
                            "timeFrame": "through study completion, an average of 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Control",
                                    "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Transoral Robotic Surgery (TORS)",
                                    "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                                },
                                {
                                    "id": "OG002",
                                    "title": "TORS+OPR",
                                    "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.92",
                                                    "spread": "0.83"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "3.43",
                                                    "spread": "0.63"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "3.22",
                                                    "spread": "0.51"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001",
                                        "OG002"
                                    ],
                                    "groupDescription": "We hypothesized that the improvements in the lateral distance on the tip of epiglottis would be more in patients who underwent TORS combined with OPR than in those who underwent only TORS and those who received conservative treatment (controls).",
                                    "nonInferiorityType": "OTHER",
                                    "nonInferiorityComment": "The Overall Number of Participants Analyzed do not appear to be equal, so we used linear regrssion to compare the mean difference among three groups.",
                                    "pValue": "<0.05",
                                    "statisticalMethod": "Regression, Linear",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "0.01",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Drug-induced Sleep Endoscopy (DISE)",
                            "description": "All patients underwent DISE in a supine position. The possible outcomes were unilevel collapse at the velum, oropharynx, tongue base, or epiglottis and multilevel collapse at any of these locations. The velum is the part of the upper airway at the level of the soft palate and uvula; the oropharynx is the pharyngeal portion at the level of the tonsils, above the tongue base. The tongue base was considered the retroglossal area; epiglottis was considered the pharyngeal region below the tongue base. The degree of obstruciton was diagnosed by an ear nose throat surgeon. The degree of obstruction ranged from 0 to 2. 0: no obstruction (\\<50%); 1: partial obstruction (50-75%); 2: complete obstruction (\\>75%).",
                            "populationDescription": "Seven participants didn't complete the whole protocol, so we didn't analyze their data.",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "calculatePct": false,
                            "timeFrame": "through study completion, an average of 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Control",
                                    "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Transoral Robotic Surgery (TORS)",
                                    "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                                },
                                {
                                    "id": "OG002",
                                    "title": "TORS+OPR",
                                    "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "The degree of obstruction in velum",
                                    "categories": [
                                        {
                                            "title": "no obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "partial obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "9"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "6"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "7"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "complete obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "11"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "The degree of obstruction in oropharynx",
                                    "categories": [
                                        {
                                            "title": "no obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "partial obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "13"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "28"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "13"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "complete obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "5"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "The degree of obstruction in tongue base",
                                    "categories": [
                                        {
                                            "title": "no obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "partial obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "16"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "9"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "complete obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "10"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "22"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "9"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "The degree of obstruction in epiglottis",
                                    "categories": [
                                        {
                                            "title": "no obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "partial obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "6"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "18"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "11"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "complete obstruction",
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "11"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "20"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "8"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001",
                                        "OG002"
                                    ],
                                    "groupDescription": "We hypothesized that TORS followed by OPR would improve upper airway obstruction more compared with TORS alone and conservative treatment (control).",
                                    "nonInferiorityType": "OTHER",
                                    "nonInferiorityComment": "Baseline characteristics among the study groups were compared using Fisher exact test for categorical variables. McNemar chi-square test used for within-group analysis.",
                                    "pValue": "<0.05",
                                    "statisticalMethod": "Fisher Exact",
                                    "paramType": "Number and percentage",
                                    "paramValue": "0.05",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Jaw Opening Muscle Strength",
                            "description": "Muscle strength of jaw was measured with a 'handheld' dynamometer (MicroFET\u25cbR2, Hoggan Scientific, USA) mounted on an adapted ophthalmic examination frame, to avoid alterations in chin and head position and to ensure consistent compression.",
                            "populationDescription": "Seven participants didn't complete the whole protocol, so we didn't analyze their data.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "kilogram force",
                            "timeFrame": "through study completion, an average of 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Control",
                                    "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Transoral Robotic Surgery (TORS)",
                                    "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                                },
                                {
                                    "id": "OG002",
                                    "title": "TORS+OPR",
                                    "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "9.14",
                                                    "spread": "3.67"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "9.63",
                                                    "spread": "3.59"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "9.68",
                                                    "spread": "2.49"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001",
                                        "OG002"
                                    ],
                                    "groupDescription": "We hypothesized that the improvements in the jaw opening muscle strength would be more in patients who underwent TORS combined with OPR than in those who underwent only TORS and those who received conservative treatment (controls).",
                                    "nonInferiorityType": "OTHER",
                                    "nonInferiorityComment": "The Overall Number of Participants Analyzed do not appear to be equal, so we used linear regrssion to compare the mean difference among three groups.",
                                    "pValue": "<0.05",
                                    "statisticalMethod": "Regression, Linear",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "2.23",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Tongue Protrusion Muscle Strength",
                            "description": "The muscle strength of the tongue was evaluated by the IOPI system, model 2.2 (Northwest, Co., LLC, Carnation, WA, USA).",
                            "populationDescription": "Seven participants didn't complete the whole protocol, so we didn't analyze their data.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "kilopascals",
                            "timeFrame": "through study completion, an average of 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Control",
                                    "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Transoral Robotic Surgery (TORS)",
                                    "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                                },
                                {
                                    "id": "OG002",
                                    "title": "TORS+OPR",
                                    "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "57.83",
                                                    "spread": "11.17"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "56.97",
                                                    "spread": "11.72"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "61.89",
                                                    "spread": "8.88"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001",
                                        "OG002"
                                    ],
                                    "groupDescription": "We hypothesized that the improvements in the tongue protrusion muscle strength would be more in patients who underwent TORS combined with OPR than in those who underwent only TORS and those who received conservative treatment (controls).",
                                    "nonInferiorityType": "OTHER",
                                    "nonInferiorityComment": "The Overall Number of Participants Analyzed do not appear to be equal, so we used linear regrssion to compare the mean difference among three groups.",
                                    "pValue": "<0.05",
                                    "statisticalMethod": "Regression, Linear",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "2.45",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Tongue Elevation Muscle Strength",
                            "description": "The muscle strength of the tongue was evaluated by the IOPI system, model 2.2 (Northwest, Co., LLC, Carnation, WA, USA).",
                            "populationDescription": "Seven participants didn't complete the whole protocol, so we didn't analyze their data.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "kilopascals",
                            "timeFrame": "through study completion, an average of 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Control",
                                    "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Transoral Robotic Surgery (TORS)",
                                    "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                                },
                                {
                                    "id": "OG002",
                                    "title": "TORS+OPR",
                                    "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "59.17",
                                                    "spread": "13.64"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "57.22",
                                                    "spread": "12.59"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "63.37",
                                                    "spread": "12.07"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001",
                                        "OG002"
                                    ],
                                    "groupDescription": "We hypothesized that the improvements in the tongue elevation muscle strength would be more in patients who underwent TORS combined with OPR than in those who underwent only TORS and those who received conservative treatment (controls).",
                                    "nonInferiorityType": "OTHER",
                                    "nonInferiorityComment": "The Overall Number of Participants Analyzed do not appear to be equal, so we used linear regrssion to compare the mean difference among three groups.",
                                    "pValue": "<0.05",
                                    "statisticalMethod": "Regression, Linear",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "4.81",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Tongue Depression Muscle Strength",
                            "description": "The muscle strength of the tongue was evaluated by the IOPI system, model 2.2 (Northwest, Co., LLC, Carnation, WA, USA).",
                            "populationDescription": "Seven participants didn't complete the whole protocol, so we didn't analyze their data.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "kilopascals",
                            "timeFrame": "through study completion, an average of 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Control",
                                    "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Transoral Robotic Surgery (TORS)",
                                    "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                                },
                                {
                                    "id": "OG002",
                                    "title": "TORS+OPR",
                                    "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "49.94",
                                                    "spread": "10.22"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "48.22",
                                                    "spread": "10.38"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "58.58",
                                                    "spread": "9.16"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001",
                                        "OG002"
                                    ],
                                    "groupDescription": "We hypothesized that the improvements in the tongue depression muscle strength would be more in patients who underwent TORS combined with OPR than in those who underwent only TORS and those who received conservative treatment (controls).",
                                    "nonInferiorityType": "OTHER",
                                    "nonInferiorityComment": "The Overall Number of Participants Analyzed do not appear to be equal, so we used linear regrssion to compare the mean difference among three groups.",
                                    "pValue": "<0.05",
                                    "statisticalMethod": "Regression, Linear",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "7.01",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Tongue Lateralization Muscle Strength",
                            "description": "The muscle strength of the tongue was evaluated by the IOPI system, model 2.2 (Northwest, Co., LLC, Carnation, WA, USA).",
                            "populationDescription": "Seven participants didn't complete the whole protocol, so we didn't analyze their data.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "kilopascals",
                            "timeFrame": "through study completion, an average of 6 months",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Control",
                                    "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Transoral Robotic Surgery (TORS)",
                                    "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study"
                                },
                                {
                                    "id": "OG002",
                                    "title": "TORS+OPR",
                                    "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "42.19",
                                                    "spread": "10.52"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "41.55",
                                                    "spread": "9.86"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "50.11",
                                                    "spread": "9.38"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001",
                                        "OG002"
                                    ],
                                    "groupDescription": "We hypothesized that the improvements in the tongue lateralization muscle strength would be more in patients who underwent TORS combined with OPR than in those who underwent only TORS and those who received conservative treatment (controls).",
                                    "nonInferiorityType": "OTHER",
                                    "nonInferiorityComment": "The Overall Number of Participants Analyzed do not appear to be equal, so we used linear regrssion to compare the mean difference among three groups.",
                                    "pValue": "<0.05",
                                    "statisticalMethod": "Regression, Linear",
                                    "paramType": "Mean Difference (Final Values)",
                                    "paramValue": "3.67",
                                    "ciNumSides": "TWO_SIDED"
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "0",
                    "timeFrame": "6 months",
                    "description": "None of the participants at risk for serious adverse events and all-cause mortality is zero becaurse control group only used conservative treatment and TORS is a safe surgery for surgery group and surgery + OPR group.",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Control",
                            "description": "Without the willingness of surgery, those participants waiting for oral appliance (Device), losing weights and using continuous positive airway pressure (Device) were distribute to control group.\n\noral appliance: It is a kind of treatment for the participants who refuse surgeries and choose to use other kinds of conservative treatment. The conservative treatments included oral appliance, losing weights and using continuous positive airway pressure. The oral appliance would be wore only at night and it would press the soft palate and protrude the jaw.\n\nusing continuous positive airway pressure: The participants only used CPAP at night. The device composed of a main machine, pipe and mask. The participants would instruct to wore the mask. The main machine would give positive airway pressure to open the airway and avoid collapsing.\n\nlosing weights: The participants would ask to lose weight by changing their diets and exercising, without using drugs and surgeries.",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 20,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 20,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 20
                        },
                        {
                            "id": "EG001",
                            "title": "Transoral Robotic Surgery (TORS)",
                            "description": "The participants underwent TORS. TORS is a kind of surgery that the surgeons would remove the tonsils and the fat tissue of tongue base and suspend the soft palate.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 42,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 42,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 42
                        },
                        {
                            "id": "EG002",
                            "title": "TORS+OPR",
                            "description": "The participants started OPR 6 weeks after TORS. Each exercise was repeated 10 times, 1-3 cycles per day, 3-5 sessions per week at their home and performed for 3 months. Patients were supervised by physical therapist once a week for 30 minutes.\n\ntransoral robotic surgery: transoral robotic surgery (TORS) which remove the extra soft tissue of the base of the tongue and soft palate in this study\n\noropharyngeal rehabilitation: OPR included exercise for soft palate, tongue and oropharynx. There are 13 movements in OPR. The movements would be teach by a physical therapist.",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 19,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 19,
                            "otherNumAffected": 0,
                            "otherNumAtRisk": 19
                        }
                    ]
                },
                "moreInfoModule": {
                    "limitationsAndCaveats": {
                        "description": "1. The small sample size of 78 participants with OSA, a higher number of male participants, and the inclusion of only participants of Asian ethnicity\n2. Including patients who appeared motivated to undergo OPR in Group SO was likely to exaggerate the effectiveness of OPR because the patients might increase the frequency of OPR\n3. Participant compliance in home-based exercise was monitored mainly through self-report\n4. The intervention period of our OPR protocol was only 12 weeks."
                    },
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictiveAgreement": false
                    },
                    "pointOfContact": {
                        "title": "Yi-Ju, Lai",
                        "organization": "Department of Physical Therapy, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan",
                        "email": "jasmine19900728@gmail.com",
                        "phone": "+886963123117"
                    }
                }
            },
            "documentSection": {
                "largeDocumentModule": {
                    "largeDocs": [
                        {
                            "typeAbbrev": "Prot_SAP",
                            "hasProtocol": true,
                            "hasSap": true,
                            "hasIcf": false,
                            "label": "Study Protocol and Statistical Analysis Plan",
                            "date": "2020-06-09",
                            "uploadDate": "2024-07-23T22:30",
                            "filename": "Prot_SAP_000.pdf",
                            "size": 3144673
                        },
                        {
                            "typeAbbrev": "ICF",
                            "hasProtocol": false,
                            "hasSap": false,
                            "hasIcf": true,
                            "label": "Informed Consent Form",
                            "date": "2020-06-09",
                            "uploadDate": "2024-07-23T22:31",
                            "filename": "ICF_001.pdf",
                            "size": 6554654
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D001049",
                            "term": "Apnea"
                        },
                        {
                            "id": "D012891",
                            "term": "Sleep Apnea Syndromes"
                        },
                        {
                            "id": "D020181",
                            "term": "Sleep Apnea, Obstructive"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D012120",
                            "term": "Respiration Disorders"
                        },
                        {
                            "id": "D012140",
                            "term": "Respiratory Tract Diseases"
                        },
                        {
                            "id": "D012818",
                            "term": "Signs and Symptoms, Respiratory"
                        },
                        {
                            "id": "D020919",
                            "term": "Sleep Disorders, Intrinsic"
                        },
                        {
                            "id": "D020920",
                            "term": "Dyssomnias"
                        },
                        {
                            "id": "D012893",
                            "term": "Sleep Wake Disorders"
                        },
                        {
                            "id": "D009422",
                            "term": "Nervous System Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M15694",
                            "name": "Sleep Apnea Syndromes",
                            "asFound": "Sleep Apnea",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4361",
                            "name": "Apnea",
                            "asFound": "Apnea",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M22010",
                            "name": "Sleep Apnea, Obstructive",
                            "asFound": "Sleep Apnea, Obstructive",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M16355",
                            "name": "Syndrome",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14957",
                            "name": "Respiration Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14977",
                            "name": "Respiratory Tract Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15623",
                            "name": "Signs and Symptoms, Respiratory",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22242",
                            "name": "Parasomnias",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22654",
                            "name": "Sleep Disorders, Intrinsic",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22655",
                            "name": "Dyssomnias",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15696",
                            "name": "Sleep Wake Disorders",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC08",
                            "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "abbrev": "BC10",
                            "name": "Nervous System Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "BXM",
                            "name": "Behaviors and Mental Disorders"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT06636682",
                    "orgStudyIdInfo": {
                        "id": "FK-PC101-01"
                    },
                    "organization": {
                        "fullName": "Cellvax Therapeutics Inc",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer",
                    "officialTitle": "A Multicenter, Adaptive, Phase 2, Randomized, Open-label Study of Irradiated Autologous Cellular Vaccine in Men With High-Risk Prostate Cancer Following Prostatectomy"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2024-10-14",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2027-02-02",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2027-05-04",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2024-10-08",
                    "studyFirstSubmitQcDate": "2024-10-08",
                    "studyFirstPostDateStruct": {
                        "date": "2024-10-15",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Cellvax Therapeutics Inc",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false,
                    "isUsExport": false
                },
                "descriptionModule": {
                    "briefSummary": "The goal of this clinical trial is to learn if the vaccine FK-PC101 works to delay or prevent the return of prostate cancer in men who have had surgery to remove their prostate cancer. It will also learn about the safety of FK-PC101. The main questions it aims to answer are:\n\nDoes FK-PC101 delay or prevent the return of prostate cancer following surgery? What medical problems do participants (subjects) have when taking FK-PC101?\n\nResearchers will compare FK-PC101 to current treatment practice to see if FK-PC101 works to prevent or delay the return of prostate cancer following surgery to remove the prostate cancer tumor.\n\nSubjects will:\n\nHave a sample of the prostate cancer tissue collected at the time of surgery to remove this tissue from the body. This tissue will then be used to create a personalized vaccine that is specific to your prostate cancer.\n\nIf randomly selected to receive the vaccine, subjects will receive the vaccine up to 7 times over a 6-month period.\n\nIn addition to the treatment visits for those randomized to receive FK-PC101, there will be up to 4 follow up visits to the clinic over a 22-month (nearly 2 year) period.\n\nFor subjects randomized to receive current treatment practice, they will be asked to attend up to 8 visits over 22 months to track if there is any detectable cancer. Should their prostate cancer return within a year following surgery, they will be eligible to receive FK-PC101, which already had been produced and thus no additional tumor tissue would need to be obtained.\n\nSubjects in both study arms will have regular blood tests and scans to test whether their prostate cancer has returned.",
                    "detailedDescription": "This is a multicenter, adaptive, Phase 2, randomized, open-label study designed to evaluate the efficacy of FK-PC101 adjuvant therapy in men with localized prostate cancer who have undergone radical prostatectomy (RP). Subjects will undergo a 3-step screening and enrollment process. Following an initial safety run-in that will include at least three subjects assigned to receive FK-PC101 vaccine and monitored closely for safety, subjects randomized to the vaccine group will receive up to 7 doses of FK-PC101, starting at 2 months post-RP. Subjects in the control group will receive standard-of-care. All subjects will have assessments at 60 days (2 months), 90 days (3 months) and 180 days (6 months) and then continue with follow-up visits at 10, 14, 18, and 22 months after randomization.\n\nFK-PC101 is an autologous cellular vaccine, with each product being manufactured from a portion of tumor from each subject's prostatectomy specimen. The primary endpoint of DFS will be compared with the control group, who will also meet all eligibility criteria but who do not receive any postoperative adjuvant therapy.\n\nSubjects will undergo a three-step eligibility process with criteria prior to RP, immediately following RP and 2 months post-RP/immediately prior to randomization.\n\nSubjects will be randomized in a 1:1 open-label fashion to the vaccine group and the control group. Subjects will be stratified based on pathologic nodal status (pN0 vs. pN1). Subjects in the vaccine group will initiate vaccine dosing with up to 7 doses given between Day 1 and Day 180 (on Days 1, 8, 15, 22, 60, 90 and 180). Subjects randomized to the control group will be followed through 8 follow-up visits through month 22 (2 years post-surgery).\n\nFollowing disease recurrence, all subjects may be treated with other prostate cancer therapies as deemed appropriate. Subjects in the control group will be eligible to receive their vaccine after disease recurrence has been documented. For subjects in the control group who elect to receive their vaccine, it must be started within 1 year of randomization. The vaccine doses may be administered prior to, during, or following other prostate cancer therapies but will follow the same schedule as for the subjects in the vaccine group."
                },
                "conditionsModule": {
                    "conditions": [
                        "Prostate Cancer (Adenocarcinoma)",
                        "Prostate CA",
                        "Prostate Cancers",
                        "Prostate Cancer (Post Prostatectomy)",
                        "Prostate Cancer",
                        "Prostate Cancer Patients Undergoing Radical Prostatectomy",
                        "High-risk Prostate Cancer"
                    ],
                    "keywords": [
                        "Vaccine",
                        "Prostatectomy",
                        "Autologous",
                        "Radical Prostatectomy"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE2"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "CROSSOVER",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 100,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "FK-PC101",
                            "type": "EXPERIMENTAL",
                            "description": "Up to 7 doses of intradermal FK-PC101 vaccine",
                            "interventionNames": [
                                "Biological: FK-PC101"
                            ]
                        },
                        {
                            "label": "Standard of Care",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "Standard of care, with possibility to cross-over to FK-PC101 vaccine should prostate cancer recur within 1 year of radical prostatectomy",
                            "interventionNames": [
                                "Biological: Standard of Care (SOC)"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "BIOLOGICAL",
                            "name": "FK-PC101",
                            "description": "Up to 7 doses of FK-PC101 will be administered intradermally between Day 1 and Day 180. The immune adjuvant Bacillus Calmette Gu\u00e9rin (BCG) will be given concurrently with Dose 1 (day 1) and Dose 2 (day 8).",
                            "armGroupLabels": [
                                "FK-PC101"
                            ]
                        },
                        {
                            "type": "BIOLOGICAL",
                            "name": "Standard of Care (SOC)",
                            "description": "Subject receives Investigator-defined standard of care, excluding adjuvant therapy. If prostate cancer recurs before 12 months after radical prostatectomy, subjects are eligible to receive up to 7 doses of intradermal FK-PC101 vaccine (first 2 given concurrently with BCG).",
                            "armGroupLabels": [
                                "Standard of Care"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Disease-free survival (DFS)",
                            "description": "DFS is defined as local prostate cancer recurrence, distant metastatic prostate cancer recurrence, biochemical recurrence of PSA, or death from any cause",
                            "timeFrame": "Up to approximately 22 months"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Time to next treatment (TTNT)",
                            "description": "Time from randomization until disease recurrence or receipt of any form of adjuvant or salvage radiotherapy, hormonal therapy including ADT, or any other form of prostate cancer therapy post-randomization",
                            "timeFrame": "Up to approximately 22 months"
                        },
                        {
                            "measure": "Metastasis-free survival (MFS)",
                            "description": "Time from date of randomization to the 1st evidence of distant metastatic prostate cancer recurrence as detected by PSMA-PET/CT or other imaging performed, or to death from any cause",
                            "timeFrame": "Up to approximately 22 months"
                        },
                        {
                            "measure": "Immune response to FK-PC101",
                            "description": "Immune response to FK-PC101 as measured by ELISpot assay (FK-PC101 arm only)",
                            "timeFrame": "From baseline until Month 22"
                        },
                        {
                            "measure": "Safety and tolerability of FK-PC101",
                            "description": "Frequency and severity of AEs per the NCI-CTCAE version 5.0",
                            "timeFrame": "Up to approximately 22 months"
                        }
                    ],
                    "otherOutcomes": [
                        {
                            "measure": "Overall survival (OS)",
                            "description": "Time from date of randomization to date of death due to any cause",
                            "timeFrame": "Up to approximately 22 months"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Has localized high-risk or very high-risk prostate cancer based on the NCCN v4.2023 classification.\n* Has \u22653 prostate biopsy cores with \u226550% tumor involvement.\n* Has PSA \\>4 ng/mL \u226428 days prior to enrollment.\n* Has no evidence of distant metastases based on PSMA-PET/CT performed \u226428 days prior to enrollment.\n* Is a candidate for radical prostatectomy, and scheduled radical prostatectomy date must be 3 to 14 days after enrollment.\n* Has not received nor plans to receive neoadjuvant (preoperative) radiation therapy, androgen deprivation therapy (ADT), or any other anticancer therapy.\n* Has a life expectancy \\>5 years.\n\nAdditional key eligibility criteria immediately postoperative for inclusion in the randomized population include:\n\n* Stage \\>pT3a (tumor has extended outside of the prostate on one side).\n* Gleason score of 8, 9, or 10 (high/very high) on prostatectomy specimen.\n* Subjects with pT3b or pT4 tumors with a Gleason sum 7 (4+3) are eligible.\n* Pelvic lymph node dissection (PLND) is required with either pN0 or pN1 nodal staging permitted.\n* Subjects must have negative surgical margins or microscopic-only positive surgical margins.\n\nFinal eligibility criteria at 2 months postoperative for randomization include:\n\n* FK-PC101 has been produced for the subject and meets all release specifications.\n* An undetectable PSA (\\<0.04 ng/mL) on the most recent test performed prior to randomization (Day -4 to -7).\n* No prior, current, or planned future postoperative or adjuvant XRT, hormonal therapy such as ADT, or any other anticancer therapy (future therapy should not be administered until evidence exists of prostate cancer disease recurrence \\[such as PSA recurrence\\]).\n* Adequate organ function based on CBC and chemistry studies within 2 weeks of Day 1 (Day -14 to -7). Specific laboratory requirements include:\n\n  * Absolute neutrophil count (ANC) \\>1000/\u00b5L\n  * Platelet count \\>100,000/\u00b5L.\n  * Hemoglobin \\>8.0 gm/dL.\n  * Estimated glomerular filtration rate (eGFR) \\>60 mL/minute based on Cockcroft-Gault formula.\n  * Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) both \\<2 \u00d7 upper limit of normal (ULN).\n  * Albumin \\>3.0 gm/dL.\n* Capable of giving signed informed consent, which includes compliance with the requirements and restrictions of the study.\n\nExclusion Criteria:\n\n* Has an additional active malignancy that may confound the assessment of the study endpoints. If the subject has a past cancer history (active malignancy within 2 years prior to study entry) with substantial potential for recurrence, this must be discussed with the Sponsor before study entry. Note: Subjects with the following concomitant neoplastic diagnoses are eligible: non-melanoma skin cancer and carcinomas in situ (including breast DCIS, transitional cell carcinoma/NMIBC, anal carcinoma, and melanoma in situ).\n* Is eligible for and elects to receive adjuvant therapy following RP.\n* Has clinically significant cardiovascular disease (e.g., uncontrolled or any New York Heart Association \\[NYHA\\] Class 3 or 4 congestive heart failure, uncontrolled angina, history of myocardial infarction, unstable angina, pulmonary embolism or stroke within 6 months prior to study entry, uncontrolled hypertension, or clinically significant arrhythmias not controlled by medication).\n* Has uncontrolled, clinically significant pulmonary disease (e.g., chronic obstructive pulmonary disease, pulmonary hypertension) that in the opinion of the Investigator would put the subject at significant risk for pulmonary complications during the study.\n* Has known metastases, such as bone, visceral, or brain or leptomeningeal metastases.\n* Has an active autoimmune disease or Grade \u22653 pneumonitis that has required systemic treatment in the past 2 years (i.e., with use of disease-modifying agents, corticosteroids, or immunosuppressive drugs). Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency) or treatment with drugs (e.g., neomercazol, carbamazole) that function to decrease the generation of thyroid hormone by a hyperfunctioning thyroid gland (e.g., in Graves' disease) is not considered a form of systemic treatment of an autoimmune disease.\n* Is currently receiving systemic steroid therapy at a prednisone equivalent dose of \\>10 mg daily for at least 1 week or other form of immunosuppressive therapy within 7 days prior to enrollment.\n* Has uncontrolled intercurrent illness including, but not limited to, uncontrolled infection, disseminated intravascular coagulation, or psychiatric illness/social situations that would limit compliance with study requirements.\n* Is at risk for disseminated BCG infection or has previously demonstrated an allergic response to BCG or its components.\n* Has known positive status for human immunodeficiency virus (HIV) or active or chronic Hepatitis (Hep) B or Hep C. Screening is not required.\n* Has any medical condition which in the opinion of the Investigator places the subject at an unacceptably high risk for toxicity.",
                    "healthyVolunteers": false,
                    "sex": "MALE",
                    "stdAges": [
                        "CHILD",
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "FK-PC101 Trial Management",
                            "role": "CONTACT",
                            "phone": "215-941-5916",
                            "email": "FKPC101@cellvx.com"
                        }
                    ],
                    "overallOfficials": [
                        {
                            "name": "Fernando Kreutz, MD PhD",
                            "affiliation": "Cellvax Therapeutics Inc",
                            "role": "STUDY_CHAIR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic",
                            "status": "ACTIVE_NOT_RECRUITING",
                            "city": "Chicago",
                            "state": "Illinois",
                            "zip": "60637",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.85003,
                                "lon": -87.65005
                            }
                        },
                        {
                            "facility": "Central Ohio Urology Group",
                            "status": "RECRUITING",
                            "city": "Gahanna",
                            "state": "Ohio",
                            "zip": "43230",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Ronney Abaza, MD",
                                    "role": "CONTACT",
                                    "phone": "614-796-2842",
                                    "email": "dublinoffice@centralohiourology.com"
                                }
                            ],
                            "geoPoint": {
                                "lat": 40.01923,
                                "lon": -82.87934
                            }
                        },
                        {
                            "facility": "Carolina Urologic Research Center",
                            "status": "RECRUITING",
                            "city": "Myrtle Beach",
                            "state": "South Carolina",
                            "zip": "29572",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Neal Shore, MD",
                                    "role": "CONTACT",
                                    "phone": "843-839-1679",
                                    "email": "nshore@auclinics.com"
                                }
                            ],
                            "geoPoint": {
                                "lat": 33.68906,
                                "lon": -78.88669
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D011471",
                            "term": "Prostatic Neoplasms"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D005834",
                            "term": "Genital Neoplasms, Male"
                        },
                        {
                            "id": "D014565",
                            "term": "Urogenital Neoplasms"
                        },
                        {
                            "id": "D009371",
                            "term": "Neoplasms by Site"
                        },
                        {
                            "id": "D009369",
                            "term": "Neoplasms"
                        },
                        {
                            "id": "D005832",
                            "term": "Genital Diseases, Male"
                        },
                        {
                            "id": "D000091662",
                            "term": "Genital Diseases"
                        },
                        {
                            "id": "D000091642",
                            "term": "Urogenital Diseases"
                        },
                        {
                            "id": "D011469",
                            "term": "Prostatic Diseases"
                        },
                        {
                            "id": "D052801",
                            "term": "Male Urogenital Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M3585",
                            "name": "Adenocarcinoma",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14335",
                            "name": "Prostatic Neoplasms",
                            "asFound": "Prostate Cancer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M8946",
                            "name": "Genital Neoplasms, Male",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M17315",
                            "name": "Urogenital Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M2876",
                            "name": "Genital Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8944",
                            "name": "Genital Diseases, Male",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M2875",
                            "name": "Urogenital Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14333",
                            "name": "Prostatic Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M27095",
                            "name": "Male Urogenital Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC04",
                            "name": "Neoplasms"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BXS",
                            "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "browseLeaves": [
                        {
                            "id": "M17360",
                            "name": "Vaccines",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4793",
                            "name": "BCG Vaccine",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M3628",
                            "name": "Adjuvants, Immunologic",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT06650982",
                    "orgStudyIdInfo": {
                        "id": "MYES\u0130LYURT4"
                    },
                    "organization": {
                        "fullName": "Necmettin Erbakan University",
                        "class": "OTHER"
                    },
                    "briefTitle": "The Effects of PechaKucha Presentation About Medical Device-Related Pressure Injuries",
                    "officialTitle": "The Effects of PechaKucha Presentation About Medical Device-Related Pressure Injuries on Knowledge and Attitudes of Nursing Students: a Randomized Controlled Study"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2024-05-15",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2024-11-16",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2024-12-16",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2024-05-15",
                    "studyFirstSubmitQcDate": "2024-10-18",
                    "studyFirstPostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR_INVESTIGATOR",
                        "investigatorFullName": "MA\u0130DE YE\u015e\u0130LYURT",
                        "investigatorTitle": "DOCTOR",
                        "investigatorAffiliation": "Necmettin Erbakan University"
                    },
                    "leadSponsor": {
                        "name": "MA\u0130DE YE\u015e\u0130LYURT",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "In the literature, no research has been found examining the knowledge and attitudes of students regarding medical device related pressure injury education given using the PK method. In addition to contributing to the existing literature, this research will also contribute to determining the effect of TAIBY training given with PK, a current presentation technique, on the learning and attitude levels of nursing students.",
                    "detailedDescription": "Medical device-associated pressure injuries occur on the tissue and mucous membranes due to the pressure created by the medical device, but differ from other pressure injuries in that they do not occur on bone protrusions. European Pressure Injury Advisory Panel (EPUAP), The National Pressure Injury Advisory Panel (NPIAP) and the Pan Pacific Pressure Injury Alliance (PPPIA) define these injuries as \"pressure injuries caused by tools used for diagnosis or treatment.\" It can develop in any anatomical region it comes into contact with, especially the ear, foot, neck, head and face. It is known that medical device-related pressure injuries constitute approximately one-third of the pressure injuries in hospitalized adult patients. Prevention and care interventions in medical device-related pressure injuries should be carried out in line with proven recommendations. is important for patient safety.\n\npread Pecha kucha (PK) is an innovative form of presentation used around the world (Byrne, 2016). PK, derived from the Japanese word meaning \"chat\", helps present creative works with visual images Pecha kucha is a compact and effective presentation method consisting of 20 slides, each presented in 20 seconds This \"20\u00d720\" format, which requires careful editing and develops the use of critical communication skills, serves as an innovative and valuable tool that allows the presenter to dynamically and systematically present important information worth sharing to the audience . Thanks to Pecha Kucha, the presenter conveys the topic quickly and clearly without deviating from the essence of the topic Beyer et al. (2012) reported that PK may be superior to traditional PowerPoint presentations in terms of learning function. Klentzin et al. (2010) also stated that PK is as effective as traditional PowerPoint presentations in retaining information. It is stated that with the pecha kucha method, information can be presented in a more concise way, without any difference in quality, compared to a longer PowerPoint presentation\n\n. PK presentation, including visual and narrative presentation, does not take more than 7-8 minutes It is stated that the use of the PK method is effective in transferring theoretical content into practice and providing emotional learning in nursing education (Byrne, 2016). Students studying in health services were given training on the prevention of pressure injuries with the PK presentation method, and it was determined that the knowledge level of the students increased with the PK method . In a study comparing PK and traditional presentation in nursing education, it was found that there was no difference between the two methods, but it was recommended that the PK method be used on issues that require attention In studies using PK in medical education, it was stated that the majority of students liked this learning method and wanted it to be used in other courses .\n\nIn the literature, no research has been found examining the knowledge and attitudes of students regarding medical device related pressure \u0131nury education given using the PK method. In addition to contributing to the existing literature, this research will also contribute to determining the effect of training given with PK, a current presentation technique, on the learning and attitude levels of nursing students."
                },
                "conditionsModule": {
                    "conditions": [
                        "Medical Device Site Injury"
                    ],
                    "keywords": [
                        "pecha kucha",
                        "medical device related pressure injury",
                        "nursing student"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "SCREENING",
                        "maskingInfo": {
                            "masking": "SINGLE",
                            "whoMasked": [
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 100,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "experimental arm",
                            "type": "EXPERIMENTAL",
                            "description": "Before medical device related pressure injury (MDRPI) training is given to students, an introductory characteristics form and knowledge and attitude surveys will be applied (pre-test). The survey questions will be administered immediately after the PK training presentation containing MDRPI information is given to the students (Posttest 1), and 4 weeks later (Posttest 2).",
                            "interventionNames": [
                                "Other: Pecha Kucha presentation on MDPRI"
                            ]
                        },
                        {
                            "label": "control arm",
                            "type": "NO_INTERVENTION",
                            "description": "Before students are given MDRPI training, an introductory characteristics form and knowledge and attitude surveys will be administered (pre-test). The survey questions will be administered immediately after the traditional educational presentation containing MDRPI information is given to the students (Posttest 1), and again 4 weeks later (Posttest 2)."
                        }
                    ],
                    "interventions": [
                        {
                            "type": "OTHER",
                            "name": "Pecha Kucha presentation on MDPRI",
                            "description": "Students in the experimental arm will be given training on MDRPI.",
                            "armGroupLabels": [
                                "experimental arm"
                            ],
                            "otherNames": [
                                "EDUCATION RELATED TO MDRPI"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Pressure injury knowledge level of students",
                            "description": "students' \"Medical Device-related Pressure Sore Knowledge Level Assessment Test score\",",
                            "timeFrame": "up to 4 weeks"
                        },
                        {
                            "measure": "students' pressure injury attitude level",
                            "description": "students' \"Pressure Injury Attitude Survey Regarding Medical Devices score\"",
                            "timeFrame": "up to 4 weeks"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Being a nursing student\n* volunteer\n\nExclusion Criteria:\n\n* Not being a nursing student\n* not volunteering",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Maide YE\u015e\u0130LYURT, PHD",
                            "role": "CONTACT",
                            "phone": "05378777581",
                            "email": "md91yesilyurt@gmail.com"
                        }
                    ],
                    "overallOfficials": [
                        {
                            "name": "Serpil YUKSEL, PHD",
                            "affiliation": "Necmettin Erbakan University",
                            "role": "STUDY_CHAIR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Aksaray University",
                            "status": "RECRUITING",
                            "city": "Merkez",
                            "country": "Turkey",
                            "contacts": [
                                {
                                    "name": "Maide YE\u015e\u0130LYURT, PHD",
                                    "role": "CONTACT",
                                    "phone": "05378777581",
                                    "email": "md91yesilyurt@gmail.com"
                                }
                            ]
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D003668",
                            "term": "Pressure Ulcer"
                        },
                        {
                            "id": "D014947",
                            "term": "Wounds and Injuries"
                        },
                        {
                            "id": "D000071576",
                            "term": "Crush Injuries"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D012883",
                            "term": "Skin Ulcer"
                        },
                        {
                            "id": "D012871",
                            "term": "Skin Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M834",
                            "name": "Crush Injuries",
                            "asFound": "Pressure Injury",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M17206",
                            "name": "Ulcer",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6870",
                            "name": "Pressure Ulcer",
                            "asFound": "Pressure Injury",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M17685",
                            "name": "Wounds and Injuries",
                            "asFound": "Injury",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M15686",
                            "name": "Skin Ulcer",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15674",
                            "name": "Skin Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC26",
                            "name": "Wounds and Injuries"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "BC17",
                            "name": "Skin and Connective Tissue Diseases"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT02152631",
                    "orgStudyIdInfo": {
                        "id": "15296"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "I3Y-MC-JPBK",
                            "type": "OTHER",
                            "domain": "Eli Lilly and Company"
                        },
                        {
                            "id": "2013-004662-33",
                            "type": "EUDRACT_NUMBER"
                        }
                    ],
                    "organization": {
                        "fullName": "Eli Lilly and Company",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer",
                    "officialTitle": "JUNIPER: A Randomized Phase 3 Study of Abemaciclib Plus Best Supportive Care Versus Erlotinib Plus Best Supportive Care in Patients With Stage IV NSCLC With a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy",
                    "acronym": "JUNIPER"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "ACTIVE_NOT_RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": true,
                        "nctId": "NCT03763604",
                        "statusForNctId": "AVAILABLE"
                    },
                    "startDateStruct": {
                        "date": "2014-10-03",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2017-09-15",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2025-12",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2014-05-23",
                    "studyFirstSubmitQcDate": "2014-05-29",
                    "studyFirstPostDateStruct": {
                        "date": "2014-06-02",
                        "type": "ESTIMATED"
                    },
                    "resultsFirstSubmitDate": "2018-08-23",
                    "resultsFirstSubmitQcDate": "2018-11-16",
                    "resultsFirstPostDateStruct": {
                        "date": "2018-12-12",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-08",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Eli Lilly and Company",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true
                },
                "descriptionModule": {
                    "briefSummary": "The main purpose of this study is to evaluate how safe and effective the study drug known as abemaciclib is in participants with lung cancer."
                },
                "conditionsModule": {
                    "conditions": [
                        "Non Small Cell Lung Cancer"
                    ],
                    "keywords": [
                        "Therapy, Platinum, Kras +"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE3"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 453,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Abemaciclib",
                            "type": "EXPERIMENTAL",
                            "description": "200 milligrams (mg) abemaciclib administered, orally, every 12 hours plus best supportive care (BSC) on Days 1 to 28 (28 day cycles).",
                            "interventionNames": [
                                "Drug: Abemaciclib"
                            ]
                        },
                        {
                            "label": "Erlotinib",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "150 mg erlotinib administered, orally, every 24 hours plus BSC on Days 1 to 28 (28 day cycles).",
                            "interventionNames": [
                                "Drug: Erlotinib"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Abemaciclib",
                            "description": "Administered orally",
                            "armGroupLabels": [
                                "Abemaciclib"
                            ],
                            "otherNames": [
                                "LY2835219"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Erlotinib",
                            "description": "Administered orally",
                            "armGroupLabels": [
                                "Erlotinib"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Overall Survival (OS)",
                            "description": "OS defined as from randomization date to the date of death due to any cause. For each participant who is not known to have died as of the data-inclusion cutoff date for overall survival analysis, OS time was censored on the last date the participant is known to be alive.",
                            "timeFrame": "From Randomization Date to Date of Death from Any Cause (Up to 32 Months)"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Percentage of Participants With Complete Response (CR) or Partial Response (PR) (Objective Response Rate [ORR])",
                            "description": "ORR was the percentage of participants achieving a best overall response (BOR) of complete response (CR) or partial response (PR) as per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1. CR defined as the disappearance of all target and non-target lesions and no appearance of new lesions. PR defined as at least a 30% decrease in the sum of the longest diameters (LD) of target lesions (taking as reference the baseline sum LD), no progression of non-target lesions, and no appearance of new lesions.",
                            "timeFrame": "From Randomization Date to Objective Progression (Up to 32 Months)"
                        },
                        {
                            "measure": "Progression Free Survival (PFS)",
                            "description": "PFS defined as the from randomization date to the first evidence of disease progression as defined by RECIST v1.1 or death from any cause. Progressive Disease (PD) was at least a 20% increase in the sum of the diameters of target lesions, with reference being the smallest sum on study and an absolute increase of at least 5 mm, or unequivocal progression of non-target lesions, or 1 or more new lesions. If a participant does not have a complete baseline disease assessment, then the PFS time was censored at the date of first dose, regardless of whether or not objectively determined disease progression or death has been observed for the participant. If a participant was not known to have died or have objective progression as of the data inclusion cutoff date for the analysis, the PFS time was censored at the last adequate tumor assessment date.",
                            "timeFrame": "From Randomization Date until Disease Progression or Death from Any Cause (Up to 32 Months)"
                        },
                        {
                            "measure": "Change From Baseline in MD Anderson Symptom Inventory-Lung Cancer (MDASI-LC) Score",
                            "description": "The MDASI-LC included 22 items + 3 additional trial-specific items, resulting in 6 collected and reported single-construct scores including core symptoms (13-item), interference (6-item), lung cancer (3-item), and trial-specific single outcomes for headache, diarrhea, and rash. A 2-construct composite core + lung cancer symptom (16-item) score was calculated. Data for all 7 scores were collected by an 11-point numeric rating scale anchored at 0 (not present or does not interfere) and 10 (as bad as you can imagine or interfered completely). The measurement range was 10 (maximum score-minimum score). Mixed Model Repeated Measure (MMRM) regression with covariates for treatment, visit, treatment\\*visit, and baseline score predicted between-group Least Squares (LS) mean differences from baseline. Group-level negative change from baseline indicated group improvement.",
                            "timeFrame": "From Randomization Date through End of Study (Up to 32 Months)"
                        },
                        {
                            "measure": "Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve During 1 Dosing Interval at Steady State",
                            "description": "PK is determined by the area under the plasma concentration versus time curve during 1 dosing interval at steady state",
                            "timeFrame": "Day 1 of Cycle 1 through Cycle 3 (28 Day Cycles)"
                        },
                        {
                            "measure": "Change From Baseline in European Quality of Life - 5 Dimensions - 5 Level (EQ-5D-5L) Score",
                            "description": "There are 5 response levels on a good-to-bad continuum of 1-5 corresponding to none, slight, moderate, severe, and extreme/unable to. The EuroQol-developed crosswalk method was used to convert the EQ-5D-5L,using United Kingdom (UK) weights, health dimensions(mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) into a single index value; the dimensions are not separately scored. The index is marked missing when \u22651 dimensions are missing. The index scores for the response patterns were anchored on full health to dead with negative values assigned to response patterns/health states considered worse than death. The best pattern is assigned the index value of 1.0; the worst pattern is assigned an index value of -0.594. Between-group differences in regression-predicted change from baseline score were estimated for the index. LS Mean value was controlled for Treatment, visit, Treatment\\*Visit and baseline.",
                            "timeFrame": "From Randomization Date through End of Study (Up to 32 Months)"
                        },
                        {
                            "measure": "Resource Utilization: Percentage of Participants Who Are Hospitalized",
                            "description": "Resource utilization is the percentage of participants who was hospitalized.",
                            "timeFrame": "From Randomization Date through End of Study (Up to 32 Months)"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Have confirmed diagnosis of stage IV non-small cell lung cancer (NSCLC) according to the American Joint Committee on Cancer Staging Handbook.\n* Determined to have detectable mutations in codons 12 or 13 of the kirsten rat sarcoma (KRAS) oncogene by an investigational assay at the study central laboratory. A KRAS positive mutation result in codons 12 or 13 of the KRAS oncogene from tumor tissue per local laboratory will be permitted in no more than 10% of randomized participants.\n* Have progressed after platinum-based chemotherapy (with or without maintenance therapy) AND have received one additional therapy which may include an immune checkpoint inhibitor or other anti-cancer therapy for advanced and/or metastatic disease OR is judged by the physician as ineligible for further standard second-line chemotherapy. Participants who have progressed after platinum-based chemotherapy and an immune checkpoint inhibitor (immunotherapy) e.g. pembrolizumab or nivolumab alone or in combination with other agents are eligible.\n* Have measureable disease as defined by the Response Evaluation Criteria in Solid Tumors (RECIST 1.1).\n* Have a performance status (PS) of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) scale.\n* Have discontinued all previous therapies for cancer (including chemotherapy, radiotherapy, immunotherapy, and investigational therapy) for at least 21 days for myelosuppressive agents or 14 days for nonmyelosuppressive agents prior to receiving study drug.\n\nExclusion Criteria:\n\n* Have received treatment with a drug that has not received regulatory approval for any indication within 14 or 21 days of the initial dose of study drug for a nonmyelosuppressive or myelosuppressive agent, respectively.\n* Have a personal history of any of the following conditions: presyncope or syncope of either unexplained or cardiovascular etiology, ventricular arrhythmia (including but not limited to ventricular tachycardia and ventricular fibrillation), or sudden cardiac arrest.\n* Have the presence of unstable central nervous system (CNS) metastasis. History of CNS metastasis or stable CNS metastases is allowed (no longer requiring active therapy such as steroid medications). Participants with a history of CNS metastases must have a brain scan (for example, magnetic resonance imaging \\[MRI\\]) within 28 days of randomization to document stability, even if there have been no changes in symptoms.\n* Have previously completed or withdrawn from this study or any other study investigating a cyclin-dependent kinase 4 (CDK4) and cyclin-dependent kinase 6 (CDK6) inhibitors, or have received treatment with a prior CDK4 and CDK6 inhibitors.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)",
                            "affiliation": "Eli Lilly and Company",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Highlands Oncology Group",
                            "city": "Fayetteville",
                            "state": "Arkansas",
                            "zip": "72703",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.06258,
                                "lon": -94.15743
                            }
                        },
                        {
                            "facility": "St. Bernards Medical Center",
                            "city": "Jonesboro",
                            "state": "Arkansas",
                            "zip": "72401",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.8423,
                                "lon": -90.70428
                            }
                        },
                        {
                            "facility": "City of Hope National Medical Center",
                            "city": "Duarte",
                            "state": "California",
                            "zip": "91010",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.13945,
                                "lon": -117.97729
                            }
                        },
                        {
                            "facility": "University of California - San Diego",
                            "city": "La Jolla",
                            "state": "California",
                            "zip": "92037",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.84727,
                                "lon": -117.2742
                            }
                        },
                        {
                            "facility": "Loma Linda University School of Medicine",
                            "city": "Loma Linda",
                            "state": "California",
                            "zip": "92350",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.04835,
                                "lon": -117.26115
                            }
                        },
                        {
                            "facility": "CBCC Global Research, Inc.",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90024",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "Central Coast Medical Oncology Corporation",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90024",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "Fort Wayne Oncology & Hematology",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90024",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "SMO TRIO -Translational Research",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90024",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "St. Joseph Heritage Medical Group",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90024",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "UCLA Department of Medicine-Hematology/Oncology",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90024",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "Cancer Care Associates Medical Group",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90095",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "Dignity Health Care Institute",
                            "city": "Sacramento",
                            "state": "California",
                            "zip": "95816",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.58157,
                                "lon": -121.4944
                            }
                        },
                        {
                            "facility": "Alegent Immanuel Cancer Center",
                            "city": "Englewood",
                            "state": "Colorado",
                            "zip": "80112",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.64777,
                                "lon": -104.98776
                            }
                        },
                        {
                            "facility": "Jewish Hospital",
                            "city": "Englewood",
                            "state": "Colorado",
                            "zip": "80112",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.64777,
                                "lon": -104.98776
                            }
                        },
                        {
                            "facility": "Oncology Hematology West",
                            "city": "Englewood",
                            "state": "Colorado",
                            "zip": "80112",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.64777,
                                "lon": -104.98776
                            }
                        },
                        {
                            "facility": "SMO Catholic Health Initiatives",
                            "city": "Englewood",
                            "state": "Colorado",
                            "zip": "80112",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.64777,
                                "lon": -104.98776
                            }
                        },
                        {
                            "facility": "St Joseph Cancer Center",
                            "city": "Englewood",
                            "state": "Colorado",
                            "zip": "80112",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.64777,
                                "lon": -104.98776
                            }
                        },
                        {
                            "facility": "St. Francis Medical Center",
                            "city": "Englewood",
                            "state": "Colorado",
                            "zip": "80112",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.64777,
                                "lon": -104.98776
                            }
                        },
                        {
                            "facility": "Medical Oncology Hematology Consultants",
                            "city": "Newark",
                            "state": "Delaware",
                            "zip": "19713",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.68372,
                                "lon": -75.74966
                            }
                        },
                        {
                            "facility": "Boca Raton Regional Hospital",
                            "city": "Boca Raton",
                            "state": "Florida",
                            "zip": "33486",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 26.3669,
                                "lon": -80.13033
                            }
                        },
                        {
                            "facility": "Halifax Medical Center",
                            "city": "Daytona Beach",
                            "state": "Florida",
                            "zip": "32114",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 29.21081,
                                "lon": -81.02283
                            }
                        },
                        {
                            "facility": "Memorial Cancer Institute",
                            "city": "Pembroke Pines",
                            "state": "Florida",
                            "zip": "33028",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 26.00315,
                                "lon": -80.22394
                            }
                        },
                        {
                            "facility": "H Lee Moffitt Cancer Center",
                            "city": "Tampa",
                            "state": "Florida",
                            "zip": "33612-9497",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 27.94752,
                                "lon": -82.45843
                            }
                        },
                        {
                            "facility": "University Cancer & Blood Center, LLC",
                            "city": "Athens",
                            "state": "Georgia",
                            "zip": "30607",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 33.96095,
                                "lon": -83.37794
                            }
                        },
                        {
                            "facility": "Ingalls Memorial Hospital",
                            "city": "Harvey",
                            "state": "Illinois",
                            "zip": "60426",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.61003,
                                "lon": -87.64671
                            }
                        },
                        {
                            "facility": "Indiana University School of Medicine",
                            "city": "Indianapolis",
                            "state": "Indiana",
                            "zip": "46202",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.76838,
                                "lon": -86.15804
                            }
                        },
                        {
                            "facility": "University of Iowa",
                            "city": "Iowa City",
                            "state": "Iowa",
                            "zip": "52242",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.66113,
                                "lon": -91.53017
                            }
                        },
                        {
                            "facility": "Cancer Center of Kansas, P.A.",
                            "city": "Wichita",
                            "state": "Kansas",
                            "zip": "67214",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.69224,
                                "lon": -97.33754
                            }
                        },
                        {
                            "facility": "Central Baptist Hospital",
                            "city": "Lexington",
                            "state": "Kentucky",
                            "zip": "40503",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.98869,
                                "lon": -84.47772
                            }
                        },
                        {
                            "facility": "University of Louisville",
                            "city": "Louisville",
                            "state": "Kentucky",
                            "zip": "40202",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.25424,
                                "lon": -85.75941
                            }
                        },
                        {
                            "facility": "Walter Reed National Military Medical Center",
                            "city": "Bethesda",
                            "state": "Maryland",
                            "zip": "20889",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.98067,
                                "lon": -77.10026
                            }
                        },
                        {
                            "facility": "Metro-West and Greater Boston CNS Research",
                            "city": "Framingham",
                            "state": "Massachusetts",
                            "zip": "01701",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.27926,
                                "lon": -71.41617
                            }
                        },
                        {
                            "facility": "Karmanos Cancer Institute",
                            "city": "Detroit",
                            "state": "Michigan",
                            "zip": "48201",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.33143,
                                "lon": -83.04575
                            }
                        },
                        {
                            "facility": "Mercy Medical Research Institute",
                            "city": "Springfield",
                            "state": "Missouri",
                            "zip": "65807",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.21533,
                                "lon": -93.29824
                            }
                        },
                        {
                            "facility": "Billings Clinic Research Center",
                            "city": "Billings",
                            "state": "Montana",
                            "zip": "59101",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 45.78329,
                                "lon": -108.50069
                            }
                        },
                        {
                            "facility": "Dartmouth Hitchcock Medical Center",
                            "city": "Lebanon",
                            "state": "New Hampshire",
                            "zip": "03756",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 43.64229,
                                "lon": -72.25176
                            }
                        },
                        {
                            "facility": "Broome Oncology",
                            "city": "Johnson City",
                            "state": "New York",
                            "zip": "13790",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.11563,
                                "lon": -75.95881
                            }
                        },
                        {
                            "facility": "Weill Cornell Medical College",
                            "city": "New York",
                            "state": "New York",
                            "zip": "10065",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.71427,
                                "lon": -74.00597
                            }
                        },
                        {
                            "facility": "Oncology Hematology Care Inc",
                            "city": "Cincinnati",
                            "state": "Ohio",
                            "zip": "45242",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.12713,
                                "lon": -84.51435
                            }
                        },
                        {
                            "facility": "Oklahoma Cancer Specialists & Research Institute, LLC",
                            "city": "Tulsa",
                            "state": "Oklahoma",
                            "zip": "74146",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.15398,
                                "lon": -95.99277
                            }
                        },
                        {
                            "facility": "Providence Cancer Center Oncology Hematology Care",
                            "city": "Portland",
                            "state": "Oregon",
                            "zip": "97213",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 45.52345,
                                "lon": -122.67621
                            }
                        },
                        {
                            "facility": "UPMC Hillman Cancer Center",
                            "city": "Pittsburgh",
                            "state": "Pennsylvania",
                            "zip": "15213",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.44062,
                                "lon": -79.99589
                            }
                        },
                        {
                            "facility": "Roper St. Francis Healthcare",
                            "city": "Charleston",
                            "state": "South Carolina",
                            "zip": "29401",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.77657,
                                "lon": -79.93092
                            }
                        },
                        {
                            "facility": "Chattanooga Oncology Hematology Associates",
                            "city": "Chattanooga",
                            "state": "Tennessee",
                            "zip": "37404",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.04563,
                                "lon": -85.30968
                            }
                        },
                        {
                            "facility": "Chattanooga Oncology Hematology Associates",
                            "city": "Nashville",
                            "state": "Tennessee",
                            "zip": "37203",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.16589,
                                "lon": -86.78444
                            }
                        },
                        {
                            "facility": "Tennessee Oncology PLLC",
                            "city": "Nashville",
                            "state": "Tennessee",
                            "zip": "37203",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.16589,
                                "lon": -86.78444
                            }
                        },
                        {
                            "facility": "Mary Crowley Cancer Research Center",
                            "city": "Dallas",
                            "state": "Texas",
                            "zip": "75230",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 32.78306,
                                "lon": -96.80667
                            }
                        },
                        {
                            "facility": "Utah Cancer Specialists",
                            "city": "Salt Lake City",
                            "state": "Utah",
                            "zip": "84106",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.76078,
                                "lon": -111.89105
                            }
                        },
                        {
                            "facility": "University of Vermont Medical Center",
                            "city": "Burlington",
                            "state": "Vermont",
                            "zip": "05401",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.47588,
                                "lon": -73.21207
                            }
                        },
                        {
                            "facility": "Virginia Commonwealth University",
                            "city": "Richmond",
                            "state": "Virginia",
                            "zip": "23298",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 37.55376,
                                "lon": -77.46026
                            }
                        },
                        {
                            "facility": "Kadlec Clinical Hematology & Oncology",
                            "city": "Kennewick",
                            "state": "Washington",
                            "zip": "99336",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 46.21125,
                                "lon": -119.13723
                            }
                        },
                        {
                            "facility": "Swedish Medical Center",
                            "city": "Seattle",
                            "state": "Washington",
                            "zip": "98104",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 47.60621,
                                "lon": -122.33207
                            }
                        },
                        {
                            "facility": "Cancer Care Northwest",
                            "city": "Valley",
                            "state": "Washington",
                            "zip": "99216",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 48.17517,
                                "lon": -117.72468
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician",
                            "city": "Berazategui",
                            "zip": "B1884BBF",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -34.76531,
                                "lon": -58.21278
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Ciudad Autonoma Buenos Aires",
                            "zip": "1025",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -34.61315,
                                "lon": -58.37723
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Ciudad Autonoma Buenos Aires",
                            "zip": "1093",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -34.61315,
                                "lon": -58.37723
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Ciudad Autonoma Buenos Aires",
                            "zip": "C1181AAX",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -34.61315,
                                "lon": -58.37723
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Rosario",
                            "zip": "2000",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -32.94682,
                                "lon": -60.63932
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician",
                            "city": "Rosario",
                            "zip": "S2000DSV",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -32.94682,
                                "lon": -60.63932
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Viedma",
                            "zip": "8500",
                            "country": "Argentina",
                            "geoPoint": {
                                "lat": -40.81345,
                                "lon": -62.99668
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Graz",
                            "zip": "8036",
                            "country": "Austria",
                            "geoPoint": {
                                "lat": 47.06667,
                                "lon": 15.45
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician",
                            "city": "Linz",
                            "zip": "4020",
                            "country": "Austria",
                            "geoPoint": {
                                "lat": 48.30639,
                                "lon": 14.28611
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Linz",
                            "zip": "4021",
                            "country": "Austria",
                            "geoPoint": {
                                "lat": 48.30639,
                                "lon": 14.28611
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Salzburg",
                            "zip": "5020",
                            "country": "Austria",
                            "geoPoint": {
                                "lat": 47.79941,
                                "lon": 13.04399
                            }
                        },
                        {
                            "facility": "Associa\u00e7\u00e3o Hospital de Caridade Iju\u00ed",
                            "city": "Ijui",
                            "zip": "98700 000",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -28.38778,
                                "lon": -53.91472
                            }
                        },
                        {
                            "facility": "Hospital Bruno Born",
                            "city": "Lajeados",
                            "zip": "95900-000",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -20.68333,
                                "lon": -47.15
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Porto Alegre",
                            "zip": "90610-970",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -30.03306,
                                "lon": -51.23
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Rio De Janeiro",
                            "zip": "20231-050",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -22.90278,
                                "lon": -43.2075
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Salvador",
                            "zip": "41253-190",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -12.97111,
                                "lon": -38.51083
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Sao Jose Rio Preto",
                            "zip": "15090-000",
                            "country": "Brazil"
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician",
                            "city": "S\u00e3o Paulo",
                            "zip": "01246000",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -23.5475,
                                "lon": -46.63611
                            }
                        },
                        {
                            "facility": "Funda\u00e7\u00e3o Antonio Prudente - Hospital do C\u00e2ncer A.C Camargo",
                            "city": "S\u00e3o Paulo",
                            "zip": "01509-010",
                            "country": "Brazil",
                            "geoPoint": {
                                "lat": -23.5475,
                                "lon": -46.63611
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.",
                            "city": "Calgary",
                            "zip": "T2N 4N2",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 51.05011,
                                "lon": -114.08529
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.",
                            "city": "Edmonton",
                            "zip": "T6G 1Z2",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 53.55014,
                                "lon": -113.46871
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.",
                            "city": "Montreal",
                            "zip": "H2L 4M1",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 45.50884,
                                "lon": -73.58781
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.",
                            "city": "Toronto",
                            "zip": "M4N 3M5",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.70011,
                                "lon": -79.4163
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.",
                            "city": "Vancouver",
                            "zip": "V5Z 4E6",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 49.24966,
                                "lon": -123.11934
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.",
                            "city": "Winnipeg",
                            "zip": "R3A 1M3",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 49.8844,
                                "lon": -97.14704
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician",
                            "city": "Beijing",
                            "zip": "100021",
                            "country": "China",
                            "geoPoint": {
                                "lat": 39.9075,
                                "lon": 116.39723
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Beijing",
                            "zip": "100071",
                            "country": "China",
                            "geoPoint": {
                                "lat": 39.9075,
                                "lon": 116.39723
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician",
                            "city": "Beijing",
                            "zip": "100730",
                            "country": "China",
                            "geoPoint": {
                                "lat": 39.9075,
                                "lon": 116.39723
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Changchun",
                            "zip": "130012",
                            "country": "China",
                            "geoPoint": {
                                "lat": 43.88,
                                "lon": 125.32278
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Changzhou",
                            "zip": "213000",
                            "country": "China",
                            "geoPoint": {
                                "lat": 31.77359,
                                "lon": 119.95401
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Chengdu",
                            "zip": "610041",
                            "country": "China",
                            "geoPoint": {
                                "lat": 30.66667,
                                "lon": 104.06667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Haikou",
                            "zip": "570311",
                            "country": "China",
                            "geoPoint": {
                                "lat": 20.04583,
                                "lon": 110.34167
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Hang Zhou",
                            "zip": "310022",
                            "country": "China"
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Hefei",
                            "zip": "230001",
                            "country": "China",
                            "geoPoint": {
                                "lat": 31.86389,
                                "lon": 117.28083
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Nanning",
                            "zip": "530021",
                            "country": "China",
                            "geoPoint": {
                                "lat": 22.81667,
                                "lon": 108.31667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Shanghai",
                            "zip": "200030",
                            "country": "China",
                            "geoPoint": {
                                "lat": 31.22222,
                                "lon": 121.45806
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Shenyang",
                            "zip": "100042",
                            "country": "China",
                            "geoPoint": {
                                "lat": 41.79222,
                                "lon": 123.43278
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Bron",
                            "zip": "69677",
                            "country": "France",
                            "geoPoint": {
                                "lat": 45.73333,
                                "lon": 4.91667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician",
                            "city": "Dijon",
                            "zip": "21034",
                            "country": "France",
                            "geoPoint": {
                                "lat": 47.31667,
                                "lon": 5.01667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Grenoble",
                            "zip": "38043",
                            "country": "France",
                            "geoPoint": {
                                "lat": 45.16667,
                                "lon": 5.71667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Lille",
                            "zip": "59037",
                            "country": "France",
                            "geoPoint": {
                                "lat": 50.63297,
                                "lon": 3.05858
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Marseille",
                            "zip": "13015",
                            "country": "France",
                            "geoPoint": {
                                "lat": 43.29551,
                                "lon": 5.38958
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Poitiers",
                            "zip": "86021",
                            "country": "France",
                            "geoPoint": {
                                "lat": 46.58333,
                                "lon": 0.33333
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Rennes",
                            "zip": "35033",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.11198,
                                "lon": -1.67429
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician",
                            "city": "Saint-Brieuc",
                            "zip": "22027",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.51513,
                                "lon": -2.76838
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "St Priest en Jarez",
                            "zip": "42270",
                            "country": "France",
                            "geoPoint": {
                                "lat": 45.47501,
                                "lon": 4.37614
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Toulouse",
                            "zip": "31059",
                            "country": "France",
                            "geoPoint": {
                                "lat": 43.60426,
                                "lon": 1.44367
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Vantoux",
                            "zip": "57070",
                            "country": "France"
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Berlin",
                            "zip": "14165",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Gera",
                            "zip": "07548",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.88029,
                                "lon": 12.08187
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Gro\u00dfhansdorf",
                            "zip": "22927",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.66667,
                                "lon": 10.28333
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Hamburg",
                            "zip": "21075",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.57532,
                                "lon": 10.01534
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Hannover",
                            "zip": "30459",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.37052,
                                "lon": 9.73322
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Heidelberg",
                            "zip": "69126",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.40768,
                                "lon": 8.69079
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Immenhausen",
                            "zip": "34376",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 51.42763,
                                "lon": 9.48017
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "N\u00fcrnberg",
                            "zip": "90419",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.45421,
                                "lon": 11.07752
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Regensburg",
                            "zip": "93053",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 49.01513,
                                "lon": 12.10161
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Rosenheim",
                            "zip": "83022",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 47.85637,
                                "lon": 12.12247
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "T\u00fcbingen",
                            "zip": "72076",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 48.52266,
                                "lon": 9.05222
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Ulm",
                            "zip": "89081",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 48.39841,
                                "lon": 9.99155
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Athens",
                            "zip": "11522",
                            "country": "Greece",
                            "geoPoint": {
                                "lat": 37.97945,
                                "lon": 23.71622
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Athens",
                            "zip": "11527",
                            "country": "Greece",
                            "geoPoint": {
                                "lat": 37.97945,
                                "lon": 23.71622
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Athens",
                            "zip": "18537",
                            "country": "Greece",
                            "geoPoint": {
                                "lat": 37.97945,
                                "lon": 23.71622
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Heraklion",
                            "zip": "71110",
                            "country": "Greece",
                            "geoPoint": {
                                "lat": 35.32787,
                                "lon": 25.14341
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Patras",
                            "zip": "26504",
                            "country": "Greece",
                            "geoPoint": {
                                "lat": 38.24444,
                                "lon": 21.73444
                            }
                        },
                        {
                            "facility": "Soroka Medical Center",
                            "city": "Beer Sheva",
                            "zip": "8410101",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 31.25181,
                                "lon": 34.7913
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Holon",
                            "zip": "5822012",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 32.01034,
                                "lon": 34.77918
                            }
                        },
                        {
                            "facility": "Hadassah Medical Center - Ein Karem",
                            "city": "Jerusalem",
                            "zip": "9112001",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 31.76904,
                                "lon": 35.21633
                            }
                        },
                        {
                            "facility": "Meir Medical Center",
                            "city": "Kfar Saba",
                            "zip": "4428164",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 32.175,
                                "lon": 34.90694
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Petah Tiqva",
                            "zip": "4941492",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 32.08707,
                                "lon": 34.88747
                            }
                        },
                        {
                            "facility": "Sheba Medical Center",
                            "city": "Tel Hashomer",
                            "zip": "5265601",
                            "country": "Israel",
                            "geoPoint": {
                                "lat": 32.04195,
                                "lon": 34.85623
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Catania",
                            "zip": "95125",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 37.49223,
                                "lon": 15.07041
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Genova",
                            "zip": "16132",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 44.40478,
                                "lon": 8.94438
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Livorno",
                            "zip": "57124",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 43.54427,
                                "lon": 10.32615
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Parma",
                            "zip": "43100",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 44.79935,
                                "lon": 10.32618
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Rome",
                            "zip": "00152",
                            "country": "Italy",
                            "geoPoint": {
                                "lat": 41.89193,
                                "lon": 12.51133
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Amagasaki",
                            "zip": "660-0892",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.71667,
                                "lon": 135.41667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Asahikawa",
                            "zip": "070-8644",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 43.77063,
                                "lon": 142.36489
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Bunkyo-ku",
                            "zip": "113-8431",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.37517,
                                "lon": 139.92991
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Bunkyo-Ku",
                            "zip": "113-8677",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.37517,
                                "lon": 139.92991
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Fukuoka",
                            "zip": "811-1395",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 33.6,
                                "lon": 130.41667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Habikino",
                            "zip": "583-8588",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.55276,
                                "lon": 135.59097
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Hirakata",
                            "zip": "573-1191",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.81352,
                                "lon": 135.64914
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Hiroshima",
                            "zip": "734-8551",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.4,
                                "lon": 132.45
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Hyogo",
                            "zip": "6608550",
                            "country": "Japan"
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kanazawa",
                            "zip": "920-8641",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 36.6,
                                "lon": 136.61667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kashiwa",
                            "zip": "277 8577",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.86224,
                                "lon": 139.97732
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kishiwada",
                            "zip": "596-8501",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.46667,
                                "lon": 135.36667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kitaadachi-Gun",
                            "zip": "362-0806",
                            "country": "Japan"
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kobe",
                            "zip": "650-0047",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.6913,
                                "lon": 135.183
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Koto-ku",
                            "zip": "135-8550",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.66667,
                                "lon": 139.81718
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kurashiki",
                            "zip": "710-8602",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.58333,
                                "lon": 133.76667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Matsuyama",
                            "zip": "791-0280",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 33.83916,
                                "lon": 132.76574
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Nagasaki",
                            "zip": "852-8501",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 32.75,
                                "lon": 129.88333
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Nagoya",
                            "zip": "464-8681",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.18147,
                                "lon": 136.90641
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Nagoya",
                            "zip": "466-8560",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.18147,
                                "lon": 136.90641
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Natori",
                            "zip": "981-1293",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 38.16667,
                                "lon": 140.88333
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Okayama",
                            "zip": "700-8558",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.65,
                                "lon": 133.93333
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Osakasayama",
                            "zip": "589-8511",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.69374,
                                "lon": 135.50218
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Osaka",
                            "zip": "534-0021",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.69374,
                                "lon": 135.50218
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Osaka",
                            "zip": "537-8511",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.69374,
                                "lon": 135.50218
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Osaka",
                            "zip": "545-8586",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.69374,
                                "lon": 135.50218
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Sakai",
                            "zip": "5918555",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.58333,
                                "lon": 135.46667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Sendai",
                            "zip": "980-0873",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 38.26667,
                                "lon": 140.86667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Shinjuku-ku",
                            "zip": "160-0023",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.2946,
                                "lon": 139.57059
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Sunto-Gun",
                            "zip": "411-8777",
                            "country": "Japan"
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Ube",
                            "zip": "755-0241",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 33.94306,
                                "lon": 131.25111
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Utsunomiya",
                            "zip": "320-0834",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 36.56667,
                                "lon": 139.88333
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Wakayama",
                            "zip": "641-8510",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 34.23333,
                                "lon": 135.16667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Yokohama",
                            "zip": "236-0004",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.43333,
                                "lon": 139.65
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Yonago",
                            "zip": "683-0826",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 35.43333,
                                "lon": 133.33333
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Yufu-shi",
                            "zip": "8795593",
                            "country": "Japan",
                            "geoPoint": {
                                "lat": 33.1956,
                                "lon": 131.37829
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Goyang-Si",
                            "zip": "10408",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.65639,
                                "lon": 126.835
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Incheon",
                            "zip": "21565",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.45646,
                                "lon": 126.70515
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Seoul",
                            "zip": "03722",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Seoul",
                            "zip": "05505",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Seoul",
                            "zip": "06351",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Seoul",
                            "zip": "06591",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.566,
                                "lon": 126.9784
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Seowon-Gu",
                            "zip": "28644",
                            "country": "Korea, Republic of"
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Suwon",
                            "zip": "16247",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 37.29111,
                                "lon": 127.00889
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Ulsan-si",
                            "zip": "44033",
                            "country": "Korea, Republic of",
                            "geoPoint": {
                                "lat": 35.53722,
                                "lon": 129.31667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Gdansk",
                            "zip": "80-219",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 54.35205,
                                "lon": 18.64637
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Lodz",
                            "zip": "90-242",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 51.75,
                                "lon": 19.46667
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Olsztyn",
                            "zip": "10-357",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 53.77995,
                                "lon": 20.49416
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Radom",
                            "zip": "26-617",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 51.40253,
                                "lon": 21.14714
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Szczecin",
                            "zip": "70-891",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 53.42894,
                                "lon": 14.55302
                            }
                        },
                        {
                            "facility": "VA Caribbean Healthcare System",
                            "city": "San Juan",
                            "zip": "00921-3201",
                            "country": "Puerto Rico",
                            "geoPoint": {
                                "lat": 18.46633,
                                "lon": -66.10572
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Baia Mare",
                            "zip": "430031",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 47.65529,
                                "lon": 23.57381
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Bucharest",
                            "zip": "022328",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 44.43225,
                                "lon": 26.10626
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Cluj-Napoca",
                            "zip": "400015",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 46.76667,
                                "lon": 23.6
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Cluj-Napoca",
                            "zip": "400058",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 46.76667,
                                "lon": 23.6
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Craiova",
                            "zip": "200347",
                            "country": "Romania",
                            "geoPoint": {
                                "lat": 44.31667,
                                "lon": 23.8
                            }
                        },
                        {
                            "facility": "Arkhangelsk Regional Clinical Oncology Dispensary",
                            "city": "Arkhangelsk",
                            "zip": "163045",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 64.5401,
                                "lon": 40.5433
                            }
                        },
                        {
                            "facility": "Private clinic \"Evimed\"",
                            "city": "Chelyabinsk",
                            "zip": "454048",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 55.15402,
                                "lon": 61.42915
                            }
                        },
                        {
                            "facility": "Krasnodar regional clinical hospital # 1 n. a. S. V. Ochapovskogo",
                            "city": "Krasnodar",
                            "zip": "350086",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 45.04484,
                                "lon": 38.97603
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kursk",
                            "zip": "305035",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 51.73733,
                                "lon": 36.18735
                            }
                        },
                        {
                            "facility": "Russian oncological scientific centre n.a. N.N. Blokhin of RAMS",
                            "city": "Moscow",
                            "zip": "115478",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 55.75222,
                                "lon": 37.61556
                            }
                        },
                        {
                            "facility": "St-Petersburg scientifical practical center of specialized kinds of medical care (oncological)",
                            "city": "Saint Petersburg",
                            "zip": "197758",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 59.93863,
                                "lon": 30.31413
                            }
                        },
                        {
                            "facility": "Saint-Petersburg city clinical oncology dispensary",
                            "city": "Saint Petersburg",
                            "zip": "198255",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 59.93863,
                                "lon": 30.31413
                            }
                        },
                        {
                            "facility": "Republic clinical oncology dispensary of MoH of Bashkortostan Republic",
                            "city": "Ufa",
                            "zip": "450054",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 54.74306,
                                "lon": 55.96779
                            }
                        },
                        {
                            "facility": "Volgograd regional clinical oncology dispensary",
                            "city": "Volzhskiy",
                            "zip": "404130",
                            "country": "Russian Federation",
                            "geoPoint": {
                                "lat": 48.78583,
                                "lon": 44.77973
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Barcelona",
                            "zip": "08003",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.38879,
                                "lon": 2.15899
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "L'Hospitalet de Llobregat",
                            "zip": "08907",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 41.35967,
                                "lon": 2.10028
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "La Coru\u00f1a",
                            "zip": "15006",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 43.37135,
                                "lon": -8.396
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Madrid",
                            "zip": "28040",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 40.4165,
                                "lon": -3.70256
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Madrid",
                            "zip": "28041",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 40.4165,
                                "lon": -3.70256
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Madrid",
                            "zip": "28050",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 40.4165,
                                "lon": -3.70256
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Malaga",
                            "zip": "29010",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 36.72016,
                                "lon": -4.42034
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Sevilla",
                            "zip": "41013",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 37.38283,
                                "lon": -5.97317
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Valencia",
                            "zip": "46026",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 39.46975,
                                "lon": -0.37739
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Chiayi",
                            "zip": "613",
                            "country": "Taiwan"
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Jhonghe City",
                            "zip": "235",
                            "country": "Taiwan"
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kaohsiung City",
                            "zip": "82445",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 22.61626,
                                "lon": 120.31333
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kaohsiung",
                            "zip": "83301",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 22.61626,
                                "lon": 120.31333
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Taichung City",
                            "zip": "404",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 24.1469,
                                "lon": 120.6839
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Taichung",
                            "zip": "40447",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 24.1469,
                                "lon": 120.6839
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Tainan",
                            "zip": "70403",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 22.99083,
                                "lon": 120.21333
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Taipei",
                            "zip": "10002",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 25.04776,
                                "lon": 121.53185
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Taipei",
                            "zip": "10449",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 25.04776,
                                "lon": 121.53185
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Taipei",
                            "zip": "11217",
                            "country": "Taiwan",
                            "geoPoint": {
                                "lat": 25.04776,
                                "lon": 121.53185
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Ankara",
                            "zip": "06100",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 39.91987,
                                "lon": 32.85427
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Ankara",
                            "zip": "06490",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 39.91987,
                                "lon": 32.85427
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Antalya",
                            "zip": "07059",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 36.90812,
                                "lon": 30.69556
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Edirne",
                            "zip": "22030",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 41.67719,
                                "lon": 26.55597
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Istanbul",
                            "zip": "34020",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 41.01384,
                                "lon": 28.94966
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Istanbul",
                            "zip": "34098",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 41.01384,
                                "lon": 28.94966
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Istanbul",
                            "zip": "34890",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 41.01384,
                                "lon": 28.94966
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Izmir",
                            "zip": "35100",
                            "country": "Turkey",
                            "geoPoint": {
                                "lat": 38.41273,
                                "lon": 27.13838
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Dnipropetrovsk",
                            "zip": "49102",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 48.4593,
                                "lon": 35.03864
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kharkiv",
                            "zip": "61070",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 49.98081,
                                "lon": 36.25272
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kriviy Rig",
                            "zip": "50048",
                            "country": "Ukraine"
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Kyiv",
                            "zip": "04107",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.45466,
                                "lon": 30.5238
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Lutsk",
                            "zip": "63000",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.75932,
                                "lon": 25.34244
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Poltava",
                            "zip": "36011",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 49.59373,
                                "lon": 34.54073
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Sumy",
                            "zip": "40005",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 50.9216,
                                "lon": 34.80029
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Uzhhorod",
                            "zip": "88000",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 48.61667,
                                "lon": 22.3
                            }
                        },
                        {
                            "facility": "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.",
                            "city": "Vinnitsa",
                            "zip": "21029",
                            "country": "Ukraine",
                            "geoPoint": {
                                "lat": 49.84639,
                                "lon": 37.71861
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "33194700",
                            "type": "DERIVED",
                            "citation": "Goldman JW, Mazieres J, Barlesi F, Dragnev KH, Koczywas M, Goskel T, Cortot AB, Girard N, Wesseler C, Bischoff H, Nadal E, Park K, Lu S, Taus A, Cobo M, Estrem ST, Wijayawardana SR, Turner K, Oakley GJ 3rd, Hurt KC, Chiang AY, Hossain AM, John WJ, Paz-Ares L. A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER. Front Oncol. 2020 Oct 26;10:578756. doi: 10.3389/fonc.2020.578756. eCollection 2020."
                        },
                        {
                            "pmid": "26432508",
                            "type": "DERIVED",
                            "citation": "Goldman JW, Shi P, Reck M, Paz-Ares L, Koustenis A, Hurt KC. Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non-Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy. Clin Lung Cancer. 2016 Jan;17(1):80-4. doi: 10.1016/j.cllc.2015.08.003. Epub 2015 Aug 18."
                        }
                    ],
                    "seeAlsoLinks": [
                        {
                            "label": "A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer",
                            "url": "https://trials.lillytrialguide.com/en-US/trial/6apfdhnUhG22E8AcMmSCCC"
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "YES",
                    "description": "Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.",
                    "infoTypes": [
                        "STUDY_PROTOCOL",
                        "SAP",
                        "CSR"
                    ],
                    "timeFrame": "Data are available 6 months after the primary publication and approval of the indication studied in the US and EU, whichever is later. Data will be indefinitely available for requesting.",
                    "accessCriteria": "A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.",
                    "url": "https://vivli.org/"
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "preAssignmentDetails": "Completers are defined as those participants who had progressive disease, death due to any cause or alive and on study at the end of study, but off treatment.",
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Abemaciclib",
                            "description": "200 milligrams (mg) abemaciclib administered, orally, every 12 hours plus best supportive care (BSC) on Days 1 to 28 (28 day cycles)."
                        },
                        {
                            "id": "FG001",
                            "title": "Erlotinib",
                            "description": "150 mg erlotinib administered, orally, every 24 hours plus BSC on Days 1 to 28 (28 day cycles)."
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "270"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "183"
                                        }
                                    ]
                                },
                                {
                                    "type": "Received at Least One Dose of Study Drug",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "265"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "175"
                                        }
                                    ]
                                },
                                {
                                    "type": "Off Treatment",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "246"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "172"
                                        }
                                    ]
                                },
                                {
                                    "type": "Death Due to Any Cause",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "30"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "20"
                                        }
                                    ]
                                },
                                {
                                    "type": "Progressive Disease",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "174"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "137"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "204"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "157"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "66"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "26"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "Adverse Event",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "32"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "4"
                                        }
                                    ]
                                },
                                {
                                    "type": "Withdrawal by Subject",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "13"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "16"
                                        }
                                    ]
                                },
                                {
                                    "type": "Noncompliance with study drug",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "Physician Decision",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "2"
                                        }
                                    ]
                                },
                                {
                                    "type": "Lost to Follow-up",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "1"
                                        }
                                    ]
                                },
                                {
                                    "type": "On Treatment",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "19"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Abemaciclib",
                            "description": "200 mg abemaciclib administered, orally, every 12 hours plus BSC on Days 1 to 28 (28 day cycles)."
                        },
                        {
                            "id": "BG001",
                            "title": "Erlotinib",
                            "description": "150 mg erlotinib administered, orally, every 24 hours plus BSC on Days 1 to 28 (28 day cycles)."
                        },
                        {
                            "id": "BG002",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "270"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "183"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "453"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "62.3",
                                                    "spread": "8.9"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "62.9",
                                                    "spread": "8.4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "62.5",
                                                    "spread": "8.7"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "calculatePct": false,
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "107"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "74"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "181"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "163"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "109"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "272"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Ethnicity (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "calculatePct": false,
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Hispanic or Latino",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "13"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "12"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "25"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Not Hispanic or Latino",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "197"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "132"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "329"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "60"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "39"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "99"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "calculatePct": false,
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "American Indian or Alaska Native",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Asian",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "56"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "41"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "97"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Native Hawaiian or Other Pacific Islander",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Black or African American",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "White",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "165"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "106"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "271"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "More than one race",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "4"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "45"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "77"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Region of Enrollment",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "calculatePct": false,
                            "classes": [
                                {
                                    "title": "Argentina",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Romania",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "14"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "United States",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "44"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "74"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Japan",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "22"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "17"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "39"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Ukraine",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "6"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "11"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Russia",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "12"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Spain",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "26"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "13"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "39"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Greece",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "6"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "7"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Canada",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "8"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Austria",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "2"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "South Korea",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "13"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "13"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "26"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Turkey",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "21"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "29"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "China",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "11"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Taiwan",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "12"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "19"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Brazil",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "12"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Poland",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "6"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "8"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Italy",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "12"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "17"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Israel",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "6"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "France",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "35"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "67"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Germany",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "14"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "44"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Overall Survival (OS)",
                            "description": "OS defined as from randomization date to the date of death due to any cause. For each participant who is not known to have died as of the data-inclusion cutoff date for overall survival analysis, OS time was censored on the last date the participant is known to be alive.",
                            "populationDescription": "All randomized participants. 81 participants were censored in the Abemaciclib arm and 56 participants were censored in the Erlotinib arm.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "months",
                            "timeFrame": "From Randomization Date to Date of Death from Any Cause (Up to 32 Months)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Abemaciclib",
                                    "description": "200 mg abemaciclib administered, orally, every 12 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib",
                                    "description": "150 mg erlotinib administered, orally, every 24 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "270"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "183"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "7.4",
                                                    "lowerLimit": "6.5",
                                                    "upperLimit": "8.8"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "7.8",
                                                    "lowerLimit": "6.4",
                                                    "upperLimit": "9.5"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "The stratification factors used in the analysis were: number of prior chemotherapy regimens (1 versus 2), Eastern Cooperative Oncology Group (ECOG) Performance Score (PS) (0 versus 1), gender (male versus female), and kirsten rat sarcoma (KRAS) mutation (GLY12CYS \\[G12C\\] vs. all others)",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.771",
                                    "statisticalMethod": "Stratified Log-Rank",
                                    "paramType": "Hazard Ratio (HR)",
                                    "paramValue": "0.968",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.768",
                                    "ciUpperLimit": "1.219",
                                    "estimateComment": "Hazard Ratio (HR) was estimated based on Stratified Cox proportional hazard model."
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Percentage of Participants With Complete Response (CR) or Partial Response (PR) (Objective Response Rate [ORR])",
                            "description": "ORR was the percentage of participants achieving a best overall response (BOR) of complete response (CR) or partial response (PR) as per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1. CR defined as the disappearance of all target and non-target lesions and no appearance of new lesions. PR defined as at least a 30% decrease in the sum of the longest diameters (LD) of target lesions (taking as reference the baseline sum LD), no progression of non-target lesions, and no appearance of new lesions.",
                            "populationDescription": "All randomized participants.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "From Randomization Date to Objective Progression (Up to 32 Months)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Abemaciclib",
                                    "description": "200 mg abemaciclib administered, orally, every 12 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib",
                                    "description": "150 mg erlotinib administered, orally, every 24 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "270"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "183"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "8.9",
                                                    "lowerLimit": "5.5",
                                                    "upperLimit": "12.3"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "2.7",
                                                    "lowerLimit": "0.4",
                                                    "upperLimit": "5.1"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Stratified by number of prior chemotherapy regimens (1 versus 2), ECOG PS (0 versus 1), gender (male versus female), and KRAS mutation (GLY12CYS \\[G12C\\] vs. all others)",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.010",
                                    "statisticalMethod": "Cochran-Mantel-Haenszel"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Progression Free Survival (PFS)",
                            "description": "PFS defined as the from randomization date to the first evidence of disease progression as defined by RECIST v1.1 or death from any cause. Progressive Disease (PD) was at least a 20% increase in the sum of the diameters of target lesions, with reference being the smallest sum on study and an absolute increase of at least 5 mm, or unequivocal progression of non-target lesions, or 1 or more new lesions. If a participant does not have a complete baseline disease assessment, then the PFS time was censored at the date of first dose, regardless of whether or not objectively determined disease progression or death has been observed for the participant. If a participant was not known to have died or have objective progression as of the data inclusion cutoff date for the analysis, the PFS time was censored at the last adequate tumor assessment date.",
                            "populationDescription": "All randomized participants. 36 participants were censored in the abemaciclib arm and 24 were censored in the erlotinib arm.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "months",
                            "timeFrame": "From Randomization Date until Disease Progression or Death from Any Cause (Up to 32 Months)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Abemaciclib",
                                    "description": "200 mg abemaciclib administered, orally, every 12 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib",
                                    "description": "150 mg erlotinib administered, orally, every 24 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "270"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "183"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3.6",
                                                    "lowerLimit": "2.8",
                                                    "upperLimit": "3.8"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "1.9",
                                                    "lowerLimit": "1.9",
                                                    "upperLimit": "2.0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "<0.000001",
                                    "statisticalMethod": "Stratified Log-Rank",
                                    "paramType": "Hazard Ratio (HR)",
                                    "paramValue": "0.583",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.470",
                                    "ciUpperLimit": "0.723"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change From Baseline in MD Anderson Symptom Inventory-Lung Cancer (MDASI-LC) Score",
                            "description": "The MDASI-LC included 22 items + 3 additional trial-specific items, resulting in 6 collected and reported single-construct scores including core symptoms (13-item), interference (6-item), lung cancer (3-item), and trial-specific single outcomes for headache, diarrhea, and rash. A 2-construct composite core + lung cancer symptom (16-item) score was calculated. Data for all 7 scores were collected by an 11-point numeric rating scale anchored at 0 (not present or does not interfere) and 10 (as bad as you can imagine or interfered completely). The measurement range was 10 (maximum score-minimum score). Mixed Model Repeated Measure (MMRM) regression with covariates for treatment, visit, treatment\\*visit, and baseline score predicted between-group Least Squares (LS) mean differences from baseline. Group-level negative change from baseline indicated group improvement.",
                            "populationDescription": "All randomized participants for cycles which at least 25% of participants in each arm have a score. MDASI-LC population included all randomized participants who completed at least 1 baseline assessment followed by at least 1 MDASI-LC result.",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "units on a scale",
                            "timeFrame": "From Randomization Date through End of Study (Up to 32 Months)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Abemaciclib",
                                    "description": "200 mg abemaciclib administered, orally, every 12 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib",
                                    "description": "150 mg erlotinib administered, orally, every 24 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "270"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "183"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "Headache",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.20",
                                                    "spread": "0.11"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.27",
                                                    "spread": "0.15"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Diarrhea",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1.91",
                                                    "spread": "0.17"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "1.32",
                                                    "spread": "0.23"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Rash",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.65",
                                                    "spread": "0.17"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "3.05",
                                                    "spread": "0.22"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Mean Core Symptom Severity",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.49",
                                                    "spread": "0.10"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.73",
                                                    "spread": "0.13"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Mean Interference",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.70",
                                                    "spread": "0.14"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.85",
                                                    "spread": "0.18"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Mean Lung Cancer Symptom Severity",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.16",
                                                    "spread": "0.09"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.23",
                                                    "spread": "0.12"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Mean Core Plus Lung Cancer Symptom Severity",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.44",
                                                    "spread": "0.09"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.65",
                                                    "spread": "0.12"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Headache",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.698",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "statisticalComment": "Analyzed by Type 3 sums of squares, model covariates included Treatment + Visit + Treatment\\*Visit + Baseline.",
                                    "paramType": "LS Mean Change Difference",
                                    "paramValue": "-0.07",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-0.44",
                                    "ciUpperLimit": "0.29",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.19"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Diarrhea",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.038",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "statisticalComment": "Analyzed by Type 3 sums of squares, model covariates included Treatment + Visit + Treatment\\*Visit + Baseline.",
                                    "paramType": "LS Mean Change Difference",
                                    "paramValue": "0.59",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.03",
                                    "ciUpperLimit": "1.15",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.28"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Rash",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "<.001",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "statisticalComment": "Analyzed by Type 3 sums of squares, model covariates included Treatment + Visit + Treatment\\*Visit + Baseline.",
                                    "paramType": "LS Mean Change Difference",
                                    "paramValue": "-2.40",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-2.94",
                                    "ciUpperLimit": "-1.86",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.27"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Mean Core Symptom Severity",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.142",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "statisticalComment": "Analyzed by Type 3 sums of squares, model covariates included Treatment + Visit + Treatment\\*Visit + Baseline.",
                                    "paramType": "LS Mean Change Difference",
                                    "paramValue": "-0.24",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-0.56",
                                    "ciUpperLimit": "0.08",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.16"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Mean Interference",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.514",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "statisticalComment": "Analyzed by Type 3 sums of square, model covariates included Treatment + Visit + Treatment\\*Visit + Baseline.",
                                    "paramType": "LS Mean Change Difference",
                                    "paramValue": "-0.15",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-0.59",
                                    "ciUpperLimit": "0.30",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.23"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Mean Lung Cancer",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.646",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "statisticalComment": "Analyzed by Type 3 sums of squares, model covariates included Treatment + Visit + Treatment\\*Visit + Baseline.",
                                    "paramType": "LS Mean Change Difference",
                                    "paramValue": "-0.07",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-0.37",
                                    "ciUpperLimit": "0.23",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.15"
                                },
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "groupDescription": "Mean Core Plus Lung Cancer",
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.188",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "statisticalComment": "Analyzed by Type 3 sums of squares, model covariates included Treatment + Visit + Treatment\\*Visit + Baseline.",
                                    "paramType": "LS Mean Change Difference",
                                    "paramValue": "-0.20",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-0.51",
                                    "ciUpperLimit": "0.10",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.15"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve During 1 Dosing Interval at Steady State",
                            "description": "PK is determined by the area under the plasma concentration versus time curve during 1 dosing interval at steady state",
                            "populationDescription": "All randomized participants who received Abemaciclib and had evaluable PK data.",
                            "reportingStatus": "POSTED",
                            "paramType": "GEOMETRIC_MEAN",
                            "dispersionType": "Geometric Coefficient of Variation",
                            "unitOfMeasure": "Hour*nanogram/milliliter (h*ng/mL)",
                            "timeFrame": "Day 1 of Cycle 1 through Cycle 3 (28 Day Cycles)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Abemaciclib",
                                    "description": "200 mg abemaciclib administered, orally, every 12 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "265"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3350",
                                                    "spread": "52"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change From Baseline in European Quality of Life - 5 Dimensions - 5 Level (EQ-5D-5L) Score",
                            "description": "There are 5 response levels on a good-to-bad continuum of 1-5 corresponding to none, slight, moderate, severe, and extreme/unable to. The EuroQol-developed crosswalk method was used to convert the EQ-5D-5L,using United Kingdom (UK) weights, health dimensions(mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) into a single index value; the dimensions are not separately scored. The index is marked missing when \u22651 dimensions are missing. The index scores for the response patterns were anchored on full health to dead with negative values assigned to response patterns/health states considered worse than death. The best pattern is assigned the index value of 1.0; the worst pattern is assigned an index value of -0.594. Between-group differences in regression-predicted change from baseline score were estimated for the index. LS Mean value was controlled for Treatment, visit, Treatment\\*Visit and baseline.",
                            "populationDescription": "All randomized participants who received at least one dose of study drug and with a baseline and at least 1 post-baseline result.",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "Standard Error",
                            "unitOfMeasure": "units on a scale",
                            "timeFrame": "From Randomization Date through End of Study (Up to 32 Months)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Abemaciclib",
                                    "description": "200 mg abemaciclib administered, orally, every 12 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib",
                                    "description": "150 mg erlotinib administered, orally, every 24 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "270"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "183"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.08",
                                                    "spread": "0.01"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.08",
                                                    "spread": "0.02"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG001"
                                    ],
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.951",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "statisticalComment": "Analyzed By Type 3 sums of squares, Change from Baseline = Treatment + Visit + Treatment\\*Visit + Baseline.",
                                    "paramType": "LS Mean Change Difference",
                                    "paramValue": "-0.00",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-0.05",
                                    "ciUpperLimit": "0.05",
                                    "dispersionType": "STANDARD_ERROR_OF_MEAN",
                                    "dispersionValue": "0.02"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Resource Utilization: Percentage of Participants Who Are Hospitalized",
                            "description": "Resource utilization is the percentage of participants who was hospitalized.",
                            "populationDescription": "All randomized participants.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "percentage of participants",
                            "timeFrame": "From Randomization Date through End of Study (Up to 32 Months)",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Abemaciclib",
                                    "description": "200 mg abemaciclib administered, orally, every 12 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                },
                                {
                                    "id": "OG001",
                                    "title": "Erlotinib",
                                    "description": "150 mg erlotinib administered, orally, every 24 hours plus BSC on Days 1 to 28 (28 day cycles)."
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "265"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "175"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "40.4"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "22.9"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "5",
                    "timeFrame": "From Baseline to End of Study (Up to 47 Months)",
                    "description": "All randomized participants who received at least one dose of study drug.",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Abemaciclib",
                            "description": "200 mg abemaciclib administered, orally, every 12 hours plus BSC on Days 1 to 28 (28 day cycles).",
                            "deathsNumAffected": 186,
                            "deathsNumAtRisk": 265,
                            "seriousNumAffected": 112,
                            "seriousNumAtRisk": 265,
                            "otherNumAffected": 247,
                            "otherNumAtRisk": 265
                        },
                        {
                            "id": "EG001",
                            "title": "Erlotinib",
                            "description": "150 mg erlotinib administered, orally, every 24 hours plus BSC on Days 1 to 28 (28 day cycles).",
                            "deathsNumAffected": 123,
                            "deathsNumAtRisk": 175,
                            "seriousNumAffected": 43,
                            "seriousNumAtRisk": 175,
                            "otherNumAffected": 161,
                            "otherNumAtRisk": 175
                        }
                    ],
                    "seriousEvents": [
                        {
                            "term": "Anaemia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 4,
                                    "numAffected": 3,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Febrile bone marrow aplasia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Febrile neutropenia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Neutropenia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pancytopenia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Atrial tachycardia",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Cardiac arrest",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Cardiac failure",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Cardiac tamponade",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Cardiopulmonary failure",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pericardial effusion",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Supraventricular tachycardia",
                            "organSystem": "Cardiac disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Tracheo-oesophageal fistula",
                            "organSystem": "Congenital, familial and genetic disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Vertigo positional",
                            "organSystem": "Ear and labyrinth disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Adrenal insufficiency",
                            "organSystem": "Endocrine disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Abdominal pain",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Diarrhoea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 10,
                                    "numAffected": 10,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Gastric haemorrhage",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Nausea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 7,
                                    "numAffected": 7,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pancreatitis",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Vomiting",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 6,
                                    "numAffected": 5,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Asthenia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 4,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Death",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Fatigue",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "General physical health deterioration",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Malaise",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Non-cardiac chest pain",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Oedema",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pyrexia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Drug-induced liver injury",
                            "organSystem": "Hepatobiliary disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hepatic failure",
                            "organSystem": "Hepatobiliary disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Bronchitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Cellulitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Clostridial sepsis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Clostridium difficile colitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Empyema",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Enterocolitis infectious",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Lung infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 4,
                                    "numAffected": 3,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Oesophageal candidiasis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Oral candidiasis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pneumocystis jirovecii pneumonia",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pneumonia",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 15,
                                    "numAffected": 13,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 9,
                                    "numAffected": 6,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pneumonia bacterial",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pneumonia fungal",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pyelonephritis acute",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Respiratory tract infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Sepsis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Sepsis pasteurella",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Septic shock",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Skin infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Urinary tract infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Ankle fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Chemical poisoning",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Fall",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hip fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Radiation pneumonitis",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Rib fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Spinal compression fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Spinal fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Alanine aminotransferase increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Aspartate aminotransferase increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 6,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Blood bilirubin increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Blood creatinine increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 6,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "International normalised ratio increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Platelet count decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 5,
                                    "numAffected": 3,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Weight decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Decreased appetite",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Dehydration",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 12,
                                    "numAffected": 10,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hypercalcaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hyperglycaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 4,
                                    "numAffected": 2,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hyperkalaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hypoalbuminaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hypocalcaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hypokalaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hyponatraemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Back pain",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Muscle spasms",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Osteoarthritis",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Osteoporosis",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Cancer pain",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Metastases to central nervous system",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Tumour pain",
                            "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Aphasia",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Cerebral infarction",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Cerebral ischaemia",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Depressed level of consciousness",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Encephalopathy",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Ischaemic stroke",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Neuralgia",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Paraesthesia",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Peripheral sensorimotor neuropathy",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Spinal cord compression",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Syncope",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Confusional state",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 4,
                                    "numAffected": 3,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Suicide attempt",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Acute kidney injury",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 15,
                                    "numAffected": 10,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Anuria",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Renal failure",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Renal impairment",
                            "organSystem": "Renal and urinary disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Acute pulmonary oedema",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Acute respiratory failure",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Chronic obstructive pulmonary disease",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Dyspnoea",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 8,
                                    "numAffected": 8,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 11,
                                    "numAffected": 7,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Haemoptysis",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 5,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hypoxia",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 3,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Interstitial lung disease",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Laryngeal obstruction",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Laryngeal oedema",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Lung infiltration",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pleural effusion",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 4,
                                    "numAffected": 2,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pleuritic pain",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pneumonitis",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 6,
                                    "numAffected": 3,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 3,
                                    "numAffected": 3,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pneumothorax",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pulmonary cavitation",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pulmonary embolism",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 5,
                                    "numAffected": 4,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pulmonary haemorrhage",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Respiratory failure",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 6,
                                    "numAffected": 4,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Respiratory tract congestion",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Subcutaneous emphysema",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Urticaria",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Deep vein thrombosis",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Embolism",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hypotension",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Peripheral arterial occlusive disease",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Shock haemorrhagic",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Superior vena cava syndrome",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "Anaemia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 163,
                                    "numAffected": 87,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 30,
                                    "numAffected": 23,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Neutropenia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 44,
                                    "numAffected": 19,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Thrombocytopenia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 25,
                                    "numAffected": 17,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 3,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Abdominal pain",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 34,
                                    "numAffected": 30,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 8,
                                    "numAffected": 8,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Constipation",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 32,
                                    "numAffected": 29,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 17,
                                    "numAffected": 15,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Diarrhoea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 331,
                                    "numAffected": 169,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 100,
                                    "numAffected": 69,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Nausea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 127,
                                    "numAffected": 94,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 33,
                                    "numAffected": 30,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Stomatitis",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 14,
                                    "numAffected": 14,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 10,
                                    "numAffected": 10,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Vomiting",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 89,
                                    "numAffected": 61,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 15,
                                    "numAffected": 15,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Asthenia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 82,
                                    "numAffected": 44,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 16,
                                    "numAffected": 13,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Fatigue",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 132,
                                    "numAffected": 73,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 38,
                                    "numAffected": 29,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Non-cardiac chest pain",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 17,
                                    "numAffected": 15,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 7,
                                    "numAffected": 7,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pyrexia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 40,
                                    "numAffected": 33,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 11,
                                    "numAffected": 11,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Aspartate aminotransferase increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 26,
                                    "numAffected": 15,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 8,
                                    "numAffected": 7,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Blood creatinine increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 81,
                                    "numAffected": 45,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Neutrophil count decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 130,
                                    "numAffected": 40,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 4,
                                    "numAffected": 2,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Platelet count decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 103,
                                    "numAffected": 42,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 7,
                                    "numAffected": 5,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Weight decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 54,
                                    "numAffected": 42,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 22,
                                    "numAffected": 16,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "White blood cell count decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 83,
                                    "numAffected": 28,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 6,
                                    "numAffected": 4,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Decreased appetite",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 133,
                                    "numAffected": 95,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 52,
                                    "numAffected": 42,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Dehydration",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 18,
                                    "numAffected": 15,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hypoalbuminaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 24,
                                    "numAffected": 18,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 15,
                                    "numAffected": 8,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hypokalaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 31,
                                    "numAffected": 22,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 10,
                                    "numAffected": 9,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Hyponatraemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 37,
                                    "numAffected": 17,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 11,
                                    "numAffected": 6,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Back pain",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 15,
                                    "numAffected": 15,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 15,
                                    "numAffected": 11,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Dizziness",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 19,
                                    "numAffected": 18,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 6,
                                    "numAffected": 5,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Headache",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 29,
                                    "numAffected": 24,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 12,
                                    "numAffected": 11,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Insomnia",
                            "organSystem": "Psychiatric disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 16,
                                    "numAffected": 15,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 7,
                                    "numAffected": 7,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Cough",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 45,
                                    "numAffected": 38,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 22,
                                    "numAffected": 21,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Dyspnoea",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 74,
                                    "numAffected": 53,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 26,
                                    "numAffected": 22,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Productive cough",
                            "organSystem": "Respiratory, thoracic and mediastinal disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 17,
                                    "numAffected": 16,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 4,
                                    "numAffected": 4,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Dermatitis acneiform",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 4,
                                    "numAffected": 1,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 68,
                                    "numAffected": 46,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Dry skin",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 14,
                                    "numAffected": 14,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 35,
                                    "numAffected": 26,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Pruritus",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 22,
                                    "numAffected": 17,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 27,
                                    "numAffected": 18,
                                    "numAtRisk": 175
                                }
                            ]
                        },
                        {
                            "term": "Rash",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA 20.0",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 14,
                                    "numAffected": 11,
                                    "numAtRisk": 265
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 68,
                                    "numAffected": 42,
                                    "numAtRisk": 175
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictionType": "GT60",
                        "restrictiveAgreement": true
                    },
                    "pointOfContact": {
                        "title": "Chief Medical Officer",
                        "organization": "Eli Lilly and Company",
                        "email": "ClinicalTrials.gov@lilly.com",
                        "phone": "800-545-5979"
                    }
                }
            },
            "documentSection": {
                "largeDocumentModule": {
                    "largeDocs": [
                        {
                            "typeAbbrev": "Prot",
                            "hasProtocol": true,
                            "hasSap": false,
                            "hasIcf": false,
                            "label": "Study Protocol: Protocol",
                            "date": "2014-05-13",
                            "uploadDate": "2018-08-23T12:04",
                            "filename": "Prot_001.pdf",
                            "size": 867602
                        },
                        {
                            "typeAbbrev": "Prot",
                            "hasProtocol": true,
                            "hasSap": false,
                            "hasIcf": false,
                            "label": "Study Protocol: Protocol (e)",
                            "date": "2016-12-20",
                            "uploadDate": "2018-08-23T12:05",
                            "filename": "Prot_002.pdf",
                            "size": 1083721
                        },
                        {
                            "typeAbbrev": "SAP",
                            "hasProtocol": false,
                            "hasSap": true,
                            "hasIcf": false,
                            "label": "Statistical Analysis Plan",
                            "date": "2017-10-02",
                            "uploadDate": "2018-08-23T12:02",
                            "filename": "SAP_000.pdf",
                            "size": 847125
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D008175",
                            "term": "Lung Neoplasms"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D012142",
                            "term": "Respiratory Tract Neoplasms"
                        },
                        {
                            "id": "D013899",
                            "term": "Thoracic Neoplasms"
                        },
                        {
                            "id": "D009371",
                            "term": "Neoplasms by Site"
                        },
                        {
                            "id": "D009369",
                            "term": "Neoplasms"
                        },
                        {
                            "id": "D008171",
                            "term": "Lung Diseases"
                        },
                        {
                            "id": "D012140",
                            "term": "Respiratory Tract Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M11172",
                            "name": "Lung Neoplasms",
                            "asFound": "Lung Cancer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M5546",
                            "name": "Carcinoma, Non-Small-Cell Lung",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14979",
                            "name": "Respiratory Tract Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M16658",
                            "name": "Thoracic Neoplasms",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11168",
                            "name": "Lung Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14977",
                            "name": "Respiratory Tract Diseases",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC04",
                            "name": "Neoplasms"
                        },
                        {
                            "abbrev": "BC08",
                            "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000069347",
                            "term": "Erlotinib Hydrochloride"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000092004",
                            "term": "Tyrosine Kinase Inhibitors"
                        },
                        {
                            "id": "D047428",
                            "term": "Protein Kinase Inhibitors"
                        },
                        {
                            "id": "D004791",
                            "term": "Enzyme Inhibitors"
                        },
                        {
                            "id": "D045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D000970",
                            "term": "Antineoplastic Agents"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M398",
                            "name": "Erlotinib Hydrochloride",
                            "asFound": "Resection",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M2889",
                            "name": "Tyrosine Kinase Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M25820",
                            "name": "Protein Kinase Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7951",
                            "name": "Enzyme Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T202",
                            "name": "Juniper",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T22",
                            "name": "Tyrosine",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "ANeo",
                            "name": "Antineoplastic Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "HB",
                            "name": "Herbal and Botanical"
                        },
                        {
                            "abbrev": "AA",
                            "name": "Amino Acids"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT06487182",
                    "orgStudyIdInfo": {
                        "id": "2022/292"
                    },
                    "organization": {
                        "fullName": "Ondokuz May\u0131s University",
                        "class": "OTHER"
                    },
                    "briefTitle": "The Effect of Reiki on the Anxiety Level of Mothers",
                    "officialTitle": "The Effect of Reiki on the Anxiety Level of Mothers Whose Children Receive Hospital Treatment"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2024-06-30",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2024-11-10",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2024-11-10",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2024-06-27",
                    "studyFirstSubmitQcDate": "2024-06-27",
                    "studyFirstPostDateStruct": {
                        "date": "2024-07-05",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "PRINCIPAL_INVESTIGATOR",
                        "investigatorFullName": "S\u00fcmeyye BAL",
                        "investigatorTitle": "Director",
                        "investigatorAffiliation": "Ondokuz May\u0131s University"
                    },
                    "leadSponsor": {
                        "name": "Ondokuz May\u0131s University",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "The aim of this study is to determine the effect of Reiki applied to mothers whose children were treated in the hospital on the anxiety level.",
                    "detailedDescription": "Hypotheses 01; there was no difference between the anxiety score of the reiki group and the anxiety score of the control group.\n\nThe study will be carried out in three different groups. The practice will start with meeting the women whose children were treated in the hospital. After the women are evaluated in terms of eligibility criteria for the research, the women who are eligible will be informed about the research and written informed consent will be obtained from the women who accept. The random distribution of women to the study groups will be carried out using the Block Randomization method. The following applications will be made to the groups.\n\nReiki Group The intervention will be applied to the reiki group to be applied in the hospital room. Reiki therapy will be applied by a practitioner with a Reiki application certificate in the application laboratory for 30 minutes while the participants lie down with their eyes closed. 4 sessions of reiki application will be applied to the intervention group for a week. Anxiety level after 4 sessions will be recorded.\n\nPlacebo Reiki will be applied to the participants in the group in the application hospital room. The practice will be carried out in the application laboratory for 30 minutes, with the participants sitting with their eyes closed. Reiki life energy will not be transferred to participants in the placebo reiki group. Since the participants' eyes are closed, they will not know that there is a transfer. Placebo Reiki application will be performed in the room 4 times during a week. Placebo application will start, and the first anxiety scores will be recorded. After 4 sessions, anxiety scores will be recorded.\n\ncontrol group; the first anxiety scores will be recorded. After a week later anxiety scores will be recorded."
                },
                "conditionsModule": {
                    "conditions": [
                        "Anxiety"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "SUPPORTIVE_CARE",
                        "maskingInfo": {
                            "masking": "SINGLE",
                            "whoMasked": [
                                "PARTICIPANT"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 120,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Reiki",
                            "type": "EXPERIMENTAL",
                            "description": "The intervention will be applied to the reiki group in the application hospital room. Reiki therapy will be applied by a practitioner with a Reiki application certificate in the application laboratory for 30 minutes while the participants lie down with their eyes closed. 4 sessions of reiki application will be applied to the intervention group for a week. Reiki application will start , the first anxiety scores will be recorded. Anxiety levels after 4 sessions will be recorded.",
                            "interventionNames": [
                                "Other: reiki"
                            ]
                        },
                        {
                            "label": "Placebo reiki",
                            "type": "SHAM_COMPARATOR",
                            "description": "Placebo Reiki will be applied to the participants in the group in the application hospital room. The practice will be carried out in the application room for 30 minutes, with the participants sitting with their eyes closed. Reiki life energy will not be transferred to participants in the placebo reiki group. Since the participants' eyes are closed, they will not know that there is a transfer. Placebo Reiki application will be performed in the room 4 times during a week. Placebo application will start and the anxiety scores will be recorded. After 4 sessions, anxiety scores will be recorded.",
                            "interventionNames": [
                                "Other: placebo reiki"
                            ]
                        },
                        {
                            "label": "control",
                            "type": "NO_INTERVENTION",
                            "description": "Routine hospital procedure will be applied. Anxiety scores will be recorded. After a week anxiety scores will be recorded."
                        }
                    ],
                    "interventions": [
                        {
                            "type": "OTHER",
                            "name": "reiki",
                            "description": "reiki",
                            "armGroupLabels": [
                                "Reiki"
                            ],
                            "otherNames": [
                                "control group",
                                "placebo reiki"
                            ]
                        },
                        {
                            "type": "OTHER",
                            "name": "placebo reiki",
                            "description": "placebo reiki",
                            "armGroupLabels": [
                                "Placebo reiki"
                            ],
                            "otherNames": [
                                "control group"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "anxiety",
                            "description": "The State Anxiety Scale assesses feelings of fear, tension, irritability, and anxiety that increase during stress in response to physical danger and psychological stress. The 20-question test allows individuals to answer within 10 minutes.\n\nIt provides answers on a four-point Likert type scale. STAI, reliability ranging from 0.83 to 0.92 It has sufficient validity and reliability with its coefficients (Vitale 2006).",
                            "timeFrame": "immediately before reiki application and immediately after the reiki application]"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* At least the 3rd day of hospitalization\n\n  * Their child has an acute or chronic disease\n  * Able to speak and write Turkish and have no communication problems\n  * No psychiatric history and not using medication\n  * Not drinking alcohol in the last 24 hours\n  * Those who have not received body-mind therapy (yoga, reiki, massage, meditation) in the last six months\n  * Mothers who volunteer to participate in the research will be included.\n\nExclusion Criteria:\n\nReiki practitioner or who also has an instructor\n\n* Having time and communication problems that cannot answer the questions asked\n* Mothers who do not volunteer to participate in the study will not be included in the study.",
                    "healthyVolunteers": true,
                    "sex": "FEMALE",
                    "minimumAge": "18 Years",
                    "maximumAge": "60 Years",
                    "stdAges": [
                        "ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "S\u00fcmeyye BAL, Ph.D",
                            "role": "CONTACT",
                            "phone": "05434276696",
                            "email": "sumeyyebal@gmail.com"
                        },
                        {
                            "name": "S\u00fcmeyye BAL, Ph.D.",
                            "role": "CONTACT",
                            "phone": "05434276696",
                            "email": "sumeyyebal@gmail.com"
                        }
                    ],
                    "overallOfficials": [
                        {
                            "name": "S\u00fcmeyye BAL, Ph.D.",
                            "affiliation": "Ondokuz May\u0131s University",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Ondokuz Mayis University",
                            "status": "RECRUITING",
                            "city": "Samsun",
                            "zip": "55200",
                            "country": "Turkey",
                            "contacts": [
                                {
                                    "name": "S\u00fcmeyye BAL, Ph.D.",
                                    "role": "CONTACT",
                                    "phone": "0(362)3121919",
                                    "phoneExt": "6424"
                                }
                            ],
                            "geoPoint": {
                                "lat": 41.27976,
                                "lon": 36.3361
                            }
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D001008",
                            "term": "Anxiety Disorders"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D001523",
                            "term": "Mental Disorders"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M4324",
                            "name": "Anxiety Disorders",
                            "asFound": "Anxiety",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M14473",
                            "name": "Psychotic Disorders",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4815",
                            "name": "Mental Disorders",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BXM",
                            "name": "Behaviors and Mental Disorders"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT05330182",
                    "orgStudyIdInfo": {
                        "id": "CDI02"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "CDMRP-PR221885",
                            "type": "OTHER_GRANT",
                            "domain": "CDMRP"
                        }
                    ],
                    "organization": {
                        "fullName": "Lumen Bioscience, Inc.",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "LMN-201 for Prevention of C. Difficile Infection Recurrence",
                    "officialTitle": "A Phase 2, Randomized, Double-blind, Placebo-controlled Study of LMN-201 for Prevention of C. Difficile Infection Recurrence"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "RECRUITING",
                    "startDateStruct": {
                        "date": "2024-08-29",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2025-12-01",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2026-04-01",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2022-04-08",
                    "studyFirstSubmitQcDate": "2022-04-08",
                    "studyFirstPostDateStruct": {
                        "date": "2022-04-15",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Lumen Bioscience, Inc.",
                        "class": "INDUSTRY"
                    },
                    "collaborators": [
                        {
                            "name": "Congressionally Directed Medical Research Programs",
                            "class": "FED"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "This is a multisite study to evaluate the safety, tolerability, and efficacy of LMN-201 in participants recently diagnosed with CDI who are scheduled to receive or are receiving SOC antibiotic therapy against C. difficile."
                },
                "conditionsModule": {
                    "conditions": [
                        "Clostridioides Difficile Infection"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE2",
                        "PHASE3"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "PREVENTION",
                        "maskingInfo": {
                            "masking": "QUADRUPLE",
                            "maskingDescription": "An open label sentinel cohort will be followed by a double-blind placebo-controlled main cohort.",
                            "whoMasked": [
                                "PARTICIPANT",
                                "CARE_PROVIDER",
                                "INVESTIGATOR",
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 375,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Sentinel Cohort",
                            "type": "EXPERIMENTAL",
                            "interventionNames": [
                                "Drug: LMN-201"
                            ]
                        },
                        {
                            "label": "LMN-201",
                            "type": "ACTIVE_COMPARATOR",
                            "interventionNames": [
                                "Drug: LMN-201"
                            ]
                        },
                        {
                            "label": "Placebo",
                            "type": "PLACEBO_COMPARATOR",
                            "interventionNames": [
                                "Drug: Placebo"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "LMN-201",
                            "description": "LMN-201 consists of orally delivered whole, dried, non-viable biomass of spirulina (Arthrospira platensis) grown from 4 separate strains, each of which has been engineered to express one of the following therapeutic proteins:\n\n* 3 toxin-binding proteins that bind and inhibit C. difficile toxin B (TcdB), an essential virulence factor for C. difficile\n* 1 lysozyme-like enzyme that selectively degrades the cell wall of C. difficile and causes rapid destruction of the organism",
                            "armGroupLabels": [
                                "LMN-201",
                                "Sentinel Cohort"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Placebo",
                            "description": "Doses of placebo will be delivered as identical-appearing cornstarch with coloring in size 00, white, opaque, capsules.",
                            "armGroupLabels": [
                                "Placebo"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Proportion of participants who achieve global cure",
                            "description": "Proportion of total participants with both successful initial CDI treatment and no CDI recurrence during the Prevention and Observation Phases (by treatment assignment).",
                            "timeFrame": "Up to 16 weeks after initiation of therapy"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Male or female, aged 18 or older.\n2. Diagnosis of CDI defined as a new or recent history of 3 or more bowel movements per day with a loose or watery consistency (Bristol Stool Scale 5, 6, or 7); a positive stool C. difficile toxin B immunoassay (stool collected no more than 7 days before first dose of LMN-201/placebo), and no other likely explanation for diarrhea. NOTE: Diarrhea is not required to be present on the day of enrollment.\n3. Provision of signed and dated informed consent form.\n4. Scheduled to receive or planning to receive a \u226428-day course of SOC antibiotic therapy for CDI. Participant must have been diagnosed with CDI for 7 or fewer days at time of initial study drug administration. SOC antibiotic therapy is defined as the receipt of oral fidaxomicin or oral metronidazole or oral vancomycin (see Section 8.2.6)\n5. May be on systemic antibiotics for an infection unrelated to the gastrointestinal tract.\n6. Ability to take oral medication and willingness to adhere to the study medication regimen.\n7. Stated willingness and ability to comply with all study procedures and availability for the duration of the study and investigator believes individual will complete the study.\n8. Access to a mobile smartphone.\n9. For females of reproductive potential: use of highly effective contraception for at least 4 weeks prior to screening and agreement to use such a method during study participation and for an additional 4 weeks after the end of study drug administration.\n10. For males of reproductive potential: agreement to use condoms or other methods to ensure effective contraception with partner during study participation and for an additional 4 weeks after the end of study drug administration.\n\nExclusion Criteria:\n\n1. Fulminant C. difficile colitis.\n2. Admitted or expect to be admitted to an intensive care unit.\n3. Underlying gastrointestinal disorder characterized by diarrhea including but not limited to chronic ulcerative colitis, Crohn's disease, celiac sprue, short bowel syndrome, dumping syndrome following gastrectomy, pancreatic insufficiency, enteric parasitic infection, viral enteritis, bacterial enteritis (salmonella, shigella, ETEC, etc.).\n4. Neutropenia (absolute neutrophil count of \\< 1000 per microliter for any reason).\n5. Current or previous treatment in past 3 months with any therapy likely to influence the outcome of this study, including but not limited to the following:\n\n   1. Bezlotoxumab (Zinplava, Merck \\& Co.), or another antibody against C. difficile toxin(s)\n   2. C. difficile vaccine\n   3. SER-109 (Seres Therapeutics)\n   4. CP101 (Finch Therapeutics)\n   5. VE303 (Vedanta Therapeutics)\n   6. Fecal microbiota transplant\n   7. Current therapy with oral exchange resins\n   8. Protracted exposure to mu-agonist opioids and/or anticholinergic medication prescribed for diarrheal symptoms (unable to stop mu-agonist opioid treatment unless on a stable dose as of onset of diarrhea and no increase in dose planned for the duration of the study.)\n6. Treatment with SOC antibiotic therapy is planned for longer than a 28-day period.\n7. Pregnancy, anticipated pregnancy, or breastfeeding.\n8. Inability or unwillingness to swallow numerous, relatively large capsules containing study drug or placebo because of a swallowing disorder or dysphagia.\n9. Inability to pass swallowed capsules into the distal small intestine because of gastroparesis, repetitive vomiting, or anatomic narrowing in the esophagus, stomach, or small intestine.\n10. Psychiatric illness that would affect compliance with medications, study capsules, or follow-up.\n11. Status as an inmate, residential mental health program, or residential substance abuse program.\n12. Terminal illness with limited life expectancy of less than 24 weeks.\n13. Poor concurrent medical risks with clinically significant co-morbid disease such that, in the opinion of the investigator, the patient should not be enrolled.\n14. Any other condition that, in the opinion of the investigator, would jeopardize the safety or rights of the individual, would make it unlikely for the individual to complete the study, or would confound the results of the study.\n\n    * Note: Use of probiotics and other food supplements (e.g., yogurt, kefir, kimchi, etc.) are not exclusionary.\n    * Note: Assuming participants meet all of the inclusion criteria and none of the exclusion criteria, participants with underlying malignancy with a good life expectancy in the study are not excluded.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Carl Mason",
                            "role": "CONTACT",
                            "phone": "12068991904",
                            "email": "trials@lumen.bio"
                        },
                        {
                            "name": "Asa Davis",
                            "role": "CONTACT",
                            "phone": "12068991904",
                            "email": "trials@lumen.bio"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Kaiser Permanente",
                            "status": "RECRUITING",
                            "city": "Los Angeles",
                            "state": "California",
                            "zip": "90027",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Primary Coordinator",
                                    "role": "CONTACT",
                                    "phone": "323-783-8977"
                                }
                            ],
                            "geoPoint": {
                                "lat": 34.05223,
                                "lon": -118.24368
                            }
                        },
                        {
                            "facility": "GI PROS Research",
                            "status": "RECRUITING",
                            "city": "Naples",
                            "state": "Florida",
                            "zip": "34102",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Primary Coordinator",
                                    "role": "CONTACT",
                                    "phone": "239-649-1336"
                                }
                            ],
                            "geoPoint": {
                                "lat": 26.14234,
                                "lon": -81.79596
                            }
                        },
                        {
                            "facility": "Metro Infectious Disease Consultants - Atlanta",
                            "status": "RECRUITING",
                            "city": "Decatur",
                            "state": "Georgia",
                            "zip": "30033",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Primary Coordinator",
                                    "role": "CONTACT",
                                    "phone": "404-297-9755",
                                    "phoneExt": "246"
                                }
                            ],
                            "geoPoint": {
                                "lat": 33.77483,
                                "lon": -84.29631
                            }
                        },
                        {
                            "facility": "Snake River Research",
                            "status": "RECRUITING",
                            "city": "Idaho Falls",
                            "state": "Idaho",
                            "zip": "83404",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Primary Coordinator",
                                    "role": "CONTACT",
                                    "phone": "208-535-8406"
                                }
                            ],
                            "geoPoint": {
                                "lat": 43.46658,
                                "lon": -112.03414
                            }
                        },
                        {
                            "facility": "Metro Infectious Disease Consultants, LLC",
                            "status": "RECRUITING",
                            "city": "Burr Ridge",
                            "state": "Illinois",
                            "zip": "60527",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Primary Coordinator",
                                    "role": "CONTACT",
                                    "phone": "630-655-8441"
                                }
                            ],
                            "geoPoint": {
                                "lat": 41.74892,
                                "lon": -87.91839
                            }
                        },
                        {
                            "facility": "DM Clinical Research",
                            "status": "RECRUITING",
                            "city": "Oak Lawn",
                            "state": "Illinois",
                            "zip": "60453",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Primary Coordinator",
                                    "role": "CONTACT",
                                    "phone": "708-253-5810"
                                }
                            ],
                            "geoPoint": {
                                "lat": 41.71087,
                                "lon": -87.75811
                            }
                        },
                        {
                            "facility": "Baptist Health Research",
                            "status": "RECRUITING",
                            "city": "Lexington",
                            "state": "Kentucky",
                            "zip": "40503",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Primary Coordinator",
                                    "role": "CONTACT",
                                    "phone": "859-639-3720"
                                }
                            ],
                            "geoPoint": {
                                "lat": 37.98869,
                                "lon": -84.47772
                            }
                        },
                        {
                            "facility": "Mercury Street Medical",
                            "status": "RECRUITING",
                            "city": "Butte",
                            "state": "Montana",
                            "zip": "59701",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Primary Coordinator",
                                    "role": "CONTACT",
                                    "phone": "406-723-1387"
                                }
                            ],
                            "geoPoint": {
                                "lat": 46.00382,
                                "lon": -112.53474
                            }
                        },
                        {
                            "facility": "Clinical Trials Network",
                            "status": "RECRUITING",
                            "city": "Mentor",
                            "state": "Ohio",
                            "zip": "44060",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Primary Coordinator",
                                    "role": "CONTACT",
                                    "phone": "440-205-1225"
                                }
                            ],
                            "geoPoint": {
                                "lat": 41.66616,
                                "lon": -81.33955
                            }
                        },
                        {
                            "facility": "Clinical Alliance for Infectious Diseases - Infectious Diseases, LLC",
                            "status": "RECRUITING",
                            "city": "Annandale",
                            "state": "Virginia",
                            "zip": "22003",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Primary Coordinator",
                                    "role": "CONTACT",
                                    "phone": "703-560-7821"
                                }
                            ],
                            "geoPoint": {
                                "lat": 38.83039,
                                "lon": -77.19637
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D007239",
                            "term": "Infections"
                        },
                        {
                            "id": "D003141",
                            "term": "Communicable Diseases"
                        },
                        {
                            "id": "D003015",
                            "term": "Clostridium Infections"
                        },
                        {
                            "id": "D012008",
                            "term": "Recurrence"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D020969",
                            "term": "Disease Attributes"
                        },
                        {
                            "id": "D010335",
                            "term": "Pathologic Processes"
                        },
                        {
                            "id": "D016908",
                            "term": "Gram-Positive Bacterial Infections"
                        },
                        {
                            "id": "D001424",
                            "term": "Bacterial Infections"
                        },
                        {
                            "id": "D001423",
                            "term": "Bacterial Infections and Mycoses"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M10283",
                            "name": "Infections",
                            "asFound": "Infection",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M6368",
                            "name": "Communicable Diseases",
                            "asFound": "Infection",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M14850",
                            "name": "Recurrence",
                            "asFound": "Recurrence",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M6247",
                            "name": "Clostridium Infections",
                            "asFound": "Clostridioides Difficile Infection",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M22700",
                            "name": "Disease Attributes",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4722",
                            "name": "Bacterial Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M19252",
                            "name": "Gram-Positive Bacterial Infections",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M12136",
                            "name": "Mycoses",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4721",
                            "name": "Bacterial Infections and Mycoses",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC01",
                            "name": "Infections"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "browseLeaves": [
                        {
                            "id": "M12070",
                            "name": "Muramidase",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T297",
                            "name": "Spirulina",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "Infe",
                            "name": "Anti-Infective Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "HB",
                            "name": "Herbal and Botanical"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT05567562",
                    "orgStudyIdInfo": {
                        "id": "2022P002327"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "K23HL141651",
                            "type": "NIH",
                            "link": "https://reporter.nih.gov/quickSearch/K23HL141651"
                        }
                    ],
                    "organization": {
                        "fullName": "Brigham and Women's Hospital",
                        "class": "OTHER"
                    },
                    "briefTitle": "Anti-Platelets in Chronic Obstructive Pulmonary Disease",
                    "officialTitle": "Dual Anti-platelet Therapy in Chronic Obstructive Pulmonary Disease Study"
                },
                "statusModule": {
                    "statusVerifiedDate": "2023-12",
                    "overallStatus": "RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2024-03-27",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2025-02-01",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2025-06-01",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2022-10-03",
                    "studyFirstSubmitQcDate": "2022-10-03",
                    "studyFirstPostDateStruct": {
                        "date": "2022-10-05",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "PRINCIPAL_INVESTIGATOR",
                        "investigatorFullName": "Carrie Pistenmaa, M.D",
                        "investigatorTitle": "Assistant Professor",
                        "investigatorAffiliation": "Brigham and Women's Hospital"
                    },
                    "leadSponsor": {
                        "name": "Brigham and Women's Hospital",
                        "class": "OTHER"
                    },
                    "collaborators": [
                        {
                            "name": "National Heart, Lung, and Blood Institute (NHLBI)",
                            "class": "NIH"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false,
                    "isUsExport": false
                },
                "descriptionModule": {
                    "briefSummary": "This is a 6 week crossover study in current and former smokers with and without COPD to evaluate whether 2 weeks of dual antiplatelet therapy (aspirin 81mg and clopidogrel 75mg) improves pulmonary perfusion (i.e. blood flow in the lungs measured on a contrast CT scan) compared to placebo.",
                    "detailedDescription": "This is a single-center Phase IIa randomized double-blind crossover study in smokers with and without chronic obstructive pulmonary disease (COPD) to test whether dual antiplatelet therapy (aspirin 81mg and clopidogrel 75mg) improves pulmonary perfusion (i.e. blood flow in the lungs) compared to placebo.\n\nWe will enroll 30 subjects (20 with COPD, 10 without) who will each take part for 6 weeks. Participants and researchers will be blinded, they will not know which medications they are on first. Each participant will be asked to take aspirin and clopidogrel together for 2 weeks and also matching placebos for 2 weeks, with a 2 week washout period in between. Pulmonary blood flow will be evaluated with a contrast-enhanced CT scan of the chest two times over the 6 week study."
                },
                "conditionsModule": {
                    "conditions": [
                        "COPD",
                        "Emphysema",
                        "Emphysema or COPD"
                    ],
                    "keywords": [
                        "Platelet Dysfunction",
                        "Pulmonary Blood Vessel Injury",
                        "COPD",
                        "Emphysema"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE2"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "CROSSOVER",
                        "interventionModelDescription": "Double-blind crossover study is a Phase 2 interventional study to assess whether dual-anti platelet therapy improves pulmonary blood flow compared to placebo",
                        "primaryPurpose": "OTHER",
                        "maskingInfo": {
                            "masking": "QUADRUPLE",
                            "maskingDescription": "All participants, investigators and care providers will be blinded as to dual-anti platelet therapy or placebo treatment",
                            "whoMasked": [
                                "PARTICIPANT",
                                "CARE_PROVIDER",
                                "INVESTIGATOR",
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 30,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "COPD Cases: Dual antiplatelet therapy first, then placebo",
                            "type": "EXPERIMENTAL",
                            "description": "Dual antiplatelet therapy (aspirin 81mg and clopidogrel 75mg) will be given for 2 weeks, followed by 2 weeks without intervention, then 2 weeks of placebo",
                            "interventionNames": [
                                "Combination Product: dual anti-platelet therapy",
                                "Drug: Placebo"
                            ]
                        },
                        {
                            "label": "COPD Cases: Placebo first, then dual antiplatelet therapy",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Placebos for each therapy (2 pills) will be given for 2 weeks, followed by 2 weeks without intervention, then 2 weeks of dual antiplatelet therapy",
                            "interventionNames": [
                                "Combination Product: dual anti-platelet therapy",
                                "Drug: Placebo"
                            ]
                        },
                        {
                            "label": "Controls: Dual antiplatelet therapy first, then placebo",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "Dual antiplatelet therapy (aspirin 81mg and clopidogrel 75mg) will be given for 2 weeks, followed by 2 weeks without intervention, then 2 weeks of placebo",
                            "interventionNames": [
                                "Combination Product: dual anti-platelet therapy",
                                "Drug: Placebo"
                            ]
                        },
                        {
                            "label": "Controls: Placebo first, then dual antiplatelet therapy",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Placebos for each therapy (2 pills) will be given for 2 weeks, followed by 2 weeks without intervention, then 2 weeks of dual antiplatelet therapy",
                            "interventionNames": [
                                "Combination Product: dual anti-platelet therapy",
                                "Drug: Placebo"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "COMBINATION_PRODUCT",
                            "name": "dual anti-platelet therapy",
                            "description": "dual anti-platelet therapy",
                            "armGroupLabels": [
                                "COPD Cases: Dual antiplatelet therapy first, then placebo",
                                "COPD Cases: Placebo first, then dual antiplatelet therapy",
                                "Controls: Dual antiplatelet therapy first, then placebo",
                                "Controls: Placebo first, then dual antiplatelet therapy"
                            ],
                            "otherNames": [
                                "aspirin 81mg EC tab",
                                "clopidogrel 75mg tab"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Placebo",
                            "description": "Placebo",
                            "armGroupLabels": [
                                "COPD Cases: Dual antiplatelet therapy first, then placebo",
                                "COPD Cases: Placebo first, then dual antiplatelet therapy",
                                "Controls: Dual antiplatelet therapy first, then placebo",
                                "Controls: Placebo first, then dual antiplatelet therapy"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Pulmonary microvascular blood volume, CV",
                            "description": "Coefficient of variation (CV) of pulmonary microvascular blood volume on dual energy CT scan, comparing on dual antiplatelet therapy to placebo",
                            "timeFrame": "6 weeks"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Pulmonary microvascular blood volume",
                            "description": "Pulmonary microvascular blood volume on dual energy CT scan, comparing on dual antiplatelet therapy to placebo",
                            "timeFrame": "6 weeks"
                        },
                        {
                            "measure": "Oxygen saturation",
                            "description": "Resting oxygen saturation",
                            "timeFrame": "6 weeks"
                        }
                    ],
                    "otherOutcomes": [
                        {
                            "measure": "Vascular pruning on CT",
                            "description": "Distal macrovascular pruning on non-contrast inspiratory CT",
                            "timeFrame": "6 weeks"
                        },
                        {
                            "measure": "Percent emphysema on CT",
                            "description": "Percent emphysema-950 on non-contrast inspiratory CT",
                            "timeFrame": "6 weeks"
                        },
                        {
                            "measure": "Functional small airways disease on CT",
                            "description": "Functional small airways disease, calculated from gas trapping on non-contrast expiratory and inspiratory CT",
                            "timeFrame": "6 weeks"
                        },
                        {
                            "measure": "Lung function",
                            "description": "Spirometry measures of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and FEV1/FVC",
                            "timeFrame": "6 weeks"
                        },
                        {
                            "measure": "Platelet activation measures",
                            "description": "Platelet activation measures by flow cytometry: circulating monocyte-platelet aggregates (unstimulated), activated GPIIb/IIIa receptor, unstimulated, and stimulated by low and high dose arachidonic acid and adenosine diphosphate, and P-selectin on the platelet surface, unstimulated, and stimulated by low and high dose arachidonic acid and adenosine diphosphate. Also urine 11d-TXB2, plasma TXB2 and aspirin-triggered lipoxin A4",
                            "timeFrame": "6 weeks"
                        },
                        {
                            "measure": "FeNO",
                            "description": "Fraction of exhaled nitric oxide",
                            "timeFrame": "6 weeks"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria - COPD Cases:\n\n* COPD (FEV1/FVC \\< 0.7, FVC \\>= LLN), GOLD Stage I/II/III (FEV1 \\>= 40%)\n* Current or former smoker of at least 10 pack years\n\nInclusion Criteria - Controls:\n\n* Normal lung function (FEV1/FVC \\>= 0.7, FEV1 and FVC \\>= LLN)\n* Current or former smoker of at least 10 pack years\n\nExclusion Criteria:\n\n* Platelet count \\< 150,000/dL or self-report of a bleeding disorder;\n* Regular use of aspirin, clopidogrel or another antiplatelet medication;\n* Allergy to aspirin, clopidogrel, albuterol or iodine/IV contrast;\n* BMI \\> 35;\n* History of intracranial hemorrhage, severe GI bleed or other life-threatening bleed;\n* Use of blood thinner (e.g. warfarin, lovenox or novel oral anti-coagulants);\n* Continuous use of supplemental oxygen at home;\n* Regular use of an NSAID;\n* Daily use of oral steroids, theophylline, roflumilast, or loop diuretics;\n* History of organ transplant or autoimmune disease on systemic therapy (rheumatoid arthritis, lupus);\n* Use of a biologic medication with regular injections;\n* Other current lung disease (interstitial lung disease, idiopathic pulmonary fibrosis, asthma);\n* IV drug use within the last year;\n* History of lung surgery to remove part of the lung;\n* Known bullae or advanced destructive emphysema in more than 1/3 of the lungs;\n* Treatment for cancer (systemic therapy or surgical/radiation within the thorax) in the last 12 months;\n* Known diagnosis of pulmonary hypertension;\n* Known systolic heart failure (RV or LV EF \\< 40%);\n* Acute or chronic renal insufficiency (estimated glomerular filtration rate \\[GFR\\] \\<60 mL/min/1.73 m2 or self-report). GFR will be calculated using the CKD-EPI equation;\n* Current or planned pregnancy in the next year;\n* Regular marijuana smoking;\n* Exacerbation of respiratory symptoms within the previous 6 weeks, such as that requiring hospitalization, oral prednisone or antibiotics to control symptoms, or longer and not yet returned to baseline; and\n* Chest, abdominal or eye surgery, or a heart attack or stroke, within the last 3 months.",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "50 Years",
                    "maximumAge": "80 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Carrie L Pistenmaa, MD, MS",
                            "role": "CONTACT",
                            "phone": "617-732-8201",
                            "email": "arc@partners.org"
                        },
                        {
                            "name": "Maria A Cinelli",
                            "role": "CONTACT",
                            "phone": "617-732-8201",
                            "email": "arc@partners.org"
                        }
                    ],
                    "overallOfficials": [
                        {
                            "name": "Carrie L Pistenmaa, MD, MS",
                            "affiliation": "Brigham and Women's Hospital",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Brigham and Women's Hospital",
                            "status": "RECRUITING",
                            "city": "Boston",
                            "state": "Massachusetts",
                            "zip": "02115",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Carrie Pistenmaa, MD, MS",
                                    "role": "CONTACT",
                                    "phone": "617-732-8201",
                                    "email": "arc@partners.org"
                                }
                            ],
                            "geoPoint": {
                                "lat": 42.35843,
                                "lon": -71.05977
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO",
                    "description": "This is a small single-center study, we do not plan to share participant level data"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D029424",
                            "term": "Pulmonary Disease, Chronic Obstructive"
                        },
                        {
                            "id": "D008173",
                            "term": "Lung Diseases, Obstructive"
                        },
                        {
                            "id": "D011656",
                            "term": "Pulmonary Emphysema"
                        },
                        {
                            "id": "D004646",
                            "term": "Emphysema"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D008171",
                            "term": "Lung Diseases"
                        },
                        {
                            "id": "D012140",
                            "term": "Respiratory Tract Diseases"
                        },
                        {
                            "id": "D002908",
                            "term": "Chronic Disease"
                        },
                        {
                            "id": "D020969",
                            "term": "Disease Attributes"
                        },
                        {
                            "id": "D010335",
                            "term": "Pathologic Processes"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M11170",
                            "name": "Lung Diseases, Obstructive",
                            "asFound": "Obstructive Pulmonary Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M23449",
                            "name": "Pulmonary Disease, Chronic Obstructive",
                            "asFound": "Chronic Obstructive Pulmonary Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M14510",
                            "name": "Pulmonary Emphysema",
                            "asFound": "Emphysema",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M7812",
                            "name": "Emphysema",
                            "asFound": "Emphysema",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M11168",
                            "name": "Lung Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M28858",
                            "name": "Vascular System Injuries",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14977",
                            "name": "Respiratory Tract Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M6147",
                            "name": "Chronic Disease",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22700",
                            "name": "Disease Attributes",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T1303",
                            "name": "Chronic Graft Versus Host Disease",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC08",
                            "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "BC14",
                            "name": "Heart and Blood Diseases"
                        },
                        {
                            "abbrev": "BC26",
                            "name": "Wounds and Injuries"
                        },
                        {
                            "abbrev": "Rare",
                            "name": "Rare Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000077144",
                            "term": "Clopidogrel"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D045505",
                            "term": "Physiological Effects of Drugs"
                        },
                        {
                            "id": "D045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        },
                        {
                            "id": "D010975",
                            "term": "Platelet Aggregation Inhibitors"
                        },
                        {
                            "id": "D058921",
                            "term": "Purinergic P2Y Receptor Antagonists"
                        },
                        {
                            "id": "D058919",
                            "term": "Purinergic P2 Receptor Antagonists"
                        },
                        {
                            "id": "D058914",
                            "term": "Purinergic Antagonists"
                        },
                        {
                            "id": "D058905",
                            "term": "Purinergic Agents"
                        },
                        {
                            "id": "D018377",
                            "term": "Neurotransmitter Agents"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M1669",
                            "name": "Clopidogrel",
                            "asFound": "Back",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M4548",
                            "name": "Aspirin",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M13865",
                            "name": "Platelet Aggregation Inhibitors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M29294",
                            "name": "Purinergic P2Y Receptor Antagonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20504",
                            "name": "Neurotransmitter Agents",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "PlAggInh",
                            "name": "Platelet Aggregation Inhibitors"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Antipy",
                            "name": "Antipyretics"
                        },
                        {
                            "abbrev": "Infl",
                            "name": "Anti-Inflammatory Agents"
                        },
                        {
                            "abbrev": "ARhu",
                            "name": "Antirheumatic Agents"
                        },
                        {
                            "abbrev": "FiAg",
                            "name": "Fibrinolytic Agents"
                        },
                        {
                            "abbrev": "Analg",
                            "name": "Analgesics"
                        }
                    ]
                }
            },
            "hasResults": false
        }
    ],
    "nextPageToken": "NF0g5JuGl_gq"
}